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ABSTRACT 
 Tuberculosis is an important health concern for Asian elephant (Elephas maximus) populations 
worldwide.  Most infections are due to Mycobacterium tuberculosis, the cause of human tuberculosis, 
though mechanisms underlying elephant susceptibility are unknown.   In humans and other studied 
species, disease progression is dependent on the character of the host immune response.  Following 
infection, leukocytes secrete protein mediators (cytokines) that orchestrate immune responses.  
Importantly, measurement of TH1 (cell-mediated) and TH2 (humoral) cytokine levels within clinical 
samples can provide valuable information regarding immune function during health and disease that may 
elucidate disease susceptibility.  Disturbances in the balance between host cell-mediated and humoral 
components of the immune response are central to tuberculosis pathogenesis.  Upon exposure, most 
humans mount an appropriate and effective TH1 dominant immune response, and consequently only 5-
10% of humans become infected and develop active tuberculosis.  In these susceptible individuals, 
inadequate systemic TH1 responses have been documented with progression of disease.  Currently, there 
is a paucity of information available on elephant immune function.   Considering altered immune 
responses to tuberculosis are believed to be instrumental in determining disease susceptibility and 
influencing pathogenesis in humans, it is plausible that immune function alterations may similarly 
contribute to tuberculosis in Asian elephants.  Therefore, this study was undertaken to investigate 
systemic and local (pulmonary) immune responses in Asian elephants with tuberculosis.   
To develop molecular tools for assessment of elephant immune function, partial mRNA 
sequences for Asian elephant interleukin (IL)-2, IL-4, IL-10, IL-12, interferon (IFN)-, tumor necrosis 
factor (TNF)-, transforming growth factor (TGF)-, glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH), and  actin were determined.  Sequence information was then utilized to design elephant-
specific, quantitative, real time RT-PCR and in situ hybridization assays for measurement of cytokine 
mRNA within samples.  Employment of these molecular techniques utilizing mRNA-based detection 
systems facilitated sensitive and specific cytokine detection and measurement in samples from a species 
for which commercial reagents were not available.  Real time RT-PCR assays were first used to assess 
normal variance in baseline cytokine levels both among different elephants and within individual 
elephants over time.  Variance of cytokine levels within multiple samples from individual elephants was 
shown to be lower than variance in cytokine levels among samples from different elephants, suggesting 
that normal variation in cytokine levels of individual elephants was not of sufficient magnitude to 
preclude identification of significant differences between animals.  In addition, cytokine level variance 
among normal Asian elephants was negligible in the cases of most analyzed cytokines.  Baseline mRNA 
levels of IL-4, IL-10, IL-12, IFN-, TNF-, and TGF- were then measured using the elephant-specific, 
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real time RT-PCR assays in unstimulated, RNA-preserved whole blood samples from 106 Asian 
elephants, 15% of which were Mycobacterium tuberculosis complex seropositive.  No statistically 
significant differences were detected between seropositive and seronegative groups for any of the 
examined cytokines, though trends towards higher baseline levels of TNF-, IFN- and IL-4 and slightly 
lower levels of TGF-, IL-10 and IL-12 were noted in the seropositive group.  
Because the majority of previous studies evaluating tuberculosis systemic immune responses and 
cytokine imbalances in humans and other species had utilized mitogen- and/or antigen-stimulated peripheral 
blood mononuclear cell (PBMC) cultures rather than unstimulated, baseline whole blood samples to assess 
differences between positive and negative groups, the next series of experiments evaluated proliferative 
responses and cytokine production in PBMC cultures from 8 tuberculosis negative and 8 positive, captive 
Asian elephants.  Standard PBMC culture techniques were first validated and optimized for use with the 
elephant samples.  Cultures were then stimulated with M. bovis purified protein derivative (PPD-B), M. 
tuberculosis culture filtrate protein (CFP)-10, and M. avium PPD (PPD-A).  Proliferation was assessed via 
brominated uridine incorporation.  Cytokine mRNA was measured in RNA extracted from cultures using 
the elephant-specific, real time RT-PCR assays.  Following stimulation with PPD-B and the mitogen, 
Concanavalin A, proliferation was higher in samples from positive elephants.  Fold differences in tumor 
necrosis factor (TNF)- and interleukin (IL)-12 values following stimulation with PPD-B and CFP-10 
were greater in the samples from positive elephants.  Levels of IFN- were also higher in the samples from 
positive elephants.   
With mycobacterial infection, local immunity is the first line of defense, and the character of the 
local immune response will determine disease progression.  In human and nonhuman primate latent 
disease, well-organized granulomas containing relatively low numbers of bacteria are associated with TH1 
cytokine expression.  In contrast,  human/nonhuman primate active disease is associated with poorly 
organized inflammatory infiltrates, extensive necrosis , and local imbalance in TH1/TH2 cytokine levels.  
No previous studies had been conducted evaluating the elephant local immune response to tuberculosis or 
associated histologic lesions.  To examine features of local immunity in elephants with tuberculosis, 
archival, formalin-fixed, paraffin-embedded lung samples from 5 tuberculosis negative and 9 tuberculosis 
positive, deceased Asian elephants were assessed.  Using routine light microscopy, pulmonary lesions 
were described and compared.  Additionally, lymphoid infiltrates within lesions were characterized by 
CD3 immunolabeling.  Finally, expression of TH1 and TH2 cytokines were determined using in situ 
hybridization (ISH) for cytokine mRNA.  In all elephant tuberculosis pulmonary lesions, infection was 
characterized histologically by granulomatous inflammation, and in most samples, inflammation was 
widespread and poorly organized with large central regions of necrosis and mineralization, similar to 
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morphologic changes associated with human/non-human primate active disease.  In the majority of these 
lesions, CD3 positive lymphocytes were rare.  In a single sample, inflammation consisted of well 
demarcated, quiescent granulomas with numerous CD3 positive lymphocytes, compatible with latent 
human/non-human primate tuberculosis pulmonary lesions.  Using ISH, IFN-, TNF-, and IL-4 mRNA 
were detected in a subset of the elephant pulmonary tuberculosis lesions;  expression typically occurred in 
viable portions of granuloma walls.   
The information on tuberculosis immunopathogenesis gained by this study represents a 
foundation for investigation of the immune response to this disease in elephants.  The results indicated 
that distinguishing features do exist in systemic immune responses between positive and negative animals 
and among pulmonary lesions of positive animals.  In the case of systemic immune responses assessed in 
peripheral blood samples, antigenic stimulation was required to produce noted differences in proliferation 
and cytokine production.  The distinction between positive and negative groups was not apparent in 
evaluated baseline, unstimulated samples.  Specifically, proliferative responses and production of TNF-, 
IL-12, and IFN- in response to stimulation with PPD-B and CFP-10 appeared to distinguish 
Mycobacterium spp. infected from uninfected individuals.  Results suggested these parameters are 
important to tuberculosis immunopathogenesis in this species and could serve as useful diagnostic 
markers and/or treatment monitoring tools.  Additionally, investigation of elephant pulmonary 
tuberculosis lesions revealed a spectrum of morphology suggestive of disease stage similar to that 
documented in humans/nonhuman primates.  Results also indicated that both TH1 and TH2 cytokines 
participate in the local immune response to mycobacterial infection.  Though results gained by this work 
have established a solid foundation for the continued investigation of elephant tuberculosis 
immunopathogenesis, much remains to be learned.  Additional and on-going investigations are necessary 
to further understanding of tuberculosis pathogenesis in elephants for the benefit of human and individual 
animal health as well as the long-term conservation of this endangered species. 
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CHAPTER 1: INTRODUCTION AND LITERATURE REVIEW 
1.1: Elephant tuberculosis 
1.1.1: Epidemiology 
 Tuberculosis is an important health concern among captive Asian (Elephas maximus) and, to a 
lesser extent, African (Loxodonta africana) elephants.  Since 1994, at least 50 culture confirmed cases 
have been diagnosed in the United States population (Mikota et al, 2001; Mikota et al, 2006; Mikota and 
Maslow, 2011; Miller, 2010).  In addition, there is concern that available diagnostics may underestimate 
the number of positive animals (Greenwald et al, 2009; Larsen et al, 2005; Lyashchenko et al, 2006; 
Lyashchenko et al, 2012; Mikota et al, 2001).  Most cases of tuberculosis in elephants have been due to 
Mycobacterium tuberculosis infections,
 
the cause of human tuberculosis, with fewer cases attributed to 
other Mycobacterium spp. (Mikota et al, 2001; Mikota et al, 2006; Mikota and Maslow, 2011; Miller, 
2010; Payeur et al, 2002).  Specifically, M. tuberculosis has been isolated from 46 Asian and 3 African 
captive U.S. elephants; M. bovis has been cultured from a single African elephant.  Within the current 
population, tuberculosis prevalence is approximately 18% in Asian and 3% in African elephants (Mikota 
and Maslow, 2011).  Various other nontuberculous Mycobacterium spp. have been isolated in the absence 
of associated lesions or disease, with the exception of 2 fatal cases of M. szulgai in African elephants 
(Lacasse et al; 2007).  Due to the endangered status and cultural importance of these animals, culling 
infected elephants is not a viable management option.  Consequently, the maintenance of such long-lived 
animals in captivity has important herd and human health implications (Mikota et al, 2001).  Infected 
elephants have been shown to pose a risk for human exposure (Michalak et al, 1998; Murphree et al, 
2011; Oh et al, 2002).  In fact, identical strains of bacteria have been isolated from elephants and humans 
in close contact providing evidence for zoonotic and/or anthropozoonotic transmission (Michalak et al, 
1998).   
 On a global scale, this disease has even greater importance considering approximately 1/3 of all 
Asian elephants are domesticated or in captivity.  Southeast Asia contains the world’s largest 
concentration of captive/domesticated Asian elephants.  Asia also has the highest human tuberculosis 
incidence, accounting for 60% of new cases globally (Bhatt and Salgame, 2007; Zuniga et al, 2012; 
www.who.int/mediacentre/factsheets/fs104).  In Southeast Asia, elephants are frequently utilized for work 
and eco-tourism resulting in close contact with human handlers.  Infected humans may serve as a 
reservoir for elephant disease and vice versa.  Recent serologic surveys suggest that elephant infection 
prevalence may equal or even surpass human infection prevalence in range countries (Mikota et al, 2006; 
Mikota and Maslow, 2011; Verma-Kumar et al, 2012).  Although tuberculosis has not yet been diagnosed 
in wild populations of Southeast Asian elephants, domesticated elephants are in close and frequent 
contact with their wild counterparts providing an opportunity for disease transmission.  In 
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domesticated/captive elephants, molecular typing has documented transmission between individuals in 
close contact (Mikota et al, 2001; Payeur et al, 2002).  The combination of high disease prevalence in the 
human population, close interaction between humans and domesticated elephants, and intermingling of 
domesticated and free-ranging elephants in Southeast Asia underscores the necessity of understanding 
tuberculosis pathogenesis in elephants for the benefit of human and individual animal health as well as the 
long-term conservation of this endangered species.  
1.1.2: Clinical signs and diagnosis 
 Tuberculosis in elephants most typically results in nonspecific, chronic, subclinical disease.  
When present, clinical signs may include weight loss, exercise intolerance, and occasionally coughing or 
abnormal discharges, but are often absent until disease is advanced. Disease manifestations are most 
commonly noted in aged or otherwise debilitated animals (Mikota et al, 2006; Mikota et al, 2001).  Of the 
50 confirmed U.S. cases, 31 were diagnosed antemortem by culture of clinical samples (mostly 
respiratory secretions), and 19 were diagnosed postmortem.  In some of these cases, clinical disease was 
never apparent, and lesions detected at necropsy were the only manifestations of infection (Mikota et al, 
2006; Mikota and Maslow, 2011; Schmitt, 2003).  Lesions detected at necropsy have ranged from focal 
quiescent pulmonary granulomas to regional or disseminated granulomatous inflammation affecting the 
lungs, thoracic and abdominal lymph nodes and liver (Mikota et al, 2001; Mikota and Maslow, 2011).   
Accurate diagnosis of elephant Mycobacterium spp. infections is challenging.  In other species 
including humans, diagnosis is achieved via intradermal tuberculin testing, thoracic radiography and/or 
immune response assays.  In adult elephants, chest radiographs are impossible, and intradermal tuberculin 
testing has proven unreliable for screening (Lewerin et al, 2005; Mikota et al, 2001).  Immune response 
assays utilized for screening in humans (i.e. QuantiFERON

 GOLD) are not currently validated or 
available for use in elephants.  However due to herd and public health concerns and because many 
infected individuals show no or only vague clinical signs of disease, routine annual testing of all captive 
elephants in the United States is required for surveillance.  Current recommendations described in the 
Guidelines for the Control of Tuberculosis in Elephants 2008 (www.aphis.usda.gov/ac/Eleph TB 
guidelines 2008.html) call for annual screening using both trunk wash mycobacterial cultures and 
serology.  For culture, three trunk wash samples are collected on separate days over the course of one 
week.  Cultures are then performed by qualified laboratories, such as the National Veterinary Services 
Laboratory.   
 Culture alone is notoriously insensitive for diagnosis of tuberculosis in elephants.  Infected 
elephants shed organisms in respiratory secretions only intermittently.  In addition, it can take up to 8 
weeks to obtain final culture test results (Mikota et al, 2001; Mikota and Maslow, 2011).  Recently, newer 
serologic tests have been developed, and due to enhanced sensitivity provided, serology is now included 
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as a recommended and reliable first line screening tool.  A unique feature of tuberculosis in elephants is a 
prominent associated humoral immune response that can be detected systemically via measurement of 
antibodies against mycobacterial antigens.  Though the humoral immune response noted in infected 
elephants does not appear to provide protection against disease, measurement of antibody responses has 
become a useful means of detecting infection serologically (Greenwald et al, 2009; Lyashchenko et al, 
2006; Lyashchenko et al, 2012).  For serologic screening, the Elephant TB STAT-PAK

 (Chembio, 
Medford, NY), a novel lateral flow antibody detection assay, is utilized.  The test employs a unique 
cocktail of several M. tuberculosis and M. bovis antigens and a blue latex bead-based signal detection 
system (Lyashchenko et al, 2006).  This test has undergone extensive experimental and clinical validation 
and has been shown to be 100% sensitive and 95% specific (Greenwald et al, 2009; Lyashchenko et al, 
2006; Lyashchenko et al, 2012).  Positive Elephant TB STAT-PAK

 results require confirmatory testing 
with the elephant tuberculosis multiple antigen print immunoassay (MAPIA) performed by Chembio 
Diagnostics.  A panel of 12 defined M. tuberculosis proteins is detected by test.  Previous studies have 
shown the 6 kDa early secretory antigenic target of M. tuberculosis (ESAT-6), M. tuberculosis culture 
filtrate protein (CFP)-10, and fusion proteins containing one or both of these molecules to be the 
dominant seroreactive proteins in tested tuberculosis positive elephants.  Though not yet commercially 
available, the elephant tuberculosis MAPIA has been shown to have 100% specificity (Greenwald et al, 
2009; Lyashchenko et al, 2012; Mikota et al, 2006).  The combination of these two serologic tests 
provides assurance false negatives and false positives will rarely occur.  Additionally, these assays have 
facilitated identification of infection in elephants up to 8 years prior to diagnosis by culture (Lyashchenko 
et al, 2006).  Though validation is on going, such findings indicate serology could have utility in 
identifying subclinically infected animals for earlier diagnosis. 
1.2: Mycobacterium tuberculosis 
 Mycobacterium tuberculosis is a Gram positive, acid-fast, aerobic, obligate intracellular pathogen 
capable of infecting a wide range of vertebrate hosts.  Human beings are the primary hosts of M. 
tuberculosis, and though infection and associated disease can affect a wide variety of host tissues, 
pneumonia is the most common manifestation.  Inhalation is the typical means of infection, and within 
the lung, most mycobacteria reside within alveolar macrophages (Raja, 2003).   
 Mycobacteria possess several virulence factors that facilitate evasion of host defenses and 
promotion of survival and growth within infected tissues.  One of the most important survival tactics 
employed by M. tuberculosis is manipulation of normal phagolysosomal maturation (Flynn and Chan, 
2003; Zuniga et al, 2012).  Phagocytes, such as macrophages, neutralize pathogens by a sequential 
process of engulfment and selective digestion.  Following phagocytosis of foreign material by a 
macrophage, engulfed material is contained within an endosome.  In order to neutralize and degrade 
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engulfed material, macrophage endosomes must fuse with activated lysosomes to form phagolysosomes.  
Activated lysosomes contain the antimicrobial compounds and enzymes required for microbial killing and 
digestion.  Importantly, fusion of activated lysosomes with endosomes facilitates acquisition of vacuolar 
ATPases that are responsible for acidification of the phagolysosome necessary for enzyme activation.  
The result of this process is exposure of the pathogen to a variety of host-derived products able to effect 
killing and degradation without damage to host tissue (Abbas and Lichtman, 2003).  Mycobacterium 
tuberculosis has been shown to influence the process of phagolysosomal maturation in several ways: 
secretion of mycobacterial products that discourage phagolysosomal fusion (mycobacterial sulfatides, 
excess ammonia); alteration of endosomal membrane transport proteins; exclusion of vacuolar ATPases 
(Flynn and Chan, 2001; Flynn and Chan, 2003; Raja, 2003; Zuniga et al, 2012). 
 Macrophage defenses rely heavily on the action of reactive oxygen and nitrogen intermediates 
generated by the oxidative burst.  Mycobacteria are capable of evading the toxic effect of these reactive 
intermediates by various means.  Mycobacterial components lipoarabinomannan and phenolicglycolipid I 
are potent free radical scavengers.  In addition, mycobacterial sulfatides interfere with macrophage 
oxygen free radical generation (Bryk et al, 2002; Flynn and Chan, 2001; Flynn and Chan, 2003; 
Kaufmann et al, 2005). 
 Once the mycobacteria have evaded killing by the above means, these pathogens can promote 
continued survival by altering host immune responses.  Mycobacterium tuberculosis is able to induce 
secretion of several host-derived anti-inflammatory mediators (Flynn and Chan, 2001; Toossi and Ellner, 
1998).  Mycobacterium tuberculosis is also able to interfere with antigen presentation necessary for T 
lymphocyte activation.  Inhibition of major histocompatibility (MHC) class II processing and presentation 
in infected cells is influenced by both mycobacterial lipoprotein antigens and pathogen-mediated 
secretion of the inhibitory cytokine, interleukin (IL)-10 (Zuniga et al, 2012).  The consequent dampening 
of the host immune response creates a more favorable environment for mycobacterial growth and 
survival. 
 All of these pathogen-derived virulence factors contribute to the success of M. tuberculosis 
infection.  However, mycobacterial factors alone do not determine the outcome of infection.  Numerous 
studies in humans and other species have shown that the character of the host immune response is central 
to influencing disease susceptibility and progression. 
1.3: Tuberculosis immunity 
 The mechanisms underlying tuberculosis susceptibility in elephants are unknown. Currently, 
information regarding elephant immune function is scarce (De Jong et al, 2003; Landolfi et al; 2009; 
Landolfi et al, 2010; Sreekumar et al, 2007).  In all species, generation of a specific, adaptive immune 
response to an infection is dependent on relative contributions of humoral and cell-mediated components 
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of the immune system (Abbas and Lichtman, 2003).  The interplay and ultimate balance between cell-
mediated and humoral responses are orchestrated by cytokines, secreted protein mediators that modulate 
immune cell proliferation and function.  The combined actions of various cytokines define the overall 
character of the immune response.  Cytokines are active both locally and systemically where they may 
have varying effects.  Based upon their role in the immune response, cytokines are categorized as TH1 
(cell-mediated) or TH2 (humoral).  In general, appropriate and protective immune responses are TH1-
dominated for intracellular pathogens and TH2-dominated for extracellular pathogens (Abbas and 
Lichtman, 2003; Kidd, 2003).  Measurement of specific cytokine levels locally and systemically can 
provide valuable information about the immune response during health and various states of disease 
(Abbas and Lichtman, 2003; Deveci et al, 2005; Dieli et al, 1999; Flynn and Chan, 2001; Jo et al, 2003; 
Kaufmann et al, 2005; Raja, 2003; Zuniga et al, 2012). 
 Though immune responses to tuberculosis are complex, a disturbance in the normal TH1 (cell-
mediated) / TH2 (humoral) balance often characterized by distinctive cytokine profiles has been 
recognized in all studied species (Bhatt and Salgame, 2007; Bhattacharyya et al, 1999; Boom et al, 2003; 
Cavalcanti et al, 2012; Cooper, 2009; Flynn and Chan, 2001; Kaufmann et al, 2005; Raja, 2003; Rhodes 
and Buddle et al, 2000; Rhodes and Palmer et al, 2000; Thacker et al, 2006, Thacker et al, 2007; Welsh et 
al, 2005; Zuniga et al, 2012).  In general, successful clearance of intracellular pathogens such as 
Mycobacterium spp. requires an adequate TH1-dominated immune response (Abbas and Lichtman, 2003; 
Kaufmann et al, 2005; Raja, 2003).  The majority of exposed humans are able to mount an effective TH1 
dominant immune response, and consequently only 5-10% of individuals exposed to M. tuberculosis 
become infected and develop clinical disease (Bhatt and Salgame, 2007; Cavalcanti et al, 2012; Flynn and 
Chan, 2001; Sundaramurthy and Pieters, 2007; Zuniga et al, 2012).  In these susceptible individuals, 
inadequate systemic TH1 responses have been documented with progression of disease (Al-Attiyah et al, 
2006; Al-Attiyah et al, 2012; Bhattacharyya et al, 1999; Demissie et al, 2004; Hussain et al, 2002; Kellar 
et al, 2011; Torres et al, 1998; Wang et al, 2012; Wassie et al, 2008).  
1.4: Cytokines in tuberculosis immunity 
 Several specific TH1 and TH2 cytokines have been recognized for their contribution to human 
tuberculosis immunopathogenesis.   
1.4.1: Interferon-γ 
Interferon (IFN)- is the prototypical TH1 cytokine that is essential for effective defense against 
mycobacterial infection (Brighenti and Andersson, 2012; Cavalcanti et al, 2012; Cooper, 2009; Flynn and 
Chan, 2001; Kaufmann et al, 2005, Raja, 2003; Zuniga et al, 2012).  It is secreted by T lymphocytes and 
results in activation of infected macrophages.  Macrophage activation is required for killing of 
intracellular mycobacteria and promotion of the cell-mediated immune response (Cavalcanti et al, 2012; 
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Raja, 2003).  Specific effects of IFN- include: increased transcription of macrophage phagocytic oxidase 
and inducible nitric oxide synthase genes for generation of reactive oxygen and nitrogen intermediates; 
increased macrophage expression of MHC I and II and co-stimulatory molecules for enhanced antigen 
processing and recognition; activation of vascular endothelial cells for promotion of T lymphocyte 
adhesion and extravasation; enhancement of macrophage interleukin (IL)-12 production; inhibition of TH2 
cell proliferation (Abbas and Lichtman, 2003).  Mice lacking IFN- and IFN- receptor genes are 
exquisitely susceptible to virulent M. tuberculosis infection.  Similarly, humans with defective IFN- and 
IFN- receptor genes are prone to variety of serious mycobacterial infections, including M. tuberculosis 
(Azad et al, 2012; Cavalcanti et al, 2012, Cooper, 2009; Flynn and Chan, 2001; Raja, 2003).   
1.4.2: Interleukin-12 
Interleukin-12 is another TH1 cytokine important in tuberculosis immunity (Cooper et al, 2007; 
Flynn and Chan, 2001; Mendez-Samperio, 2010).  It is secreted primarily by activated macrophages and 
acts on T lymphocytes.  In the presence of IL-12, naïve (TH0) T lymphocytes differentiate into the TH1 
lymphocytes that drive the cell-mediated immune response.  Interleukin-12 also stimulates T lymphocyte 
production of IFN- and enhances the cytolytic capabilities of CD8+ and cytotoxic T lymphocytes (Abbas 
and Lichtman, 2003).  Humans and mice with IL-12 or IL-12 receptor gene defects exhibit increased 
susceptibility to mycobacterial infection (Azad et al, 2012; Flynn and Chan, 2001; Mendez-Samperio, 
2010; Raja, 2003).   
1.4.3: Interleukin-2  
Interleukin-2 also participates in cell-mediated immune responses by promoting proliferation of 
activated lymphocytes.  It is secreted by activated T lymphocytes in small amounts directly at the site of 
activation and works in an autocrine and/or paracrine fashion to stimulate proliferation of other activated 
lymphocytes.  Interleukin-2 also induces secretion of T lymphocyte derived cytokines, such as IFN- and 
IL-4, and potentiates apoptotic cell death of activated T lymphocytes via the FAS-FAS ligand pathway.  
This IL-2 mediated promotion of activated T lymphocyte apoptosis provides important immune self-
regulation against autoimmune disease (Abbas and Lichtman, 2003).   
1.4.4: Tumor necrosis factor-α 
Tumor necrosis factor (TNF)- is a mediator of the innate immune response to a variety of insults.  
The principal biologic action of TNF- is recruitment and activation of neutrophils and monocytes in 
response to tissue damage or infection (Abbas and Lichtman, 2003).  In the case of mycobacterial infection, 
TNF- is synergistic with IFN- in increasing macrophage phagocytic and mycobactericidal activities 
within infected tissues.  Effective organization and maintenance of granulomas responsible for control of 
mycobacterial disease also requires TNF- (Brighenti and Andersson, 2012; Cavalcanti et el, 2012; Cooper, 
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2009; Ehlers, 2003; Natarajan et al, 2011).  Murine models of M. tuberculosis infection lacking TNF- or 
the TNF- receptor display a deficient granulomatous response.  Fewer granulomas form, and those that do 
are disorganized and lack significant numbers of both activated or epithelioid macrophages and co-localized 
lymphocytes (Cavalcanti et al, 2012; Ehlers, 2003; Flynn and Chan, 2001; Kaufmann et al, 2005).  This 
cytokine is also believed to be important in modulation of the inflammatory response with M. tuberculosis 
infection.  Aberrant TNF- expression has been associated with host-mediated destruction of infected tissue 
that may contribute to clinical disease severity (Brighenti and Andersson, 2012; Ehlers, 2003; Flynn and 
Chan, 2001). 
1.4.5: Interleukin-4 
 The prototypical TH2 cytokine implicated in tuberculosis immunopathogenesis is IL-4.  This 
cytokine is secreted by TH2 lymphocytes and functions to induce the differentiation of naïve T lymphocytes 
into additional TH2 lymphocytes for promotion of humoral immunity.  Importantly, IL-4 serves as negative 
regulator of cell-mediated immunity by counteracting TH1 responses and the effects of IFN- (Abbas and 
Lichtman, 2003; Kidd, 2003).  In tuberculosis, IL-4 has been associated with active, progressive disease 
(Demissie et al 2006; Wassie et al, 2008).  Studies in gene knockout mice have reported reduced 
mycobacterial growth in the absence of IL-4.  In addition, relatively elevated levels of IL-4 seen in cases of 
progressive disease are believed to facilitate TNF--mediated tissue destruction and fibrosis.  In the absence 
of IL-4, murine tuberculosis models lack tissue destruction and fibrosis despite TNF- challenge (Raja, 
2003; Rook et al, 2004).   
1.4.6: Interleukin-10 
Interleukin-10 is another TH2 cytokine implicated in the immunopathogenesis of tuberculosis.  This 
cytokine can be produced by both macrophages and T lymphocytes, and its actions are largely anti-
inflammatory.  Interleukin-10 is responsible for suppression of T lymphocyte proliferation, macrophage 
deactivation, and down-regulation of IL-12 production (Abbas and Lichtman, 2003; Cavalcanti et al, 2012).  
In fact, as a survival strategy, M. tuberculosis can induce host production of IL-10 by infected macrophages 
to dampen protective cell-mediated immune responses (Redpath et al, 2001; Zuniga et al, 2012).   
1.4.7: Transforming growth factor-β 
Transforming growth factor (TGF)- is another TH2 cytokine with anti-inflammatory properties that 
can derail the protective TH1 immune response to tuberculosis.  This cytokine suppresses T lymphocyte 
responses by down-regulating IL-2-mediated proliferative signals.  Another effect of TGF- is macrophage 
deactivation both directly through inhibition of reactive oxygen and nitrogen intermediate generation and 
indirectly by counteracting effects of IFN- and TNF- (Abbas and Lichtman, 2003; Toossi and Ellner, 
1998).  Similar to IL-10, M. tuberculosis can induce host macrophages to secrete TGF-.  In addition, high 
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concentrations of TGF- at the site of infection have been associated with enhanced tissue destruction and 
fibrosis (Toossi and Ellner, 1998). 
1.5: Immunopathogenesis of human tuberculosis 
1.5.1: Infection and disease progression 
 Innate immunity is the first line of defense against mycobacterial infection.  In some cases, innate 
defenses are sufficient, and infection is thwarted.  In most exposed humans, however, innate immunity is not 
sufficient to prevent infection.  Adaptive, cell-mediated immune responses are then required to prevent 
progression of disease (Abbas and Lichtman, 2003, Natarajan et al, 2011; Raja, 2003).   
 Initially, in all infected humans, TH1 adaptive immune responses occur both locally and 
systemically.  In resistant individuals who account for approximately 90% of those infected, robust TH1 
responses are sustained and result in containment of disease.  These individuals often remain latently 
infected lifelong, though recrudescent disease is possible.  In susceptible humans, initial systemic TH1 
immune responses diminish with time.  This phenomenon is referred to as “peripheral anergy,” because the 
character of the systemic immune response does not reflect responses at the site of disease.  Diminished 
systemic TH1 responses are also often associated with relative increases in TH2 responses.  Consequently, 
human progressive disease may exhibit systemic TH2 dominance.  Finally, local TH1 immune responses 
begin to falter.  Local containment of disease fails, and widespread dissemination may ensue (Brighenti and 
Andersson, 2012; Cavalcanti et al, 2012; Flynn and Chan, 2001, Kaufmann et al, 2005). 
1.5.2: Systemic immune responses in human tuberculosis 
 Considering the importance of TH1 and TH2 cytokines to the immunopathogenesis of tuberculosis, 
numerous human studies have been conducted that compare systemic levels of these cytokines in patients 
with active clinical disease and in healthy, in-contact controls.  Altogether, findings of these human 
studies have been illustrative of TH1/TH2 imbalance that likely contributes to susceptibility and influences 
disease progression.  Many studies evaluating the human systemic immune response to tuberculosis have 
found that susceptible individuals with clinical disease exhibit lower systemic (peripheral blood) levels of 
IFN- than healthy controls (Bhattacharyya et al, 1999; Cavalcanti et al, 2012; Demissie et al, 2006; Hussain 
et al, 2002; Sanchez et al, 1994; Seah and Rook, 2001; Torres et al, 1999; Wassie et al, 2008); similar 
findings are typical of laboratory rodent models of human tuberculosis (Kaufmann et al, 2005; Raja, 2003).  
Some human studies, however, have reported higher levels of IFN- in patients than controls (Al-Attiyah et 
al, 2006; Demissie et al, 2004; Kellar et al, 2011; Kim et al, 2012).  These differences may be a consequence 
of duration of infection at the time of cytokine evaluation.  In both susceptible and resistant humans, the 
initial immune response following infection is characterized by TH1 domination that includes elevated IFN- 
levels.  In the resistant individuals, this response prevents disease.  In susceptible individuals, initial robust 
TH1 responses dwindle resulting in relative TH2 dominance and disease progression (Boussiotis et al, 2000; 
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Dlugovitzky et al, 1997; Flynn and Chan, 2001; Kaufmann et al, 2005; Raja, 2003).  Experimental 
methodology and means of cytokine detection have not been uniform in the many human studies, and thus 
these variables may also have impacted variation in findings. 
 Several human studies have linked a TH2-dominated systemic immune response, characterized by 
relatively elevated levels of IL-4, with human tuberculosis susceptibility (Bhattacharyya et al, 1999; 
Brighenti and Andersson, 2012; Demissie et al, 2006; Dlugovitzky et al, 1997; Sanchez et al, 1994; Seah 
and Rook, 2001; Surcel et al, 1994; van Crevel et al, 2000; Wassie et al, 2008).  Other similar studies failed 
to demonstrate a significant difference in IL-4 levels between patients and controls (Demissie et al, 2004; 
Torres et al, 1999).  It has been suggested that relative, as opposed to absolute, increases in IL-4 levels may 
influence disease.  According to these studies, decreased IFN-:IL-4 is characteristic of patients as compared 
with controls and has been identified as a feature of more advanced disease (Brighenti and Andersson, 2012; 
Flynn and Chan, 2001; van Crevel et al, 2000).  The role of IL-4 in tuberculosis immunopathogenesis is 
further complicated by the existence of IL-42, a splice variant of IL-4 lacking exon 2.  This IL-4 variant is 
found in primates, rabbits, and woodchucks, and functions as a natural antagonist of IL-4.  Though IL-42 
can be distinguished from IL-4 by RT-PCR, antibody-based assays, such as flow cytometry and ELISA, 
commonly used in previous studies are not discriminative.  Therefore, it is unknown how much, if any, IL-4 
detected and measured in most previous studies represents true and active IL-4 (Rook et al, 2004). 
 Increased systemic levels of the TH2 cytokine, IL-10, and decreased systemic levels of the TH1 
cytokine, IL-12, have been associated with tuberculosis susceptibility in humans (Al-Attiyah et al 2006; 
Boussiotis et al, 2000; Cavalcanti et al, 2012; Cooper, 2009; Cooper et al, 2007; Demissie et al, 2004; 
Dlugovitzky et al, 1997; Hussain et al, 2002; Kim et al, 2012; Mendez-Samperio, 2009; Song et al, 2000; 
Torres et al, 1999).  High levels of IL-10 have also been specifically correlated with increased clinical 
disease severity and patients that fail to react to tuberculin skin tests highlighting the key role of this 
cytokine in tuberculosis immunopathogenesis (Boussiotis et al, 2000; Dlugovitzky et al, 1997). 
 In regards to IL-2, results of human studies evaluating systemic levels in samples derived from 
peripheral blood have varied.  A proportion of studies have found systemic levels of IL-2 to be significantly 
lower in patients with active disease than healthy controls (Khanna et al, 2003; Sanchez et al, 1994; Talreja 
et al, 2003).  Some more recent studies evaluating systemic levels of multiple cytokines, including IL-2, 
following mycobacterial antigenic stimulation have detected increased levels of IL-2 in patients as 
compared with healthy controls (Kellar et al, 2011; Kim et al, 2012).  Levels of IL-2 are influenced by stage 
of disease; levels are lower in patients with advanced disease as compared with levels in mildly or 
moderately (potentially more recently infected) affected individuals (Dlugovitzky et al, 1997; Wang et al, 
2012).  This phenomenon could account for some discrepancies among previous studies.  In other cases, 
however, no significant differences in systemic IL-2 levels between patients and controls were found 
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(Torres et al, 1999).  Because, IL-2 is produced transiently and only at sites of T lymphocyte activation, 
systemic levels may be very low.  Variable assay sensitivity could further account for variable results among 
human studies.    
 Both TNF- and TGF- are most recognized for contributions to local immune responses at the site 
of infection or damage (Abbas and Lichtman, 2003).  These cytokines are detectable and active systemically 
as well, however, and thus have been measured in human peripheral blood samples to evaluate their 
contribution to tuberculosis immunopathogenesis.  Many studies have documented increased systemic levels 
of TNF- following mycobacterial antigen stimulation in patients as compared with healthy controls 
(Borgstrom et al, 2012; Cavalcanti et al, 2012; Kellar et al, 2011).  In a study that measured baseline levels 
of TNF-, no difference was found between human patients with active pulmonary tuberculosis and M. 
bovis bacillus Calmette-Guerin (BCG) vaccinated healthy controls.  In the same study, stimulation of 
isolated and cultured peripheral blood mononuclear cells with certain mycobacterial antigens resulted in 
higher TNF- levels in control samples (Al-Attiyah et al, 2006).  In another study, though mean secretion 
levels of TNF- were higher in patients, statistically significant differences between the groups were lacking 
(Hussain et al, 2002).  Altogether, findings indicate TNF- plays a role in human tuberculosis pathogenesis.  
The precise contribution of systemic TNF- to disease, however, may be dependent on disease stage.  With 
mycobacterial infection, TGF- is produced in excess and is primarily expressed locally at sites of active 
disease (Toossi and Ellner, 1998).  One study found that monocytes from human active tuberculosis patients 
constitutively express TGF- and have an expanded capacity to produce the cytokine upon in vitro 
stimulation with M. tuberculosis antigens (Toossi et al, 1995).  In concert with IL-10, TGF- functions as an 
inhibitory cytokine associated with active, progressive disease.  Elevated systemic levels have been 
documented in human tuberculosis patients providing support for the role of TGF- in tuberculosis 
immunopathogenesis (Olobo et al, 2001). 
1.5.3: Local immune responses in human tuberculosis 
 The same cytokines studied in investigations of the systemic immune response to tuberculosis are 
important locally at primary sites of mycobacterial infection.  Mycobacterium tuberculosis is an inhaled 
pathogen and consequently, most commonly infects the lungs of susceptible individuals.  Inhaled 
mycobacteria reside primarily within alveolar macrophages; these host cells provide the first line of local 
defense against established infection by secreting IL-12 and other inflammatory cytokines to initiate a 
protective cell-mediated immune response (Sundaramurthy and Pieters, 2007).  In resistant individuals, 
the combined effects of TH1 cytokines and other components of the cell-mediated immune response result 
in organized granulomatous inflammation, mycobacterial killing, and local containment of infection.  In 
susceptible individuals, the initial TH1 dominated response is not sustained.  Local levels of TH1 
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cytokines, such as IFN-, IL-12 and TNF-, decrease resulting in relative elevation of IL-4 levels.  
Secretion of other TH2 cytokines (IL-10, TGF-) is also increased.  The result is poorly organized 
granulomatous inflammation and ineffectual mycobacterial killing that facilitate disease progression 
(Bhatt and Salgame, 2007; Brighenti and Andersson, 2012; Raja, 2003, Schwander and Dheda, 2011; 
Sundaramurthy and Pieters, 2007; Zuniga et al, 2012).   
 Numerous human studies have sought to elucidate tuberculosis immunopathogenesis by 
comparing cytokine secretion both locally and systemically in active disease patients and healthy controls.  
Several have found that despite a lack of significant difference in systemic levels of TH1 cytokines as 
measured in PBMC cultures between patients and controls, patients can display increased production of 
both TH1 and TH2 cytokines locally as measured in mononuclear cells obtained by bronchoalveolar lavage 
(Barnes et al, 1990; Barnes et al, 1993; Boras et al, 2006; Brighenti and Andersson, 2012; Herrera et al, 
2009; Schwander and Dheda, 2011).  These findings form the basis for the hypothesis of “peripheral 
anergy” in tuberculosis immunology.  According to the hypothesis, susceptible individuals can be 
identified by their failure to display a systemically detectable TH1 immune response with active infection.  
Unfortunately, some studies have reported contrary results that weaken the hypothesis (Flynn and Chan, 
2001; Raja, 2003).  Because the immune response is a dynamic process influenced by both susceptibility 
and progression of disease, it is difficult to draw any definitive conclusions from these studies without 
knowledge of disease stage. 
 In situ studies evaluating the morphology of the local immune response and distribution of local 
cytokine expression have been informative.  Well-organized granulomas associated with low numbers of 
mycobacteria and latent disease are distinguished from the poorly-organized, multi-bacillary granulomas 
of active, progressive infection by several features.  Latent granulomas have richly vascularized walls and 
are typically solid with large numbers of activated, epithelioid macrophages.  Progressive granulomas are 
poorly vascularized and often contain large central regions of necrosis with few activated macrophages 
(Fuller et al, 2003; Ulrichs et al, 2005; Ulrichs and Kaufmann, 2006).  In addition, progressive 
granulomas of active disease are associated with decreased expression of IFN-, TNF-, and IL-12 
(Arriaga et al, 2002; Fenhalls et al, 2000; Fenhalls et al, 2002; Fuller et al, 2003; Smith et al, 2002; 
Ulrichs et al, 2005).  Local expression of IL-4 was only reported with progressive granulomas and often 
correlated with greater degrees of necrosis (Fenhalls et al, 2002).  Evaluation of bronchoalveolar lavage 
samples from active pulmonary tuberculosis patients has provided additional evidence of a local TH2 
immune response that likely impacts disease.  These samples have been shown to contain increased levels 
of IL-10 and TGF- (Bonecini-Almeida et al, 2004; Schwander and Dheda, 2011).   Mycobacterium-
induced secretion of IL-10 and TGF- by infected macrophages within lesions could account for this 
trend in susceptible individuals (Redpath et al, 2001; Toosi and Ellner, 1998). 
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1.6: Tuberculosis in cattle and deer 
In domestic cattle and several cervid species, tuberculosis is most commonly caused by 
Mycobacterium bovis infection.  Though the offending pathogen is not identical, disease associated with 
M. bovis in bovids and cervids closely resembles human tuberculosis due to M. tuberculosis.  In addition, 
studies investigating the immunopathogenesis of M. bovis infection suggest the host immune response 
plays a role in determining disease progression similar to the situation seen in M. tuberculosis-related 
human disease.  In fact, aberration in immune function appears to be the common thread among 
tuberculosis infections of all species studied to date, however, the precise character of documented 
aberrations is not constant.  Whether variation can be attributed to host or pathogen differences or some 
combination of the two remains to be determined.   
1.6.1: Systemic immune responses 
 In cattle and deer infected with M. bovis, the systemic immune response has been characterized 
by elevated levels of both IL-4 and IFN- (Hook et al, 1996; Palmer et al, 2004; Rhodes and Palmer et al, 
2000; Thacker et al, 2006; Thacker et al, 2007; Waters et al, 2006; Waters et al, 2003; Welsh et al, 2005).  
This contrasts with responses in human disease where differences in IL-4 levels are variable.  The 
immune response of cattle and deer susceptible to M. bovis infection is often described as TH0 dominated 
as opposed to TH1 or TH2 dominated.  Naïve or TH0 lymphocytes express both IFN- and IL-4 genes, and 
it is believed that this undifferentiated cytokine expression profile may contribute to disease susceptibility 
in infected cattle and deer. 
 Fewer studies have examined systemic levels of other cytokines in M. bovis infected deer and 
cattle.  In separate studies, Thacker et al measured levels of IL-10 in PBMC cultures of cattle and deer 
stimulated with mycobacterial antigen (Thacker et al, 2006; Thacker et al, 2007).  In the cattle, samples 
from infected animals had lower levels of IL-10 than those of uninfected controls.  In addition, among the 
infected animals, those with advanced disease as evidenced by more severe and widespread postmortem 
lesions, had lower systemic levels of IL-10 than infected animals with less advanced disease.  Overall, 
more robust systemic immune responses were associated with increased severity of disease in the 
examined cattle (Thacker et al, 2007).  These findings contrast with results of the study done by Welsh et 
al in which elevated levels of IL-10 were associated with more severe lesions in infected cattle (Welsh et 
al, 2005).  In the deer, no significant differences in levels of IL-10 were detected between samples from 
infected and uninfected animals.  Levels of TGF- were also measured in the deer samples, and similar to 
IL-10, no significant differences were noted (Thacker et al, 2006).  Thacker et al also reported increased 
levels of IL-12 and TNF- in PBMC cultures from infected deer and cattle, respectively (Thacker et al, 
2006; Thacker et al, 2007). 
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1.6.2: Local immune responses 
 Far less is known about the local immune response in M. bovis infected cattle and/or deer, 
because very few studies addressing this subject have been conducted.  Widdison et al evaluated cytokine 
expression in lymph node samples from BCG vaccinated and unvaccinated cattle challenged with M. 
bovis.  Expression profiles differed between the vaccinated and unvaccinated groups.  In the unvaccinated 
group, levels of IL-4, IL-10, IL-6, and TNF- decreased post-challenge with M. bovis; levels of IFN- 
and IL-12 remained constant.  In the vaccinated group, levels of IFN- decreased post-challenge while 
levels of IL-4 and IL-6 were unchanged.  Moreover, absolute levels of IL-4 and IL-10 were higher in 
samples from vaccinated than unvaccinated animals.  Overall, more advanced lesions and higher bacterial 
loads were correlated with decreased levels of IL-4, IL-10, and TNF-, characteristic of unvaccinated 
samples (Widdison et al, 2006).  These findings suggested that immune modulation, including enhanced 
expression of IL-4, IL-10, and TNF-, provided by vaccination limited the extent of local disease in the 
cattle.  In the Thacker et al study, lymph node cells adjacent to tuberculosis lesions were isolated from 
infected cattle and cultured.  Cells from lesions of greater severity expressed higher levels of IFN-, TNF-
, and IL-4 than cells from lesions of lesser severity (Thacker et al, 2007).  Witchell et al found higher 
mRNA levels of IFN-, TNF-, and IL-10 in lymph node samples from infected cattle as compared with 
uninfected controls.  Interleukin-4 mRNA levels were undetectable.  Additionally, in infected lymph 
nodes, higher IFN-/IL-10 values were associated with more severe lesions (Witchell et al, 2010).  
Results of these three studies conflict complicating any definitive interpretation of bovine local immune 
responses to tuberculosis.   In a recent study, M. bovis pulmonary granulomas in naturally infected fallow 
deer were characterized histologically and immunohistochemically.  Early stage granulomas were 
associated with higher numbers of macrophages and enhanced immunolabeling for inducible nitrous 
oxide synthase and IFN- as compared with later stage granulomas.  Local expression of TNF- was 
found to be low in all examined granulomas regardless of stage (Garcia-Jimenez et al, 2012). 
 In a single study, bovine systemic and local immune responses to tuberculosis were compared 
(Rhodes and Buddle et al, 2000).  Both PBMCs and lymph node cells were harvested from infected cattle 
and evaluated for proliferative responses and cytokine production following exposure to mycobacterial 
antigens.  No significant differences in proliferation or production of IL-2, IFN-, or TGF- were noted 
between PBMCs and lymph node cells.  Based upon these results the authors suggest that peripheral 
anergy despite active local immunity reported in cases of human tuberculosis does not occur in bovine 
tuberculosis (Rhodes and Buddle et al, 2000). 
 Unfortunately, the vast majority of studies investigating bovine and cervine tuberculosis have 
relied on experimental infection.  In addition, frequently, the number of study subjects has been quite 
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small.  In light of these constraints, it may not be appropriate to draw correlates with human studies of 
natural disease.  It remains to be determined whether elephant immune responses to M. tuberculosis 
infection will mirror responses characteristic of natural human disease, be similar to those noted in 
experimental M. bovis infection, or be completely unique from all previous reports in other species. 
 1.7: Study significance 
 Although the exact alterations vary among species, altered immune responses to tuberculosis are 
believed to be instrumental in determining disease susceptibility and influencing pathogenesis.  
Considering the impact of mycobacterial infection on individual elephant and herd health and the current 
paucity of knowledge regarding elephant immune function (particularly cell-mediated immune function), 
directed studies investigating the immunopathogenesis of tuberculosis in this species are crucial.  
Therefore, this study aims to characterize both local and systemic immune responses in tuberculosis 
infected and uninfected Asian elephants.  Results of this study will provide perspective on 
immunopathogenesis of tuberculosis in elephants, ideally elucidate mechanisms underlying increased 
disease susceptibility in this endangered species, and serve as a foundation for future research. 
 The information gained from this study may also have valuable clinical and management 
applications.  Treatment dosages and regimes for elephant tuberculosis infections continue to be evaluated 
and optimized (Miller, 2010).  Development of reliable tools for monitoring treatment efficacy is essential 
to facilitate protocol improvement.  Newly developed diagnostic tests such as the Multiple Antigen Print 
Immunoassay (MAPIA) and the Elephant TB STAT-PAK
®
 (Chembio, Medford, NY) have shown 
potential for early diagnosis and monitoring of treatment, although samples sizes of monitored animals 
remain relatively small (Greenwald et al, 2009; Larsen et al, 2005; Lyashchenko et al, 2006; Lyashchenko 
et al, 2012).  Evaluation of systemic cytokine expression may prove to be an important adjunct diagnostic 
and treatment-monitoring tool.  In humans, characteristic alterations in systemic cytokine expression 
compatible with tuberculosis have been detected in susceptible individuals prior to serologic evidence of 
infection, and resolution of altered cytokine expression has been correlated with treatment and clinical 
resolution of disease (Deveci et al, 2005; Dieli et al, 1999; Jo et al, 2003).  Detection of differences in 
peripheral blood IFN- levels following mycobacterial antigen stimulation between infected and 
uninfected individuals is the basis for first line, screening human tuberculosis diagnostics such as the 
QuantiFERON

 GOLD test (Manuel et al, 2008; Pai et al, 2008).  Confirmation of similar differences in 
systemic cytokine levels between tuberculosis positive and negative elephants could justify development 
of a similar test for use in elephants.  These clinical applications of cytokine expression monitoring 
illustrate practical as well as academic utility and further demonstrate how an understanding of immune 
function in disease can provide important and useful insight into disease pathogenesis and management of 
elephant populations worldwide. 
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1
CHAPTER 2: DEVELOPMENT OF ASIAN ELEPHANT-SPECIFIC CYTOKINE REAL TIME 
RT-PCR ASSAYS 
2.1: Abstract 
 Infectious disease is an important factor in Asian elephant (Elephas maximus) health and long-
term species survival.  In studying disease pathogenesis, it is important to consider not only the pathogen, 
but also the effectiveness of the host immune response.  Currently, there is a paucity of information 
available on elephant immune function.  Measurement of cytokine levels within clinical samples can 
provide valuable information regarding immune function during health and disease that may elucidate 
disease susceptibility.  To develop tools for assessment of elephant immune function, partial mRNA 
sequences for Asian elephant interleukin (IL)-2, IL-4, IL-10, IL-12, interferon (IFN)-, tumor necrosis 
factor (TNF)-, transforming growth factor (TGF)-, glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH), and  actin were determined.  Sequence information was then utilized to design elephant-
specific primers and probes for quantitative, real time, RT-PCR assays facilitating the measurement of 
cytokine mRNA.  Greater than 300 bps of Asian elephant mRNA sequence were determined for each 
cytokine of interest.  Consistent and reproducible, real time, RT-PCR assays with efficiencies of greater 
than 93% were also developed.   Assay sensitivities ranged from less than 1 to 4250 DNA copies, with the 
exception of IL-12, which had decreased sensitivity.  Employment of molecular techniques utilizing 
mRNA-based detection systems, such as real time, RT-PCR, facilitate sensitive and specific cytokine 
detection and measurement in samples from species for which commercial reagents are not available.  
Future studies utilizing these techniques to compare elephant immune function during health and in the 
face of infection will be useful for characterizing the contribution of the elephant immune system to 
disease. 
2.2: Introduction 
 The Asian elephant (Elephas maximus) is an endangered species listed in Appendix I of the 
Convention on International Trade in Endangered Species (CITES; www.cites.org/eng/app/appendices).  
Appendix I species are the most endangered, considered currently threatened with extinction (Nowak, 
1999).  In addition to factors such as habitat loss and human-animal conflict, infectious disease 
contributes to the endangered status of the Asian elephant.  Both free-ranging and captive Asian elephants 
are susceptible to a variety of infectious diseases (Schmitt, 2003; Mikota et al, 2001).  With infectious 
                                               
1 Chapter 2 methodologies and a subset of the results have been previously published by the author and 
are reprinted here with permission: Landolfi, J.A., Schultz, S.A., Mikota, S.K., Terio K.A., 2009. 
Development and validation of cytokine quantitative, real time RT-PCR assays for characterization of 
Asian elephant immune responses. Vet. Immunol. Immunopath. 131, 73-78. 
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disease, outcome is dependent on both direct pathogen-mediated damage to infected tissues and host 
immune system-mediated effects.  Host immune responses are modulated and enhanced by cytokines, 
protein mediators secreted by activated immune cells.  Cytokines act on immune cells both locally and 
systemically to regulate cell proliferation, differentiation, and activation.  The types of cytokines secreted 
by activated immune cells are dependent on the offending pathogen and host status at the time of 
infection.  Cell-mediated immune responses, driven by TH1 cytokines such as interferon (IFN)- and 
interleukin (IL)-12, are essential for control of intracellular pathogens.  Humoral immune responses, 
mediated by TH2 cytokines such as IL-4 and IL-10, are required for elimination of extracellular 
pathogens.  The overall balance of TH1 and TH2 cytokine levels determines the character, and thus 
effectiveness, of an immune response (Abbas and Lichtman, 2003; Kidd, 2003).  Therefore, measurement 
of cytokine levels within samples can provide important information about the immune response during 
health and various states of disease.  
 Disease susceptibility can be the result of aberrant or inadequate host immune responses that fail 
to control infection.  In humans, individuals susceptible to certain intracellular pathogens (Mycobacterium 
tuberculosis, Leishmania spp.) have been shown to have inadequate TH1 immune responses.  Resistant 
humans exposed to identical strains of the pathogens do not develop disease, suggesting the host immune 
response plays a crucial role in determination of susceptibility (Kaufmann et al, 2005; Kidd, 2003).  
Important infectious agents of Asian elephants include M. tuberculosis and Asian elephant 
endotheliotropic herpesvirus (Mikota et al, 2001; Mikota and Maslow, 2011; Richman et al, 2000; 
Richman et al, 1999; Schmitt, 2003).  Both agents are obligate intracellular pathogens requiring an 
adequate cell-mediated immune response for disease prevention.  The cause of Asian elephant 
susceptibility to these pathogens is unknown, though it would seem plausible that immune function 
alterations may contribute.  Currently, there is a paucity of information available on elephant immune 
function (De Jong et al, 2003; Sreekumar et al, 2007).  Molecular assays to facilitate the measurement of 
cytokines within elephant samples are one tool that is needed to better assess elephant immune function 
and determine the potential contribution of the elephant immune system to disease susceptibility.    
 For this study, Asian elephant partial mRNA sequences for interleukin (IL)-2, IL-4, IL-10, IL-12, 
interferon (IFN)-, tumor necrosis factor (TNF)-, transforming growth factor (TGF)-., glyceraldehyde 
3-phosphate dehydrogenase (GAPDH), and  actin were determined.  Sequences were then used to design 
elephant-specific, quantitative, real time, RT-PCR assays.  Resultant assays were employed to detect and 
measure cytokine mRNA within Asian elephant peripheral whole blood samples. 
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2.3: Materials and methods 
2.3.1: Samples 
 Peripheral whole blood samples from 16 adult, female, captive/domesticated Asian elephants 
were used in this study.  Seven of the elephants were tuberculosis seropositive based upon results of the 
Elephant TB STAT-PAK

 (Chembio, Medford, NY).  The remaining 9 elephants were seronegative.  For 
14 of the 16 elephants, blood was collected into EDTA anticoagulant tubes.  To preserve RNA, 1.25 ml of 
anticoagulated whole blood were immediately transferred to sterile 5 ml cryovials containing 3.25 ml of 
RNAlater (Ambion, Austin, TX).  Samples were inverted to mix and stored frozen at -80C for later 
analyses.  For the remaining two elephants, 2.5 ml of whole blood were collected directly into PAXgene 
Blood RNA tubes (PreAnalytix/Qiagen, Valencia, CA) and then stored at -80C for later analyses. 
2.3.2: RNA extraction and reverse transcription 
 For each RNAlater sample, RNA was extracted from 2 ml of the RNAlater-preserved whole 
blood using a commercially available kit (RiboPure Blood; Ambion) according to manufacturer’s 
instructions.  RNA was eluted with a total of 100 µl kit-supplied, elution solution.  Following extraction, 
samples were treated with DNAse (Ambion) to control for DNA contamination.  For the PAXgene 
samples, RNA was extracted from 2.5 ml of PAXgene RNA-preserved whole blood using a commercially 
available kit (PAXgene Blood RNA Kit IVD; PreAnalytiX/Qiagen) including an on-column DNAse 
digestion step (RNAse-free DNAse I set; Qiagen) according to manufacturer’s instructions.  RNA was 
eluted with a total of 80 µl kit-supplied elution buffer.  For all samples, 20 µl of RNA were reverse 
transcribed per sample in a 40-µl reaction using a commercially available kit (iScript cDNA synthesis kit; 
Bio-Rad, Hercules, CA).  Spectrophotometry and conventional PCR detection of two housekeeping 
genes, GAPDH and  actin, were used to confirm integrity of RNA extraction and reverse transcription. 
2.3.3: Determination of Asian elephant cytokine mRNA sequences 
 Cytokine sequencing primers were designed based upon consensus alignments of mRNA 
sequences for various species accessioned in Genbank.  Based upon availability for individual cytokines, 
sequences of Florida manatee (Trichechus manatus latirostris), bottlenose dolphin (Tursiops truncatus), 
harbor porpoise (Phocoena phocoena), orca (Orcinus orca), domestic horse (Equus callabus), domestic 
pig (Sus scrofa), domestic cow (Bos taurus), Bactrian camel (Camelus bactrianus), water buffalo 
(Bubalus bubalis), llama (Llama glama), chimpanzee (Pan troglodytes), and human were typically 
included in each alignment.  For IFN-, TNF-, and IL-4, Genbank accessioned Asian elephant sequences 
(IFN-: EU000432, EF203241; TNF-: AJ550768; IL-4: EU000424) became available during the course 
of the study and were subsequently included in consensus alignments.   Primer sequences were selected 
based upon relative consensus among available species.  Melting temperature and secondary structure of 
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candidate primers were analyzed using Primer Express 3.0 software (Applied Biosystems, Foster City, 
CA).   
 PCR reactions were conducted at 25 µl and included 10X PCR buffer with 15 mM MgCl2 
(Applied Biosystems), 200 µM dNTPs (Applied Biosystems), 6.25 pmol of each primer, and 1.25 units 
AmpliTaq Gold polymerase (Applied Biosystems).  Thermal cycling conditions included a 10 minute hot 
start at 95C followed by 35 cycles of denaturing at 94C for one minute, annealing at 55C for one 
minute, and extension at 72C for one minute.  Final extension was done at 72C for 5 minutes.  Assays 
were performed on a GeneAmp PCR System 9700 thermocycler (Applied Biosystems).  PCR products 
were visualized on a 1.5% agarose gel stained with ethidium bromide.  Products were purified using a 
commercially available reagent containing a mixture of exonuclease and shrimp alkali phosphatase 
(ExoSapit; Amersham Biosciences, Piscataway, NJ) and then sequenced using fluorescent dye 
terminators on an Applied Biosystems 3730XL 96-capillary automated DNA sequencer at a commercial 
facility (University of Chicago Cancer Research Center DNA Sequencing Facility).   
2.3.4: Development and validation of Asian elephant cytokine quantitative, real time RT-PCR assays 
 Asian elephant cytokine mRNA sequences determined in this study were used to design primers 
and probes for use in real time, RT-PCR assays.  Amplicons were selected to cross postulated gene 
intron-exon junction sites based upon location of these sites in the human genes (UCSC Genome 
Bioinformatics site, www.genome.ucsc.edu).  Products of conventional PCR reactions (master mix and 
cycling conditions as described above) using real time primers and either input elephant cDNA or DNA 
were examined via agar gel electrophoresis to confirm real time amplicons included intron-exon junctions 
sites.  Differences in product size for input cDNA and DNA as visualized on ethidium bromide-stained, 
1.5% agarose gels demonstrated inclusion of junction sites within real time amplicons.  After locations of 
real time amplicons were defined, Taqman minor groove binding (MGB) probes with attached 
fluorophores were designed for each cytokine using consensus alignments and Primer Express 3.0 
software (Applied Biosystems). 
To determine assay efficiency, standard curves were constructed for each cytokine using purified 
PCR product serial dilutions (1:1x10
3
 – 1:1x108).  Efficiency was calculated as 10(-1/slope) -1.  In order to 
determine primer concentration for optimal PCR amplification efficiency, a series of reactions were run 
with varying primer concentrations (250 nmol, 450 nmol, 700 nmol, and 900 nmol) for each cytokine.  To 
determine assay sensitivity, reactions were run using standard PCR product serial dilutions for each 
cytokine.  Standards were serially diluted until no amplification was detected by the real time RT-PCR 
assays.  Dilution concentrations were measured using spectrophotometry (SmartSpec Plus, Bio-Rad).  
The number of DNA molecule copy numbers in 10 l of a particular dilution was calculated using the 
concentration and molecular weight of the amplicon (copy number = [ng DNA * 6.022x10
23
] / [length 
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(bps) * 1x10
9
 ng/g * 650 g/mole of bps]).  The sensitivity of each assay was determined based upon the 
number of DNA molecule copies within the most dilute serial sample that still exhibited specific 
amplification.  
 All real time PCR reactions were run in a simplex format in triplicate and contained Taqman 
Gene Expression Master Mix (Applied Biosystems), 250 nmol probe, and RNAse-free water to a final 
reaction volume of 25 µl.  Reactions also included a commercially available exogenous, non-template, 
internal control (Taqman Exogenous Internal Control; Applied Biosystems) to confirm PCR amplification 
and detect potential amplification inhibitors within samples.  Thermocycling conditions included UNG 
activation at 50C for 2 minutes and AmpliTaq Gold enzyme activation at 95C for 10 minutes followed 
by 40 cycles of denaturation for 15 seconds at 95C and annealing/extension for one minute at 60C.  All 
assays were performed on the Applied Biosystems 7300 Real Time PCR System.  Amplification was 
monitored in the FAM channel for FAM-labeled probes (IL-2, IL-4, IL-10, IL-12, INF-, TNF-, TGF-) 
and in the NED channel for NED-labeled probes (GAPDH and  actin).  Representative replicates for 
each sample were then visualized on a 1.5% agarose gel developed with ethidium bromide to confirm that 
amplification represented single, appropriately-sized products. 
2.3.5: Evaluation of candidate housekeeping genes for normalization of cytokine gene expression 
 In order to evaluate potential housekeeping genes (HKGs) for use in this study, GAPDH and -actin 
levels were compared between RNAlater tuberculosis positive (N=7) and tuberculosis negative (N=7) 
samples using the elephant-specific real time, RT-PCR assays designed as described above.  Mean 
differences in housekeeping gene mRNA average Ct values between tuberculosis positive and negative 
subsets were analyzed using a Student’s t test.   
2.4: Results 
2.4.1: Asian elephant cytokine mRNA sequences 
 Prior to initiation of this study, little Asian elephant cytokine gene sequence information was 
available.  Genbank accessioned Asian elephant cytokine mRNA sequences were limited to IFN-, TNF-
, and IL-4, and all sequences were partial.  Sequencing in this study was necessary to facilitate later 
development of quantitative, real time, RT-PCR assays.  In the absence of published Asian elephant 
sequences, consensus primers were developed based upon alignments of cytokine mRNA sequences 
available in Genbank and used to determine partial cytokine cDNA sequences that included gene intron-
exon junctions.  Additional sequencing of genes for which published information was already available 
was pursued to ensure adequate intron-exon junction sites were included.  Genbank accession numbers 
for Asian elephant cytokine and HKG sequences obtained by this study are listed in Table 2.1.  For each 
cytokine, available sequences from up to 5 different individuals sequenced during the course of the study 
were accessioned. 
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2.4.2: Development and validation of real time RT-PCR protocols 
 Quantitative, real time RT-PCR assays were developed for measurement of Asian elephant 
cytokine mRNA within peripheral blood samples using sequence information determined above (Table 
2.2).  For all cytokines and both HKGs, real time amplicons included at least one intron-exon junction 
site.  Where possible, the probe or primers were designed to directly cross junction sites.  For some 
cytokines, junctions sites were located elsewhere within the amplicon.  Inclusion of gene intron-exon 
junctions in real time PCR amplicons ensured that any contaminant DNA remaining in samples, despite 
prior DNAse treatment, would not be amplified in the reactions.  For all cytokines and HKGs, 
conventional PCR reactions utilizing real time primers resulted in products of different sizes for input 
cDNA and DNA (see  actin example, Fig. 2.1).  In addition, agarose gel visualization of representative 
replicate samples from real time RT-PCR reactions revealed single, appropriately-sized bands for all 
cytokines, GAPDH, and  actin indicating assay-specific amplification of cytokine mRNA of interest. 
 For all cytokines and HKGs, highest amplification efficiency as determined from standard curve 
slopes was obtained using 900 nmol primer concentrations within the reactions (Table 2.3).  For all 
assays, optimal amplification efficiencies of 93% or greater were achieved using 900 nmol primer 
concentrations (Table 2.4). 
 Real time RT-PCR assay sensitivity varied among cytokines and HKGs evaluated.  The 
sensitivity of detection for each assay is listed in Table 2.4. 
2.4.3: Evaluation of candidate HKGs 
 For both candidate housekeeping genes, GAPDH and  actin, mean differences in average Ct 
values between tuberculosis positive and negative groups did not significantly deviate from zero (GAPDH p 
= 0.1693,  actin p = 0.4215). 
2.5: Discussion 
 Information regarding elephant immune function is scarce (De Jong et al, 2003; Sreekumar et al, 
2007).  In other studied species, however, it is recognized that the combined effects of host immune 
mediators and direct damage caused by offending pathogens determine disease outcome (Abbas and 
Lichtman, 2003).  Thus, understanding the dynamics of immune function during health and in the face of 
infection can provide valuable insight into disease susceptibility.  Assessment of cytokine levels within 
clinical samples provides a means to study immune function and understand the role of the immune system 
in disease development.   
 Because the majority of cytokines are typically present and active at low concentrations in blood 
and tissues, detection and quantitative measurement of cytokines can be challenging (Abbas and Lichtman, 
2003; Dallman et al, 1991; Doherty et al, 2005; Overbergh et al, 2003).  Sensitive detection systems are 
required.  Due to its high sensitivity, real time, RT-PCR is well suited to this application.  In addition, via 
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sequence-specific detection of cytokine mRNA of interest within samples, real time RT-PCR also offers 
exquisite detection specificity (Hayden, 2004; Leutenegger et al, 1999; Overbergh et al, 2003; Wittwer et al, 
2004).  Protein based detection systems (ELISA, Elispot, biologic assays), are useful for cytokine 
assessment in humans and many domestic species but rely on species-specific reagents (antibodies) that are 
typically not commercially available for most exotic species.  As a mRNA based detection system, real time 
RT-PCR does not require species-specific, commercial reagents facilitating its application in any species for 
which sequence information is available.  Real time RT-PCR is also desirable from the perspective of 
sample volume.  Other mRNA-based detection systems, such as Northern blot and ribonuclease protection 
assay require large amounts of RNA that may not be available with all samples (Dean et al, 1998; Hayden, 
2004; Leutenegger et al, 1999).  For all these reasons, development of quantitative, real time, RT-PCR 
assays for the measurement of cytokines within Asian elephant peripheral blood samples was pursued. 
 Prior to initiation of this study, little Asian elephant cytokine mRNA sequence information was 
available.  Thus, the first objective of the study involved sequencing of Asian elephant cytokine and 
housekeeping genes of interest.  For all genes, 300 bps or greater of mRNA sequence information was 
obtained.  Asian elephant cytokine and HKG sequence information was then utilized to design quantitative, 
real time, RT-PCR assays for measurement of cytokine mRNA within peripheral blood samples.   
 All cytokines of interest were consistently detected and measured within purified PCR product 
dilutions utilized for assay validation.  Assay efficiency was reproducible and minimally impacted by 
inclusion of Taqman exogenous internal positive control reagents.  Assay sensitivity varied among 
examined cytokines, likely reflecting constraints of limited available sequence and optimal assay design, 
including the necessity of designing real time RT-PCR amplicons across intron-exon junction sites.    
Simultaneous comparison of specific cytokine expression, as measured by real time RT-PCR, with 
that of a HKG provides a means to correct for variations in input RNA among samples as a result of RNA 
degradation, variation in extraction efficiency, or reverse transcription.  Candidate housekeeping genes are 
those displaying constitutive expression levels unaffected by variables of interest (Overbergh et al, 2003; 
Wittwer et al, 2004).  Comparisons of GAPDH and  actin baseline expression levels between tuberculosis 
positive and tuberculosis negative elephants in this study showed neither gene was significantly affected by 
tuberculosis infection status.  Consequently, both genes met the criteria of an appropriate HKG when 
comparing baseline cytokine levels in studies of elephant tuberculosis.    
  
   
 Asian elephant cytokine mRNA sequence information will be valuable to future studies 
investigating elephant immune function.  This information provides the foundation for the design and 
application of molecular techniques that assess the elephant immune system.   Asian elephant-specific real 
time RT-PCR assays developed by this study are useful for the evaluation of systemic immune responses 
within elephant peripheral whole blood samples.  Similar assays can likely be validated for use in a variety 
 29 
of clinical samples.  Utilization of these assays in future studies comparing systemic immune responses 
between healthy and diseased (i.e. tuberculosis or herpesvirus positive) elephants will begin to elucidate the 
contribution of the elephant immune system to disease susceptibility. 
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2.7: Table and Figures 
Table 2.1: Genbank accession numbers for Asian elephant cytokines and HKGs obtained by this study 
 
Cytokine/HKG Genbank accession numbers 
GAPDH FJ423086, FJ423087, FJ423088, 
FJ423089 
-actin FJ423082, FJ423083, FJ423084, 
FJ423085, FJ423112 
TNF- FJ423108, FJ423109, FJ423110, 
FJ423111 
TGF- FJ423104, FJ423105, FJ423106, 
FJ423107 
IFN- FJ423090, FJ423091 
IL-2 FJ423092, FJ423093 
IL-4 FJ423094, FJ42395 
IL-10 FJ423096, FJ423097, FJ423098, 
FJ423099 
IL-12 FJ423100, FJ423101, FJ423102, 
FJ423103 
 
Legend: Sequences from up to 5 different individual Asian elephants were accessioned for each gene 
dependent upon availability.
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Table 2.2: Asian elephant real time RT-PCR primers and probes 
 
Gene Primers Probe 
GAPDH F: 
2
AAGATCGTCAGCAATGCCTCC
23 
R: 
109
TTCTGGGTGGCAGTGATG
127 
82TGGAGGGACTCATGACC98 
 
-actin F: 
660
GGCAGGTCATCACCATTGG
678 
R: 
722
ACAGGATTCCATTCCCAGGAA
742 
689TTCCGCTGCCCCGAG703 
 
TNF- F: 
277
GAGATCCAAGTGACAAGCCTGTAG
295 
R: 
317
TGAAGTTGCCCCTCGGTTT
340 
297TTGTAGCAAACCCC310 
 
TGF- F: 
141
CGCCTGCTGAGGCAAAGT
158 
R: 
201
GAGGTAGCGCCAGGAATCATT
221 
181AGCTGTACCAGAAATATA198 
IFN- 
(158-265) 
F: 
158
GCAAGTGATTCAGATGTAGCGGA
180 
R: 
243
AAAGGAAACAATCTGGCTCTGAA
265 
208GAAGAACTGGAAAGAGGAG226 
IFN- 
(145-302) 
F: 
145
GGAATATCTTAATGCAACTGATTCA
171 
R: 
279
CCTGGTTGTCTTTCAAGTTGTCAA
302
 
208GAAGAACTGGAAAGAGGAG226 
IL-2 F: 
2
CAGCTCAGGAGCTACAGGGATCT
24 
R: 
94
GATGCTTTGACAAAAGGAATCCA
116 
44ATCTACGCAGCAACCAT60 
 
IL-4* F: 
217
ATCAAAACGCTGAACAGCCTCACA
235 
R: 
279
GTGTTCTTGGAGGCAGCAA
302 
236GACTGTAGCAGACGCCT252 
 
IL-10* F: 
373
CCCTGGGGGAAAAGCTGA
390 
R: 
502
CTCACGCATGGCTTTGTAGA
521 
424GATTTCTTCCCTGT437 
 
IL-12* F: 
437
CCATGAATGCAAAGCTTCTGAT
458 
R: 
533
TGTGGCACAGTCTCACTGTTGA
554 
491ACATGTTGGCAGCTAT506 
 
 
Legend: Postulated intron-exon junction sites crossed by primers or probes are indicated by bold and 
underlined bases within the respective sequences.  *Junction sites for IL-4, IL-10, and IL-12 are within 
the amplicon but are not within the primer or probe sequence.  All sequences are listed 5’ to 3’.  F = 
forward primer; R = reverse primer.  Superscript numbers refer to the location of the primer/probe within 
the Asian elephant sequence (Genbank accession numbers FJ423082 – FJ423112 as listed in Table 2.1) 
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Table 2.3: Asian elephant real time RT-PCR assay efficiency at varying primer concentrations 
 
Cytokine Primer conc. (nmol) Standard curve slope Efficiency (%) 
GAPDH 250 -3.65 87.9 
 450 -3.69 87.2 
 700 -3.51 90.6 
 900 -3.47 94.2 
 actin 250 -3.51 90.6 
 450 -3.6 89.5 
 700 -3.59 89.9 
 900 -3.46 94.5 
IL-2 250 -3.46 94.5 
 450 -3.46 94.5 
 700 -3.49 93.4 
 900 -3.4 96.8 
IL-4 250 -4.49 67 
 450 -3.81 83 
 700 -3.58 90.3 
 900 -3.38 97.6 
IL-10 250 -3.5 93 
 450 -3.42 96 
 700 -3.38 97.6 
 900 -3.36 98.4 
IL-12 250 -3.53 92 
 450 -3.54 91.6 
 700 -3.54 91.6 
 900 -3.43 95.7 
TNF- 250 -3.43 95.7 
 450 -3.42 96 
 700 -3.45 94.9 
 900 -3.39 97.2 
TGF- 250 -3.49 93.4 
 450 -3.43 95.7 
 700 -3.45 94.9 
 900 -3.4 96.8 
IFN- (158-265) 250 -4.45 67.8 
 450 -3.73 85.4 
 700 -3.49 93.4 
 900 -3.48 93.8 
IFN- (145-302) 250 -3.49 93.4 
 450 -3.43 95.7 
 700 -3.38 97.6 
 900 -3.39 97.2 
 
Legend: Efficiency is calculated as 10
(-1/slope)
 -1.  
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Table 2.4: Asian elephant real time RT-PCR assay efficiency and sensitivity 
 
Gene Standard 
curve slope 
Efficiency Sensitivity (dsDNA copy number) 
GAPDH -3.47 94.2% < 1 
 actin -3.46 94.5% < 1 
TNF- -3.39 97.2% < 1 
TGF- -3.40 96.8% 2990 
IFN- (158-265) -3.48 93.8% 4250 
IFN- (145-302) -3.39 97.2% 3 
IL-2 -3.46 94.5% 479 
IL-4 -3.38 97.6% 542 
IL-10 -3.36 98.4% 3620 
IL-12 -3.43 95.7% 42400 
 
Legend: Efficiency is calculated as 10
(-1/slope)
 -1.  Sensitivity represents the minimal detectable number of 
dsDNA copies within 10 µl of sample (copy number = [ng DNA * 6.022x10
23
] / [length (bps) * 1x10
9
 
ng/g * 650 g/mole of bps]).  DNA concentration was determined via spectrophotometry. 
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Figure 2.1: Conventional PCR amplification of Asian elephant -actin 
 
 
 
Fig. 2.1: Agarose (1.5%) gel stained with ethidium bromide: Conventional PCR amplicons using  actin 
real time PCR primers on cDNA and DNA are of different sizes confirming amplicons contain gene 
intron/exon junctions.  Lane 1: 100 base pair ladder; Lane 2: negative control; Lane 3: Asian elephant 
cDNA, 96 bps; Lane 4: Asian elephant DNA, approximately 190 bps; Lane 5: Asian elephant DNA, 
approximately 190 bps. 
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CHAPTER 3: PERIPHERAL BLOOD CYTOKINE LEVEL VARIATION IN NORMAL ASIAN 
ELEPHANTS 
3.1: Abstract 
 Infectious disease is an important factor in Asian elephant (Elephas maximus) health and species 
survival.  In studying disease pathogenesis, both the pathogen and the effectiveness of the host immune 
response must be considered.  Measurement of cytokine levels within clinical samples can provide 
information regarding immune function during health and disease that may elucidate disease 
susceptibility.  However, knowledge of normal variation in cytokine levels among healthy individuals is 
first required to facilitate interpretation of potentially significant differences in cytokines levels that may 
distinguish diseased and healthy animals.  Therefore, this study employed previously developed, 
elephant-specific real time RT-PCR assays to measure mRNA levels of interleukin (IL)-4, IL-10, IL-12, 
tumor necrosis factor (TNF)-, transforming growth factor (TGF)-, interferon (IFN)-, and  actin 
within serial RNA-preserved whole blood samples collected weekly from 10 captive, healthy Asian 
elephants.  The degree of normal variation in cytokine expression was determined both among different 
elephants and within individual elephants over time.  Variance of cytokine levels within multiple samples 
from individual elephants was shown to be lower than variance in cytokine levels among samples from 
different elephants, suggesting that normal variation in cytokine levels of individual elephants is not of 
sufficient magnitude to preclude identification of significant differences between animals.  In addition, 
cytokine level variance among normal Asian elephants was negligible in the cases of most analyzed 
cytokines.  Specifically, no significant variance was detected in IL-4, IL-12 and TGF- levels; variance in 
IL-10 values was attributed to presumed sample degradation among some samples.  Variance in TNF- 
values appeared to be relatively greater than other examined cytokines.  For IFN-, insufficient assay 
sensitivity impacted evaluation of variance. 
3.2: Introduction 
Survival of the Asian elephant (Elephas maximus), an endangered species listed in Appendix I of 
the Convention on International Trade in Endangered Species (CITES; 
www.cites.org/eng/app/appendices), is currently threatened by factors such as habitat loss and human-
animal conflict.  Additionally, infectious disease contributes to the endangered status of this species.  
Both free-ranging and captive Asian elephants are susceptible to a variety of infectious diseases (Schmitt, 
2003; Mikota and Malsow, 2011; Mikota et al, 2001).  With any infectious disease, outcome is dependent 
on both direct pathogen-mediated damage to infected tissues and host immune system-mediated effects.  
Host immune responses rely on cytokines, protein mediators secreted by activated immune cells that 
modulate and enhance immune defenses.  Cytokines act on immune cells both locally and systemically to 
regulate cell proliferation, differentiation, and activation.  Cytokines secreted by activated immune cells 
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differ depending on the offending pathogen and host status at the time of infection.  Cell-mediated 
immune responses, driven by TH1 cytokines such as interferon (IFN)- and interleukin (IL)-12, are 
essential for control of intracellular pathogens, whereas humoral immune responses, mediated by TH2 
cytokines such as IL-4 and IL-10, are required for elimination of extracellular pathogens.  The overall 
balance of TH1 and TH2 cytokine levels determines the character, and thus effectiveness, of an immune 
response (Abbas and Lichtman, 2003; Kidd, 2003).  Therefore, measurement of cytokine levels within 
samples can provide useful information about the immune response during health and various states of 
disease.  
 Currently, little information concerning the function of elephant immune system is available (De 
Jong et al, 2003; Landolfi et al, 2009; Sreekumar et al, 2007).  Molecular assays to facilitate the 
measurement of cytokines within elephant samples have been developed (Landolfi et al., 2009; 
Dissertation Chapter 2).  Without knowledge of the normal variation in cytokine levels among different 
elephants and within individual elephants over time, however, differences in isolated cytokine 
measurements may be difficult to interpret.  Consequently, this study was initiated to determine the 
degree of variation in baseline cytokine mRNA levels present in serial RNA-preserved peripheral whole 
blood samples collected weekly from 10 tuberculosis negative Asian elephants in good general health.  
The degree of normal variation was determined both among different elephants and within individual 
elephants over time.  In addition, variables such as age, sex, and presence of active osteoarthritis and/or 
foot lesions were evaluated for covariance with the cytokine variables. 
3.3: Materials and methods 
3.3.1: Samples 
 Peripheral whole blood samples from 10 United States captive Asian elephants housed at two 
separate facilities were used in this study.  With cooperation of each elephant, blood was collected from 
the ear vein into EDTA anticoagulant tubes.  To preserve RNA, 1.25 ml of anticoagulated whole blood 
were immediately transferred to sterile 5 ml cryovials containing 3.25 ml of RNAlater (Ambion, Austin, 
TX).  Samples were inverted to mix and stored frozen at -80C for later analyses.  For elephants 1-6, five 
consecutive weekly blood samples were obtained; for elephants 7-10, four consecutive weekly blood 
samples were obtained. 
3.3.2: RNA extraction and reverse transcription 
RNA was extracted from 2 ml of the RNAlater-preserved whole blood using a commercially 
available kit (RiboPure Blood; Ambion) according to manufacturer’s instructions.  RNA was eluted with 
a total of 100 µl kit-supplied, elution solution.  Following extraction, samples were treated with DNAse 
(Ambion) to control for DNA contamination.  For all samples, 40 µl of RNA were reverse transcribed per 
sample in an 80-µl reaction using a commercially available kit (iScript cDNA synthesis kit; Bio-Rad, 
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Hercules, CA).  Spectrophotometry and conventional PCR detection of the housekeeping gene (HKG),  
actin, were used to confirm integrity of RNA extraction and reverse transcription. 
3.3.3: Real time RT-PCR 
 Previously developed and validated elephant-specific, real time RT-PCR assays for the detection 
of interleukin (IL)-4, IL-10, IL-12, tumor necrosis factor (TNF)-, transforming growth factor (TGF)-, 
interferon (IFN)-158-265, and  actin were utilized in this study (Landolfi et al., 2009; Dissertation Chapter 
2).  All real time PCR reactions were run in a simplex format in triplicate and contained Taqman Gene 
Expression Master Mix (Applied Biosystems), 900 nmol of each forward and reverse primers, 250 nmol 
probe, and RNAse-free water to a final reaction volume of 25 µl.  Reactions also included a commercially 
available exogenous, non-template, internal control (Taqman Exogenous Internal Control; Applied 
Biosystems) to confirm PCR amplification and detect potential amplification inhibitors within samples.  
Thermocycling conditions included UNG activation at 50C for 2 minutes and AmpliTaq Gold enzyme 
activation at 95C for 10 minutes followed by 40 cycles of denaturation for 15 seconds at 95C and 
annealing/extension for one minute at 60C.  All assays were performed on the Applied Biosystems 7300 
Real Time PCR System.  Amplification was monitored in the FAM channel for FAM-labeled probes (IL-
4, IL-10, IL-12, INF-, TNF-, TGF-) and in the NED channel for the NED-labeled probe ( actin).  In 
addition to negative controls, each plate included cytokine/HKG-specific standards (diluted PCR product, 
1:1x10
6
 and 1:1x10
8
) used to monitor and control for interassay variation.  Amplification products of 
sample replicates were evaluated for consistency; variation among each sample’s replicate threshold 
amplification (Ct) values used in later quantitative calculations did not exceed two standard deviations of 
the mean.  Representative replicates for each sample were visualized on a 1.5% agarose gel developed 
with ethidium bromide to confirm that amplification represented single, appropriately sized products.   
 Fold differences (FD) were calculated using a modified  Ct (comparative Ct) method in which 
specific assay efficiency values were utilized (instead of the value of “2” that would assume 100% 
efficiency);  actin values were used for normalization (Ct = averaged cytokine Ct for Elephant X – 
averaged  actin Ct for Elephant X).  Values were calibrated two ways to accommodate evaluation of 
normal variation both within individuals and among elephants.  For assessment of variation within 
individuals over time, the normalized average Ct value (Ct) of the first sample from each elephant was 
used to calibrate all remaining samples from that individual.  For assessment of variation among 
elephants, the normalized average Ct value calculated from all samples was used for calibration.  
Normalized and calibrated (Ct) values were used to compute FD (assay efficiency-Ct) in cytokine 
mRNA amplification. 
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3.3.4: Statistical analyses 
 Analyses were performed using averaged Ct values, normalized average Ct values (Ct; 
normalized to  actin), and calculated FD for each sample.  The data were evaluated at each of these three 
levels to assess variance both in the raw, unmanipulated values obtained directly from real time PCR 
results as well as in calculated values (Ct and FD).  The calculated values take into consideration 
differences in input RNA that are essential to accurate quantification of samples.   
 Basic descriptive statistics were calculated for each data set (Average Ct, Ct, FD).  To assess the 
degree of variation in baseline cytokine levels within individual animals over time, within variation was 
compared to variation among all 10 animals for each cytokine of interest.  For each animal, within 
variance was calculated using the weekly consecutive samples from that individual.  Then for each 
cytokine, within variance values from all 10 animals were averaged to generate a single average within 
variance for Ct, Ct, and FD values.  The within variance value was compared to variance values 
calculated from among all 10 animals.   
 Analysis of Variance (ANOVA) computations were done to examine differences in mean values 
among animals.  For cytokines showing statistically significant differences across evaluated means, a 
multiple comparison (Tukey’s) method was employed to identify specific differences between animals.  
Simple and multiple linear regression models were also employed to identify potential covariance with 
other variables.  For these analyses, cytokine variance (calculated from Ct, Ct, and FD values) was the 
dependent variable, and individual and combinations of other potentially significant factors (age, sex, 
presence of active osteoarthritis and/or foot lesions, anti-inflammatory treatments) served as independent 
variables. 
3.4: Results 
 Demographic and clinical history information for all 10 study elephants is summarized in Table 
3.1.  All elephants were considered tuberculosis negative at the time of sample collection based upon 
negative results of previous trunk wash mycobacterial cultures.  All cytokines with the exception of IL-4 
and IFN- were detected and able to be quantified in all samples from all 10 elephants.  Interleukin-4 
failed to amplify in four of the examined samples: elephant 2 week 1 and week 3; elephant 7 week 2; and 
elephant 10 week 2.  In the majority of the samples, IFN- was not detected.  It could only be detected 
and quantified in samples from 3 animals (elephants 5, 9, and 10).  Samples that failed to amplify were 
excluded from subsequent analyses. 
 Descriptive statistical calculations for averaged Ct values and Ct values are summarized in 
Tables 3.2 and 3.3, respectively.  The highest Ct variance was noted for IFN- and IL-4.  Variance of 
Ct values for the remaining cytokines was substantially lower. 
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 Table 3.4 compares Ct variance within individual elephants over time to Ct variance among all 
elephants.  Average within variance for each cytokine is less than the among variance for that particular 
cytokine.  Similar findings were noted when comparing within and among variance values calculated 
from FD (data not shown).   
 Analysis of Variance (ANOVA) computations produced significant F ratios ( = 0.05) for TNF- 
(p = <0.0001; p = <0.0001) and IL-10 (p = 0.0007; p = 0.0032) using Ct and FD values, respectively.  
Calculated F ratios for IL-4, IL-12 and TGF- were not significant.  Using raw averaged Ct values, 
ANOVA computations for all cytokines produced insignificant F ratios. 
 In the case of IL-10, values from elephant 2, specifically, were identified by Tukey’s multiple 
comparison method as being responsible for the significant variance.  Comparisons among other 
elephants did not reveal significant differences.  For TNF-, the only significant difference to account for 
variance was between elephant 4 and 7 values.   
Regression analyses identified no significant covariates among examined variables (age, sex, 
presence of active osteoarthritis and/or foot lesions, anti-inflammatory treatments). 
3.5: Discussion 
 Two major findings regarding variance of baseline cytokine levels in peripheral blood samples 
from normal Asian elephants were established by this study.  First, variance of cytokine levels within 
multiple samples from individual elephants was shown to be lower than variance in cytokine levels 
among samples from different elephants.  This finding suggests that normal variation in baseline cytokine 
levels of individual elephants is not of sufficient magnitude to preclude identification of significant 
differences between animals.  Identification of such a trend provides validation for the use of single or 
few samples to represent the baseline cytokine levels within an individual, and also facilitates the 
comparison of cytokine levels between animals without the need for multiple samples/animal.  In 
addition, study analyses suggested outside factors, including age, sex, presence of active osteoarthritis 
and/or foot lesions, and anti-inflammatory treatments, do not impact baseline cytokine level variance.   
 Second, cytokine level variance among normal Asian elephants was negligible in the cases of 
most analyzed cytokines for which sufficient mRNA amplification data was available.  For IL-12 and 
TGF-, samples from all 10 elephants yielded detectable and quantifiable real time RT-PCR results with 
no significant differences among samples.  Similarly, no significant differences in IL-4 levels were 
identified among examined samples.  Such findings imply that all samples can be assumed to have 
originated from the same population with negligible variance.  In other words, results of this study 
suggest no significant variance exists in peripheral blood baseline levels of IL-4, IL-12 and TGF- of 
clinically normal Asian elephants.   
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For IL-10, however, ANOVA revealed significant variance in calculated Ct and FD values.  
Multiple comparison revealed that elephant 2 values were significantly different from other samples.  The 
 actin levels in two of the elephant 2 samples were substantially lower than the remaining elephant 2 
samples and samples from other elephants.  Because the  actin values are used to normalize sample 
values in both Ct and FD calculations to control for the amount of input RNA, the resulting values were 
significantly different.  Thus, in the case of elephant 2, the amount of input RNA (possibly due to 
variation in extraction efficiency or degradation in the samples) and not actual IL-10 levels, may have 
impacted assay performance and accounted for noted variance.  Though sample degradation was 
considered a possible contributing factor, blood from elephant 2 was shipped and, upon receipt at the 
laboratory, stored with the samples from elephants 1 and 3-6 that did not have the same low  actin 
levels.  Removal of elephant 2 from IL-10 ANOVA computations resulted in an insignificant F ratio.  
With TNF-, ANOVA results indicated significant variance was present, however, multiple comparison 
methods attributed variance to differences between only 2 elephants, elephant 4 and 7.  These results were 
not totally unexpected considering elephant 4 had some of the highest and elephant 7 some of the lowest 
Ct and FD values among all the examined samples.  Overall, these findings suggest that variance in 
TNF- levels of normal Asian elephants is greater than that of other examined cytokines.   
Assay sensitivity impacted analysis of IFN- variance.  The majority of examined samples failed 
to amplify.  Separate analysis of the samples with amplification was considered invalid due to the low 
number of samples.  Ultimately, in light of these hindrances, data available from the current study was not 
considered sufficient to evaluate variance in baseline IFN- levels of normal Asian elephants.  These 
findings suggest that baseline mRNA IFN- levels in Asian elephants are negligible in health and, thus 
consistent measurement may require immune cell stimulation and/or assays with enhanced sensitivity. 
An important caveat to this interpretation, however, is that sample size was relatively small and 
may have impacted results.  Similarly, regression analyses evaluating covariance of age, sex, and other 
factors must also be interpreted with caution due to limited sample size.  For example, only three male 
elephants were available for analysis, and these three animals were also the only elephants with active 
osteoarthritis and/or foot lesions and receiving anti-inflammatory treatments (Table 3.1).  Future studies 
on larger sample populations will be essential to confirm the preliminary findings on baseline cytokine 
variance in normal Asian elephants reported here. 
 Results of all analyses utilizing raw averaged Ct values showed no significant differences.  These 
findings confirmed variance attributable solely to interassay variability was nonexistent.  Therefore, it is 
important to note that variance discussed above could be specifically attributed to actual differences in 
cytokine levels detected within samples. 
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 Together, these findings represent baseline data regarding variance of peripheral blood cytokine 
levels in normal Asian elephants.  Future evaluation of greater numbers elephants will be necessary to 
further validate these findings and to establish clinically useful reference ranges for normal peripheral 
blood baseline cytokine levels.  Based upon the results reported here, negligible variance in levels of most 
examined cytokines within and among animals suggests useful normal reference ranges could be 
established.  Subsequently, clinical evaluation of peripheral blood cytokine levels may become a useful 
tool for routine assessment of elephant immune function. 
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3.7: Tables and Figures 
Table 3.1: Elephant demographic information and clinical history 
Elephant Age 
(years) 
Sex Osteoarthritis Foot lesions Anti-inflammatory 
treatments 
1 46 M - + - 
2 37 M + + + 
3 25 M + + + 
4 26 F - - - 
5 14 F - - - 
6 15 F - - - 
7 35 F - - - 
8 20 F - - - 
9 38 F - - - 
10 10 F - - - 
 
Table 3.2: Descriptive statistics for cytokine and housekeeping gene averaged Ct values  
 
Cytokine Total N Mean Median S.D. Range Variance 
 actin 46 19.81 19.39 1.95 10.17 3.8 
IL-4 42* 33.84 33.6 1.35 5.96 1.81 
IL-10 46 30.72 30.5 1.6 8.96 2.57 
IL-12 46 31.09 30.93 1.17 7.16 1.38 
TNF- 46 27.58 27.44 1.85 8.87 3.43 
TGF- 46 21.23 20.81 1.76 9.65 3.11 
IFN-158-265 11* 35.95 35.84 2.31 6.67 5.35 
 
*Statistical calculations for IL-4 excluded 4 non-amplifying samples.  Statistical calculations for IFN- 
excluded 35 non-amplifying samples. 
 
Table 3.3: Descriptive statistics for cytokine Ct values (cytokine values normalized to  actin) 
 
Cytokine Total N Mean Median S.D. Range Variance 
IL-4 42* 14.16 14.32 1.89 11.73 3.55 
IL-10 46 10.92 11.08 0.77 3.34 0.6 
IL-12 46 11.28 11.48 1.06 5.21 1.12 
TNF- 46 7.77 7.22 1.3 5.53 1.7 
TGF- 46 1.52 1.49 0.3 1.1 0.09 
IFN-158-265 11* 16.19 15.14 3.01 9 9.04 
 
*Statistical calculations for IL-4 excluded 4 non-amplifying samples.  Statistical calculations for IFN- 
excluded 35 non-amplifying samples. 
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Table 3.4: Comparison of average within and among variance calculated from Ct values 
 
Cytokine Among 
Ct 
variance 
Within Ct variance for each animal Average  
within Ct 
variance 1 2 3 4 5 6 7 8 9 10 
IL-4 11.03 0.59 20.92 0.29 2.60 12.26 1.04 23.20 2.03 1.06 37.52 10.15 
IL-10 0.60 0.50 0.42 0.10 0.53 0.48 0.22 0.12 0.01 0.44 0.77 0.36 
IL-12 1.12 0.53 0.42 0.19 1.13 3.68 0.91 0.16 0.32 0.08 2.16 0.96 
TNF- 1.70 0.28 0.07 0.11 0.63 1.03 1.98 0.28 0.07 0.15 1.27 0.59 
TGF- 3.13 0.09 29.38 0.05 0.05 0.14 0.02 0.01 0.02 0.11 0.18 3.00 
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CHAPTER 4: EVALUATION OF SYSTEMIC IMMUNE RESPONSES IN MYCOBACTERIUM 
TUBERCULOSIS COMPLEX SEROPOSITIVE ASIAN ELEPHANTS 
4.1: Abstract  
 Mycobacterium spp. infection is an important health concern for Asian elephant (Elephas 
maximus) populations worldwide.  The disease is of particular concern considering its potential to impact 
not only individual animal but also herd and public health.  Though elephant tuberculosis susceptibility is 
poorly understood, immune function alterations are central to disease pathogenesis in other species and 
likely impact outcome of mycobacterial infections in elephants.  Measurement of immune mediator 
(cytokine) levels within blood samples can provide information regarding immune function that may 
elucidate disease susceptibility.  For this study, baseline mRNA levels of interleukin (IL)-4, IL-10, IL-12, 
interferon (IFN)-, tumor necrosis factor (TNF)-, and transforming growth factor (TGF)- were 
measured using elephant-specific, real time RT-PCR assays in RNA-preserved whole blood samples from 
106 Asian elephants, 15% of which were Mycobacterium tuberculosis complex seropositive.  The 
Elephant TB STAT-PAK

, a novel lateral-flow antibody detection assay developed for specific use in 
elephants, was used to determine serologic status for the study.  No statistically significant differences 
were detected between seropositive and seronegative groups for any of the examined cytokines when 
levels were analyzed as continuous variables.  Seropositive animals had higher levels of TNF- and lower 
levels of TGF- than seronegative animals when cytokine levels were coded and analyzed as categorical 
variables.  Trends towards higher levels of IFN- and IL-4 and slightly lower levels of IL-10 and IL-12 
were noted in the seropositive group though differences between groups were not statistically significant.  
Presence of other inflammatory conditions was found to be a significant confounding variable in the 
analysis of the relationship between tuberculosis status and TNF- levels, necessitating its inclusion in 
statistical models.  Age and sex were not found to significantly affect the relationship between 
tuberculosis status and any of the cytokines measured.  These findings provide a foundation for future 
research into the immunopathogenesis of elephant tuberculosis.  
4.2: Introduction 
 The Asian elephant  (Elephas maximus) is an endangered species listed in Appendix I of the 
Convention on International Trade in Endangered Species (CITES; www.cites.org/eng/app/appendices; 
Nowak, 1999).  Infectious disease, in addition to factors such as habitat loss and human-animal conflict, 
contributes to the endangered status of the Asian elephant (Mikota et al 2001; Schmitt, 2003).  Of 
                                               
2 Chapter 4 methodologies and a subset of the results have been previously published by the author and 
reprinted with permission: Landolfi, J.A., Mikota S.K., Chosy, J., Lyashchenko, K.P., Giri, K., Gairhe, 
K., Terio, K.A., 2010. Comparison of systemic cytokine levels in Mycobacterium spp. seropositive and 
seronegative Asian elephants (Elephas maximus). J. Zoo Wildl. Med. 41(3): 445-455. 
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particular concern is Mycobacterium tuberculosis infection, the main cause of tuberculosis in humans 
(Angkawanish et al, 2010; Mikota et al, 2006; Mikota et al, 2001; Mikota and Maslow, 2011; Miller, 
2010; Payeur et al, 2002; Verma-Kumar et al, 2012).   Since 1994, at least 50 culture-confirmed M. 
tuberculosis complex cases have been diagnosed in the United States captive elephant population, and the 
majority of these cases have been due to M. tuberculosis specifically (Mikota et al, 2001; Mikota et al, 
2006; Mikota and Maslow, 2011; Miller, 2010).  In addition, there is concern that available diagnostics 
may underestimate the number of infected animals (Greenwald et al, 2009; Larsen et al, 2005; 
Lyashchenko et al, 2006; Lyashchenko et al, 2012; Mikota et al, 2001).  Similar to the disease in humans 
and other species, tuberculosis in elephants is a chronic infection (Mikota et al, 2001; Mikota and 
Maslow, 2011; Schmitt, 2003).  The maintenance of such long-lived animals in captivity has important 
herd and human health implications (Mikota et al, 2001).  Infected elephants have been shown to pose a 
risk for human exposure (Michalak et al, 1998; Murphree et al, 2011; Oh et al, 2002).  Identical strains of 
the bacteria have been isolated from elephants and humans in close contact (Michalak et al, 1998; Payeur 
et al, 2002).   
 This disease has even greater importance on a global scale.  Southeast Asia, home to 
approximately 1/3 of all captive working Asian elephants, also boasts the highest incidence of human 
tuberculosis at 60% of the global case total (Bhatt and Salgame, 2007; Zuniga et al, 2012; 
www.who.int/mediacentre/factsheets/fs104).  Though precise values have yet to be confirmed, recent 
serologic surveys suggest that elephant infection prevalence may equal or even surpass human infection 
prevalence in range countries (Mikota et al, 2006; Mikota and Maslow, 2011; Verma-Kumar et al, 2012).  
To date, 85% of the captive elephant population in Nepal has been tested, and 23% of these animals are 
tuberculosis seropositive (S. Mikota, unpublished data).  Southeast Asian elephants are used for work and 
ecotourism resulting in close contact with humans.  Infected humans may serve as a reservoir for elephant 
disease and vice versa.  Although tuberculosis has not yet been diagnosed in wild populations of 
Southeast Asian elephants, captive working elephants are in close and frequent contact with their wild 
counterparts providing an opportunity for disease transmission.  The combination of high disease 
prevalence in the human population, close interaction between humans and captive working elephants, 
and intermingling of captive working and free-ranging elephants in Southeast Asia underscores the 
necessity of understanding tuberculosis pathogenesis in elephants for the benefit of human and individual 
animal health as well as the long term conservation of this endangered species.     
 In all species, generation of a specific, adaptive immune response to an infection is dependent on 
the balance between humoral and cell-mediated components of the immune system (Abbas and Lichtman, 
2003).  The interplay and ultimate balance between cell-mediated and humoral responses is orchestrated 
by cytokines, secreted protein mediators that modulate immune cell proliferation and function.  Based 
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upon their role in the immune response, cytokines are categorized as TH1 (cell-mediated) or TH2 
(humoral).  In general, appropriate and protective immune responses are TH1-dominated for intracellular 
pathogens and TH2-dominated for extracellular pathogens (Abbas and Lichtman, 2003; Kidd, 2003).  
Because mycobacteria are intracellular pathogens, adequate production of TH1 cytokines including 
interferon (IFN)-, tumor necrosis factor (TNF)-, interleukin (IL)-12, and IL-2 are required for effective 
immunity.  Conversely, TH2-dominated responses with production of TH2 cytokines including IL-4, IL-
10, and transforming growth factor (TGF)- dampen cell-mediated responses and can lead to progression 
of Mycobacterium spp. infection (Abbas and Lichtman, 2003; Cavalcanti et al, 2012; Kaufmann et al, 
2005; Kellar et al, 2011; Raja, 2003; Wang et al, 2012; Zuniga et al, 2012).  Measurement of specific 
cytokine levels locally and systemically can provide valuable information about the immune response 
during health and various states of disease (Abbas and Lichtman, 2003; Flynn and Chan, 2001; Kaufmann 
et al, 2005; Raja, 2003; Zuniga et al, 2012).
 
 Though immune responses to tuberculosis are complex, a disturbance in the normal TH1/ TH2 
cytokine balance is central to disease pathogenesis in all studied species (Bhatt and Salgame, 2007; 
Bhattacharyya et al, 1999; Boom et al, 2003; Cavalcanti et al, 2012; Cooper, 2009; Flynn and Chan, 
2001; Kaufmann et al, 2005; Raja, 2003; Rhodes and Buddle et al, 2000; Thacker et al, 2006; Welsh et al, 
2005; Zuniga et al, 2012).  In humans, for example, the majority of exposed individuals are able to mount 
an effective TH1 dominant immune response, and consequently only 5-10% of humans exposed to M. 
tuberculosis become infected and develop clinical disease (Bhatt and Salgame, 2007; Cavalcanti et al, 
2012; Flynn and Chan, 2001; Sundaramurthy and Pieters, 2007; Zuniga et al, 2012).  In these susceptible 
individuals, inadequate systemic TH1 responses have been documented with progression of disease (Al-
Attiyah et al, 2006; Al-Attiyah et al, 2012; Bhattacharyya et al, 1999; Demissie et al, 2004; Hussain et al, 
2002; Kellar et al, 2011; Torres et al, 1998; Wassie et al, 2008). 
 
Considering altered immune responses to 
tuberculosis are believed to be instrumental in determining disease susceptibility and influencing 
pathogenesis in humans, it is plausible that immune function alterations may similarly contribute to 
Mycobacterium spp.-related disease in Asian elephants.  The mechanisms underlying tuberculosis 
susceptibility in elephants are unknown, and currently, information regarding elephant immune function is 
scarce (De Jong et al, 2003; Landolfi et al, 2009; Sreekumar et al, 2007).  This study aimed to characterize 
systemic immune responses in RNA-preserved, peripheral whole blood samples from 106 captive 
working Asian elephants in Nepal, 15% of which were tuberculosis seropositive, using quantitative, real 
time RT-PCR.   Previously designed and validated, elephant-specific assays were utilized to measure 
baseline mRNA levels of IL-4, IL-10, IL-12, IFN-, TNF-, and TGF- within the samples (Landolfi et 
al, 2009; Dissertation Chapter 2).  Ultimately, results were analyzed for differences in levels of TH1 and 
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TH2 cytokines between seropositive and seronegative samples to identify and characterize a potential 
systemic immune system contribution to Asian elephant tuberculosis susceptibility. 
4.3: Materials and Methods 
4.3.1: Samples 
 Peripheral whole blood samples from 106 captive working Asian elephants in Nepal were used in 
this study.  In Nepal, captive working elephants reside within multiple stables maintained by the 
government, private facilities (hotels and lodges), and national conservation organizations.  Housing 
among different stables is uniform and consists of roofed, open-sided enclosures with dirt and sand 
substrate.  Elephant diets consist primarily of native grasses; grass rations are supplemented with 
unhusked rice, molasses, and salt.  For the study, peripheral blood was collected from an ear vein into 
EDTA anticoagulant tubes.  To preserve RNA, 1.25 ml of anticoagulated whole blood were immediately 
transferred to sterile 5 ml cryovials containing 3.25 ml of RNAlater (Ambion, Austin, TX).  Samples 
were inverted to mix and stored frozen at -20C for approximately one month prior to transport to the 
United States.  Samples were transported in a liquid nitrogen dry shipper for importation.  In the United 
States, samples were stored at -20C at a collaborating facility for approximately 1 week prior to express 
overnight shipment on dry ice to the laboratory; upon receipt samples were stored at -80C until analyzed.  
At the time of sample collection, elephants also received complete physical examinations.  The presence 
of any concurrent condition associated with a potentially significant inflammatory response based upon 
subjective assessment by attending clinicians was noted.  Because reliable trunk wash mycobacterial 
cultures were not available, tuberculosis infection status was determined based upon the results of the 
Elephant TB STAT-PAK

 (Chembio Diagnostics, Inc., Medford, NY), a novel lateral-flow antibody 
detection assay developed for specific use in elephants.  Blood samples for serologic testing were 
collected at the same time as RNA-preserved blood sample collection.  Elephant TB STAT-PAK

 tests 
were run at the Chembio laboratory.  For the purposes of this study, samples reactive to the test were 
classified as seropositive, and samples non-reactive to the test were classified as seronegative. 
4.3.2: RNA extraction and reverse transcription 
 For each sample, RNA was extracted from 2 ml of the RNAlater-preserved whole blood using a 
commercially available kit (RiboPure Blood; Ambion) according to manufacturer’s instructions.  RNA 
was eluted with a total of 100 l kit-supplied, elution solution.  Following extraction, samples were 
treated with DNAse (Ambion) to control for DNA contamination.  To synthesize cDNA for use in real 
time PCR assays, 35 l of RNA were reverse transcribed per sample in a 70-l reaction using a 
commercially available kit (iScript cDNA synthesis kit; Bio-Rad, Hercules, CA).  Spectrophotometry 
(SmartSpec, Bio-Rad) and conventional PCR detection of two housekeeping genes (HKGs),  actin and 
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GAPDH, were used to confirm integrity of RNA extraction and reverse transcription.  PCR reactions 
were done at 25 l and included 10X PCR buffer with 15 mM MgCl2 (Applied Biosystems, Foster City, 
CA), 200 M dNTPs (Applied Biosystems), 6.25 pmol of each primer, and 1.25 units AmpliTaq Gold 
polymerase (Applied Biosystems).  Thermal cycling conditions included a 10-minute hot start at 95C 
followed by 35 cycles of denaturing at 94C for one minute, annealing at 55C for one minute, and 
extension at 72C for one minute.  Final extension was done at 72C for 5 minutes.  Assays were 
performed on a GeneAmp PCR System 9700 thermocycler (Applied Biosystems).  PCR products were 
visualized on a 1.5% agarose gel stained with ethidium bromide. 
4.3.3: Asian elephant cytokine quantitative, real time RT-PCR assays 
 Quantitative, real time RT-PCR assays previously developed and validated for specific use in 
elephant samples were utilized to measure mRNA levels of IL-4, IL-10, IL-12, IFN-158-265, TNF-, TGF-
, GAPDH, and  actin within the samples (Landolfi et al, 2009; Dissertation Chapter 2).  Within a subset 
of the samples (N=59), IFN- was also measured using a second, more sensitive IFN- assay, IFN-145-302 
(Dissertation Chapter 2).  All real time PCR reactions were run in a simplex format in triplicate (IL-4, IL-
10, IL-12, IFN-,  actin, GAPDH) or duplicate (TNF-, TGF-) and contained Taqman Gene 
Expression Master Mix (Applied Biosystems), 250 nmol probe, 900 nmol of both forward and reverse 
primers, and RNAse-free water to a final reaction volume of 25 l.  Reactions also included a 
commercially available exogenous, non-template, internal control (Taqman Exogenous Internal Control; 
Applied Biosystems) to confirm PCR amplification and detect potential amplification inhibitors within 
samples.  Thermocycling conditions included UNG activation at 50C for 2 minutes and AmpliTaq Gold 
enzyme activation at 95C for 10 minutes followed by 40 cycles of denaturation for 15 seconds at 95C 
and annealing/extension for one minute at 60C.  All assays were performed on the Applied Biosystems 
7300 Real Time PCR System.  Amplification was monitored in the FAM channel for FAM-labeled 
probes (IL-4, IL-10, IL-12, INF-, TNF-, TGF-) and in the NED channel for NED-labeled probes ( 
actin, GAPDH). In addition to negative controls, each plate included cytokine/HKG-specific standards 
(diluted elephant PCR product, 1:1x10
6
 and 1:1x10
8
) used to monitor and control for interassay variation.  
Amplification products of sample replicates were evaluated for consistency; variation among each 
sample’s replicate threshold amplification (Ct) values used in later quantitative calculations did not 
exceed two standard deviations of the mean.  Representative replicates for each sample were visualized 
on a 1.5% agarose gel stained with ethidium bromide to ensure amplification represented single, 
appropriately sized products.  Any samples that failed to amplify despite amplification of diluted (1:1x10
6 
and 1:1x10
8
) elephant PCR product standards and exogenous internal positive control DNA were 
analyzed for possible sequence polymorphism within the real time amplicon that could account for 
 50 
amplification failure.  A 300-600 bp segment of the cytokine gene of interest that included the real time 
amplicon was sequenced.  Obtained sequences were evaluated for any polymorphisms within the real 
time amplicon.   Relative quantification of cytokine mRNA amplification was determined using a 
modified  Ct (comparative Ct) method in which specific assay efficiency values were utilized (instead 
of the value of “2” that would assume 100% efficiency).  Replicate threshold amplification (Ct) values for 
each sample were averaged.  All samples were normalized to two HKGs,  actin and GAPDH.  For each 
cytokine, normalized average Ct values ( Ct) of samples from all seronegative animals lacking history of 
exposure to any seropositive elephants were averaged, and this value was used for calibration of all 
individual samples.  Resultant normalized and calibrated ( Ct) values determined for each sample were 
used to compute fold difference (assay efficiency
-Ct
) in cytokine mRNA amplification. 
4.3.4: Statistical analyses 
 Datasets were assessed for normality using the Shapiro-Wilk test prior to application of 
parametric analyses. To confirm validity of  actin and GAPDH as appropriate HKGs for normalization 
of real time RT-PCR data, average Ct values for all 16 seropositive and 16 randomly selected 
seronegative samples were evaluated using a paired t test. 
For all initial analyses, tuberculosis serologic status was evaluated as the dependent variable.  To 
evaluate the significance of individual cytokine level differences between seropositive and seronegative 
groups, student’s t tests (unequal population variance) were utilized.  For t tests, the cytokine fold 
difference was analyzed as a continuous independent variable.  Individual cytokine level differences were 
also examined using logistic regression.  For these analyses, the cytokine fold difference variable was 
coded categorically (high: >1; low: ≤ 1).  The value of “1” was used to distinguish groups categorically, 
because in light of Ct fold difference calculations, any individual sample average Ct value equaling the 
calibrator value (average of the seronegative, unexposed animal values) would result in a calculated fold 
difference of one for that sample.  Samples with fold difference values greater than one had higher 
cytokine levels than the calibrator; samples with fold difference values less than or equal to one had 
cytokine levels lower than or equal to the calibrator.  Logistic regression analyses were also conducted for 
all possible combinations of the categorical cytokine fold difference variables. 
 Additional analyses were then conducted to address influence of potential confounding variables 
such as age, sex, and presence of other inflammatory conditions at the time of sample collection.  For 
these analyses, cytokine fold difference was evaluated as the dependent variable.  Presence of other 
inflammatory conditions was assessed through physical examination at the time of sample collection; any 
condition associated with a potentially significant inflammatory response based upon subjective 
assessment by attending clinicians was considered in these analyses.  For the purpose of statistical 
analyses, this variable was coded categorically: 0 = no other significant disease present (N=62); 1 = other 
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potentially significant disease present (N=44).  Simple linear (continuous cytokine fold difference) and 
logistic (categorical cytokine fold difference) regression models with serologic status as the independent 
variable were evaluated first for each cytokine.  To address potential confounding variables, multiple 
linear regression models incorporating all possible combinations of serologic status, age, sex, and 
presence of other disease were then evaluated. 
4.4: Results 
 The majority of elephants were female (91/106) with a median age of 40 years, and range of 7-71 
years.  Based upon the Elephant TB STAT-PAK

 (Chembio) results, 16 (15%) elephants were 
tuberculosis seropositive and the remaining 90 (85%) elephants were seronegative.  No seropositive or 
seronegative elephants displayed any clinical signs suggestive of tuberculosis-related disease (weight 
loss, nasal discharge, coughing) at the time of initial sample collection.  Physical examination findings 
indicated all study animals were in general good health.  A proportion of the study animals (44/106; 42%) 
had minor and/or localized disease including focal subcutaneous or aural abscessation, colic, 
pododermatitis, open skin wounds, parasitism, and/or lameness.  Conditions in these animals were 
considered to be potentially associated with a systemic inflammatory response and thus were noted for 
inclusion in later statistical analyses.  Physical examination abnormalities such as cracked nails, abnormal 
nail growth, corneal plaques, and/or pregnancy were not considered to be associated with a systemic 
inflammatory response; such conditions were not among those evaluated for confounding in later 
statistical analyses. 
 Since the time of initial sample collection, six, three seropositive and three seronegative, of the 
study animals have died.   One of the deceased seropositive animals that died approximately one year 
following sample collection exhibited acute weight loss prior to death.  In another seropositive animal 
that died approximately one and a half years after sample collection, chronic weight loss and regurgitation 
over the course of one year prior to death was documented.  No promontory clinical signs were noted in 
the third deceased seropositive elephant that died three years after sample collection.  In all three 
seropositive animals, gross lesions compatible with tuberculosis were documented postmortem.  In one of 
these cases, postmortem culture was performed and confirmed infection.  No postmortem gross lesions 
compatible with tuberculosis were noted in the three deceased seronegative animals; culture was not done 
in these cases. 
 For all cytokines of interest, mRNA was amplified in the study samples using elephant-specific 
real time RT-PCR assays.  For all assays, amplification of exogenous internal positive control DNA 
confirmed PCR amplification.  Diluted elephant PCR product standards amplified as expected for all 
cytokines and HKGs ensuring consistent assay efficiency and minimal interassay variation.   
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 Interferon- mRNA did not amplify in 30 (28 seronegative and 2 seropositive) of the study samples 
using the IFN-158-265 assay but did amplify in these samples with the more sensitive IFN-145-302 assay.  
Amplification of diluted elephant PCR product standards and exogenous internal positive control DNA 
run with the samples excluded technical error as a likely cause of failed amplification in the first assay.   
In addition, analysis of a 500 bp sequence of the elephant IFN- gene that included the real time amplicon 
did not identify sequence polymorphisms to account for amplification failure in any of these 30 samples.    
The data set exhibited no significant departure from normality (Shapiro-Wilk; p = 0.061).  Mean 
differences in  actin and GAPDH average Ct values between tuberculosis seropositive and seronegative 
groups did not significantly deviate from zero (p = 0.4215 and p = 0.59, respectively) indicating either HKG 
was appropriate for normalization of the elephant samples.  In addition, differences in calculated fold 
difference values between seropositive and seronegative groups were similar regardless of which HKG was 
used for normalization.  Descriptive statistical calculations for averaged Ct values and Ct values ( actin 
normalized) of both seropositive and seronegative groups are summarized in Tables 4.1a/4.1b and 
4.2a/4.2b, respectively.  
 Seropositive samples generally had higher mean fold differences for IL-4, IFN-, and TNF- and a 
lower mean fold difference for TGF- than seronegative samples (Fig. 1).  No statistically significant 
differences were detected between seropositive and seronegative groups for any of the examined cytokines 
when cytokine fold difference values were analyzed as continuous variables (Table 4.3).  When cytokine 
fold difference was analyzed as a categorical variable, however, differences in TNF- and TGF- between 
groups were statistically significant (Table 4.3).  Evaluation of categorically coded cytokine values in 
combinations did not strengthen the predictive value of the model over TNF- or TGF- evaluated alone.  
Differences between groups for IL-4 and IFN- were not statistically significant in either continuous or 
categorical analyses (Table 4.3).   In the case of IFN-, no statistically significant differences were present 
between seronegative and seropositive groups irrespective of which IFN- assay was used for measurement.  
(Table 4.3).  Analysis of values obtained using the IFN-158-265 assay was completed excluding the 30 non-
amplifying samples.  Mean fold differences for IL-10 and IL-12 were slightly lower in the seropositive 
samples though standard errors of seropositive and seronegative samples for both cytokines overlapped.  No 
statistically significant differences were found (Fig. 1; Table 4.3).   
 Additional tests analyzing cytokine fold difference as the dependent variable and serologic status as 
the independent variable produced similar results to previous analyses.  Statistically significant differences 
were noted only for categorical TNF- and TGF- (p = < 0.05 for both).  Addition of age, sex, and/or 
presence of other inflammatory conditions variables to the model did not significantly affect the relationship 
between serologic status and categorical TGF- fold difference values.  For TNF-, the addition of presence 
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of other inflammatory conditions as a variable with serologic status already in the model did affect the 
relationship between serologic status and categorical TNF- fold difference values; statistically significant 
differences between seropositive and seronegative groups were present  (p = < 0.05).  No significant effect 
was noted with addition of age and/or sex variables to the model. 
4.5: Discussion 
 Human tuberculosis infections have been characterized by distinctive cytokine profiles indicative of 
TH1/TH2 imbalance; within susceptible individuals with active disease, systemic TH1 cytokine levels are 
decreased while TH2 cytokine levels are relatively increased (Cavalcanti et al, 2012; Demissie et al, 2004; 
Flynn and Chan, 2001; Kaufmann et al, 2005; Raja, 2003; Wassie et al, 2008).  Because, similar to humans, 
the majority of elephant tuberculosis infections are due to M. tuberculosis, (Mikota et al, 2006; Mikota and 
Maslow, 2011; Miller, 2010; Payeur et al, 2002) it was considered plausible that comparable TH1/TH2 
imbalance may contribute to elephant tuberculosis susceptibility.  However, significant differences in 
baseline systemic cytokine expression between tuberculosis seropositive and seronegative elephants 
evaluated in this study were lacking for the cytokines analyzed.  Additionally, in some cases, trends in 
cytokine expression between the two groups were contrary to those reported in some human studies (i.e. 
higher levels of TH1 cytokines, TNF- and IFN-, in seropositive as compared with seronegative elephants).  
Overall, baseline systemic cytokine levels of seropositive elephants evaluated in this study were modest.  
Though the data showed trends suggestive of elevations in baseline levels of both TH1 and TH2 cytokines in 
seropositive animals, statistically significant differences in cytokine mRNA expression (continuous FD 
values) between the two groups were lacking.  These results indicate that baseline cytokine levels 
measurable in unstimulated, peripheral whole blood via elephant-specific, quantitative, real time RT-PCR 
cannot reliably distinguish seropositive from seronegative individuals.   
Though it is certainly possible that fundamental differences exist between the human and elephant 
systemic immune response to tuberculosis, specific variables related to duration of infection at the time of 
evaluation and experimental design may partially account for discrepancies in results between previous 
human studies and the current elephant study.  Characteristic cytokine profiles with TH1/TH2 imbalance 
(decreased TH1 and relatively increased TH2 cytokine levels) described in human studies are associated with 
cases of progressive or active clinical disease (Al-Attiyah et al, 2006; Al-Attiyah et al, 2012; Bhattacharyya 
et al, 1999; Demissie et al, 2004; Flynn and Chan, 2001; Hussain et al, 2002; Kellar et al, 2010; Sanchez et 
al, 1994; Seah and Rook, 2001; Surcel et al, 1994; Torres et al, 1998; Wassie et al, 2008).  In elephants, 
mycobacterial infection is a chronic, subclinical disease that typically only manifests in aged and/or 
otherwise stressed individuals (Mikota et al, 2001; Mikota and Maslow, 2011; Schmitt, 2003).  In fact, 
several of the documented captive U. S. elephant tuberculosis cases have been diagnosed postmortem 
following death due to other causes (Mikota et al, 2006; Mikota and Maslow, 2011; Miller, 2010).  The 
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nature of the disease in elephants and limitations of current elephant tuberculosis diagnostics impair accurate 
identification of infection stage in this species (Greenwald et al, 2009; Larsen et al 2005; Lyashchenko et al, 
2006; Lyashchenko et al, 2012; Mikota et al, 2006).  Consequently, parallels to human tuberculosis 
immunopathogenesis reliant upon clinical manifestations of disease are difficult to extrapolate to elephants.  
Without specific knowledge of infection duration and disease stage in the study elephants, interpretation of 
the potential immunopathologic importance of noted cytokine level differences, or lack there of, between 
seropositive and seronegative samples is complicated.   
 In addition, the majority of previous studies evaluating tuberculosis systemic immune responses and 
cytokine imbalances in humans and other species have utilized mitogen- and/or antigen-stimulated 
peripheral blood mononuclear cell (PBMC) cultures rather than RNA-preserved whole blood samples to 
assess differences between positive and negative groups (Al-Attiyah et al, 2006; Al-Attiyah et al, 2012; 
Bhattacharyya et al, 1999; Flynn and Chan, 2001; Hussain et al, 2002; Rhodes and Buddle et al, 2000; 
Rhodes and Palmer et al, 2000; Sanchez et al, 1994; Seah and Rook, 2001; Surcel et al, 1994; Thacker et al, 
2006; Thacker et al, 2007; Torres et al, 1998; Welsh et al, 2005).  It may be that differences in some 
cytokine levels between seropositive and seronegative elephants are too small to be distinguished in 
unstimulated peripheral whole blood samples.  Most cytokines are potent mediators secreted in small 
amounts and degraded quickly to avoid nonspecific immune activation (Abbas and Lichtman, 2003).  
Cytokine gene transcription is similarly transient.  Consequently, some cytokine mRNA levels may be too 
low within peripheral blood samples to facilitate accurate comparison between groups.  Samples used in this 
study were collected in the field during large-scale health surveys of Asian elephants in Nepal; 
circumstances were not conducive to processing and handling necessary for preparation of PBMC cultures.  
In a few human studies where real time RT-PCR assays have been used to measure levels of IL-4 and IFN- 
in RNA extracted from unstimulated whole blood samples, elevated IL-4 and relatively diminished IFN- 
levels have been associated with tuberculosis susceptibility (Demissie et al, 2006; Wassie et al, 2008).  In 
these human studies, RNA extraction was performed immediately after collection.  Though elephant blood 
samples were preserved with RNAlater (Ambion) and frozen shortly after collection, RNA extraction was 
not performed until receipt at the lab approximately one month or more post collection.  Studies in other 
species have shown that delayed processing and extraction of whole blood samples may impact gene 
expression as measured by real time PCR detection of mRNA (Doherty et al, 2005; Sheridan et al, 2012).  
Constraints on sample processing due to the field nature of collection in this study may have impacted 
cytokine gene expression and thus levels of mRNA detectable within the elephant samples.  Though concern 
over these potential impediments existed prior to initiation of the study, it was considered worthwhile to 
attempt analyses using the whole blood samples because of availability and ease of acquisition and 
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processing for assay.  Regardless of results, this study was considered valuable towards the establishment of 
a foundation for future research into elephant immunity and tuberculosis immunopathogenesis. 
 It is also important to note that in this study, elephant tuberculosis status was assigned based upon 
the results of the Elephant TB STAT-PAK

 (Chembio), a serologic test, rather than culture.  According to 
the Guidelines for the Control of Tuberculosis in Elephants 2008 (www.aphis.usda.gov/ac/Eleph TB 
guidelines 2008.html), the Elephant TB STAT-PAK

 is currently recommended as a first-line screening 
test for tuberculosis diagnosis due to its exquisite sensitivity (Greenwald et al, 2009; Lyashchenko et al, 
2012).  This test employs a unique cocktail of selected M. tuberculosis and M. bovis antigens, including 
ESAT-6, CFP-10 and MBP83, for antibody detection.  The test has been shown to be 100% sensitive and 
95.2% specific.  Deficiency in specificity has been attributed in part to recognition of MBP83 antigen in 
few elephant cases of nontuberculous Mycobacterium spp. infections (Greenwald et al, 2009; 
Lyashchenko et al, 2006; Lyashchenko et al, 2012).  Though previous studies investigating the diagnostic 
utility of this test have shown seroreactivity is largely limited to cases of culture-confirmed M. tuberculosis 
complex infections, few cases of false positive results have been noted.  A proportion of tested elephants 
that were culture negative but previously exposed to a culture positive elephant displayed seroreactivity with 
the test (Greenwald et al, 2009).  In light of the poor sensitivity of trunk wash mycobacterial culture in 
elephants, however, it is possible that Elephant TB STAT-PAK

 “false positives” may represent true, 
early infections.  The test is able to detect antibodies of all immunoglobulin classes, including IgM, 
potentially affording it increased sensitivity over other currently available diagnostics (Greenwald et al, 
2009; Lyashchenko et al, 2006).  It is possible that partial cross-reactivity of the Elephant TB STAT-PAK

 
due to infection with nontuberculous Mycobacterium spp. and/or previous exposure to infected individuals 
could have led to misclassification of some study animals.  
 In the absence of any statistically significant differences in continuous cytokine fold difference 
values between the seropositive and seronegative groups, cytokine fold difference values were coded 
categorically and reanalyzed to aid in identification of any potential trends in cytokine expression between 
the two groups.  Failure to demonstrate statistically significant differences between seropositive and 
seronegative groups when cytokine fold difference was analyzed as a continuous variable may have been 
due to the overall low levels of cytokine mRNA within the baseline, unstimulated whole blood samples.  
Among examined cytokines, only categorical TNF- and TGF- levels differed between tuberculosis 
seropositive and seronegative elephants with statistical significance.  Though these results were suggestive 
of differences in levels of these cytokines between the seropositive and seronegative groups, the potential 
functional significance of such differences could not be determined by this study. 
Both TNF- and TGF- are detectable and active systemically, but are most recognized for 
contributions to local immune responses at the site of infection or damage (Abbas and Lichtman, 2003).  In 
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the case of mycobacterial infection, TNF- is synergistic with IFN- in increasing macrophage phagocytic 
and mycobactericidal activities.  Effective granuloma organization and maintenance responsible for control 
of mycobacterial disease also requires TNF- (Brighenti and Andersson, 2012; Cavalcanti et al, 2012; 
Ehlers, 2003).  Few studies of the systemic immune response to tuberculosis in other species have evaluated 
systemic TNF- levels.  In one study, no difference in baseline levels of TNF- between human patients 
with active pulmonary tuberculosis and M. bovis bacillus Calmette-Guerin vaccinated healthy controls was 
found.  Following stimulation of isolated and cultured PBMCs, controls had significantly higher TNF- 
levels (Al-Attiyah et al, 2006).  In other studies, greater TNF- responses have been detected in patients as 
compared with healthy controls following mycobacterial antigen stimulation (Cavalcanti et al, 2012; 
Hussain et al, 2002; Kellar et al, 2011).   
 In the elephants, the expression of TNF- in the seropositive group was higher than that of the 
seronegative group (Fig. 1).  A portion of the noted difference, however, may have been attributable to 
confounding factors.  Logistic regression models suggested that the presence of other inflammatory 
conditions could also significantly impact TNF- fold difference values.   Such confounding could impair 
the ability to distinguish differences in TNF- expression levels attributable to tuberculosis infection from 
those resulting from presence of other inflammatory conditions or a combination of the two.  After 
controlling for the presence of other inflammatory conditions variable, the results showed that seropositive 
individuals were still more likely to have high rather than low TNF- values.  Tumor necrosis factor- is a 
cytokine of the innate immune response that functions in early immunity to a variety of infectious and 
noninfectious insults (Abbas and Lichtman, 2003; Natarajan et al, 2011).  Though a sensitive indicator of a 
local or systemic pro-inflammatory response, TNF- is not considered a specific marker for any type of 
infection.  This lack of specificity is demonstrated by the results in this study and argues against the use of 
TNF- levels alone for evaluation of tuberculosis infection in elephants.  Though TNF- is primarily a 
mediator of the innate immune response, it also participates in adaptive immune responses through largely 
pro-inflammatory effects that are synergistic with those of the other TH1 cytokines (Abbas and Lichtman, 
2003; Cavalcanti et al, 2012; Kaufmann et al, 2005; Natarajan et al, 2011).  Comparatively higher systemic 
TNF- levels in seropositive elephants may be indicative of an active TH1 immune response associated with 
infection.   
 With mycobacterial infection, TGF- is produced in excess and is primarily expressed locally at 
sites of active disease (Brighenti and Andersson, 2012; Toossi and Ellner, 1998).  As an inhibitor of T 
lymphocyte activation and function, TGF- down-regulates protective TH1 immune responses.  Locally, 
TGF- interferes with macrophage activation both by direct inhibition of reactive oxygen and nitrogen 
intermediate generation and indirect counteraction of protective effects of IFN-  and TNF-.  One study 
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found that monocytes from human active tuberculosis patients constitutively express TGF- and have an 
expanded capacity to produce the cytokine upon in vitro stimulation with M. tuberculosis antigens (Toossi 
et al, 1995).  In the examined elephant samples, TGF-  levels were lower in the seropositive group (Fig 1).  
Considering the importance of this cytokine in local immunity, sequestration of TGF--producing 
monocytes/macrophages at the site of infection may account for lower systemic levels of TGF- noted in 
the seropositive elephants.  Alternatively, systemic TGF- levels in tuberculosis seropositive elephants may 
be sensitive to stage of infection.  Future studies investigating cytokine gene expression within infected 
elephant tissues may help elucidate the role of TGF- in elephant local tuberculosis immunity.  
 Though statistical significance was lacking in continuous and categorical analyses of other 
cytokines of interest, general trends suggestive of some difference between tuberculosis seropositive and 
seronegative elephants did exist for several cytokines.  Mean levels of both IFN- and IL-4 were higher for 
the seropositive group (Fig. 1).  In the majority of studies evaluating the human systemic immune response 
to tuberculosis, susceptible individuals with active clinical disease exhibit lower levels of IFN- than healthy 
controls (Bhattacharyya et al, 1999; Demissie et al, 2004; Demissie et al, 2006; Hussain et al, 2002; Sanchez 
et al, 1994; Seah and Rook, 2001; Torres et al, 1998; Wassie et al, 2008); similar findings are typical of 
laboratory rodent models of human tuberculosis (Cavalcanti et al, 2012; Kaufmann et al, 2005; Raja, 2003).  
However, a few human studies found higher levels of IFN- in patients than controls (Al-Attiyah et al, 2006; 
Dlugovitzky et al, 1997; Kellar et al, 2011).  The differences in these results are likely a consequence of 
duration of infection at the time of cytokine evaluation (Boussiotis et al, 2000; Dlugovitzky et al, 1997; 
Flynn and Chan, 2001; Kaufmann et al, 2005; Raja, 2003; Wang et al, 2012).   It is also important to note 
that differences between groups are typically only noted following stimulation with mitogens and/or 
mycobacterial antigens (Al-Attiyah et al, 2006; Sanchez et al, 1994; Torres et al, 1998).  In the elephants, 
infection stage was unknown, and cytokine levels were evaluated in the absence of any stimulation, which 
may have accounted for the large variation in IFN- levels among seropositive elephants and differences 
between seropositive and seronegative elephants as compared with trends seen in most human studies.  
 Several human studies have linked a TH2-dominated systemic immune response, characterized by 
relatively elevated levels of IL-4, with human tuberculosis susceptibility (Bhattacharyya et al, 1999; 
Demissie et al, 2006; Dlugovitzky et al, 1997; Sanchez et al, 1994; Seah and Rook, 2001; Surcel et al, 1994; 
van Crevel et al, 2000; Wassie et al, 2008).  The seropositive elephant samples had a higher IL-4 mean fold 
difference than the seronegative samples indicating a similar pathogenesis may contribute to elephant 
tuberculosis susceptibility.  Increased systemic levels of the TH2 cytokine, IL-10, and decreased systemic 
levels of the TH1 cytokine, IL-12, are associated with tuberculosis susceptibility in humans (Al-Attiyah et al, 
2006; Boussiotis et al, 2000; Cavalcanti et al, 2012; Cooper et al, 2007; Demissie et al, 2004; Dlugovitzky et 
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al, 1997; Hussain et al, 2002; Song et al, 2000; Torres et al, 1998).  Similar to the trend seen in human 
studies, elephant IL-12 mean fold difference values were lower in the seropositive group (Fig 1).  In contrast 
to the human studies, the mean fold difference values for IL-10 in the elephant samples were slightly lower 
in the seropositive group (Fig 1).   
 Though the majority of elephant tuberculosis cases have been M. tuberculosis infections, as is the 
case in human disease, the elephant immune system may not respond to infection with the same 
mechanisms.  The elephant systemic immune response may be distinct from the human response and 
possibly more similar to that of domestic cattle where the character of systemic TH1/TH2 imbalance is 
variable and often mixed with elevations in levels of both TH1 and TH2 cytokines (Rhodes and Buddle et al, 
2000; Rhodes and Palmer et al, 2000; Thacker et al, 2007; Welsh et al, 2005).  In one study of cattle 
experimentally infected with M. bovis, significant differences in systemic IFN-, TGF-, and IL-2 cytokine 
levels between infected and uninfected animals were not found (Rhodes and Buddle et al, 2000).  In other 
studies, samples from infected animals contained higher levels of IFN-, TNF-, and IL-4 than those of 
uninfected controls (Rhodes and Palmer et al, 2000; Thacker et al, 2007).  In a bovine study investigating 
trends in cytokine expression with progression of disease, advanced disease was associated with increased 
IL-4:IFN- (Welsh et al, 2005).  In all of these studies, disease was experimentally induced, stimulated 
PBMC cultures were used, and the number of study subjects evaluated was small.  Experimental M. bovis 
infection has also been investigated in white-tailed deer where significantly increased levels of IL-4 and 
IFN- were detected systemically in infected individuals (Thacker et al, 2006).  Similar to most previous 
studies in other species, the white-tailed deer study employed stimulated PBMC cultures.  Elephant cytokine 
levels were assessed in unstimulated RNA-preserved whole, blood samples.  This difference in 
methodology may, at least in part, explain why only trends and not statistically significant differences in IL-
4 and IFN- levels were found in the current study.  Based upon the available data, it is uncertain if the 
elephant systemic immune response to mycobacterial infection closely resembles that of any of the other 
previously studied species.  
 In light of current results, future studies involving longitudinal sampling of animals to elucidate 
whether cytokine levels change with infection course would be informative.  Additionally, considering 
significant differences in baseline, unstimulated peripheral blood cytokine levels were not detected in this 
study, future experiments examining proliferative and secretory responses following stimulation of PBMC 
cultures and/or whole blood samples from positive and negative elephants will be key to expanding upon 
current data.  Trends in cytokine level differences between positive and negative samples seen in this study 
may be better demonstrated or confirmed significant in samples stimulated with mycobacterial antigens.  
Future work evaluating immune responses following stimulation could provide valuable diagnostic 
information, and if monitored longitudinally, may offer insight into progression of infection and treatment 
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response.  Results of this study in combination with on-going investigations into elephant tuberculosis 
immunopathogenesis will be essential for elucidation of Asian elephant mycobacterial susceptibility.   
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4.7: Tables and Figures 
 
Table 4.1a: Descriptive statistics for cytokine and housekeeping gene averaged Ct values from 
tuberculosis seropositive samples 
 
Cytokine Total N Mean Median S.D.* Range Variance 
GAPDH 16 20.41 19.93 1.65 6.69 2.73 
 actin 16 18.48 18.27 1.17 4.91 1.37 
IL-4 16 33.15 33.05 1.02 3.92 1.05 
IL-10 16 29.16 29.23 1.21 4.05 1.46 
IL-12 16 30.1 29.78 0.93 3.17 0.87 
TNF- 16 24.98 24.84 1.45 6 2.11 
TGF- 16 21.16 20.69 1.65 6.74 2.73 
IFN- (158-265) 14** 34.38 34.57 1.09 4.14 1.2 
IFN- (145-302) 15 31.28 30.78 1.67 6.78 2.79 
 
Table 4.1b: Descriptive statistics for cytokine and housekeeping gene averaged Ct values from 
tuberculosis seronegative samples  
 
Cytokine Total N Mean Median S.D.* Range Variance 
GAPDH 90 20.45 20.11 1.32 5.71 1.75 
 actin 90 18.64 18.47 1.12 4.94 1.25 
IL-4 90 33.36 33.07 1.28 6.24 1.63 
IL-10 90 29.17 29.07 1.17 6.94 1.36 
IL-12 90 30.05 29.8 0.93 4.3 0.86 
TNF- 90 25.43 25.31 1.38 8.36 1.54 
TGF- 90 21.05 20.76 1.38 7.63 1.91 
IFN- (158-265) 62** 34.61 33.87 2.05 8.62 4.2 
IFN- (145-302) 44 31.5 31.2 1.48 7.74 2.19 
 
* S.D. = standard deviation. **Statistical calculations excluded non-amplifying samples.  
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Table 4.2a: Descriptive statistics for cytokine gene ΔCt values (normalized to  actin) from tuberculosis 
seropositive samples  
 
Cytokine Total N Mean Median S.D.* Range Variance 
IL-4 16 14.68 14.64 1.2 5.19 1.45 
IL-10 16 10.68 10.77 0.82 3.48 0.67 
IL-12 16 11.62 11.5 0.73 2.53 0.53 
TNF- 16 6.5 6.44 0.52 1.85 0.27 
TGF- 16 2.68 2.52 0.61 2.48 0.38 
IFN- (158-265) 14** 15.83 15.86 1.36 5.24 1.84 
IFN- (145-302) 15 13.62 13.46 1.2 4.53 1.44 
 
Table 4.2b: Descriptive statistics for cytokine gene ΔCt values (normalized to  actin) from tuberculosis 
seronegative samples 
 
Cytokine Total N Mean Median S.D.* Range Variance 
IL-4 90 14.73 14.63 1.11 5.92 1.24 
IL-10 90 10.53 10.48 0.87 4.5 0.76 
IL-12 90 11.41 11.43 0.67 4.41 0.45 
TNF- 90 6.79 6.72 0.68 4.83 0.47 
TGF- 90 2.4 2.33 0.59 4.48 0.35 
IFN- (158-265) 62** 16.07 15.55 2.08 8.69 4.31 
IFN- (145-302) 44 13.87 13.9 1.15 5.87 1.32 
 
 * S.D. = standard deviation. **Statistical calculations excluded non-amplifying samples.   
 
 
Table 4.3: Statistical significance of differences in individual cytokine fold difference values between 
seropositive and seronegative groups as assessed by students’ t tests (fold difference = continuous 
independent variable) and logistic regression (fold difference = categorical independent variable) 
 
Variable type Cytokine P value 
 
Continuous IL-4 0.5374 
 IL-10 0.4745 
 IL-12 0.4035 
 TNF- 0.1674 
 TGF- 0.0690 
 IFN- (158-265) 0.3408 
 IFN- (145-302) 0.3894 
Categorical IL-4 0.9831 
 IL-10 0.3564 
 IL-12 0.5341 
 TNF- 0.0237 
 TGF- 0.0499 
 IFN- (158-265) 0.9093 
 IFN- (145-302) 0.0934 
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Figure 4.1: Cytokine fold difference means and standard errors 
 
 
Fig. 4.1: The graph depicts relative levels, represented by mean fold difference, of each cytokine of interest 
for seropositive (N=16) and seronegative (N=90) groups.  The standard error of each calculated mean fold 
difference is shown by the associated error bars. 
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CHAPTER 5: PULMONARY TUBERCULOSIS IN ASIAN ELEPHANTS: HISTOLOGIC 
LESIONS WITH CORRELATION TO LOCAL IMMUNE RESPONSES 
5.1: Abstract 
 With mycobacterial infection, local immunity is the first line of defense, and the character of the 
local immune response will determine disease progression.  In human and nonhuman primate latent 
disease, well-organized granulomas containing relatively low numbers of bacteria are associated with TH1 
cytokine expression.  In contrast,  human/nonhuman primate active disease is associated with poorly 
organized inflammatory infiltrates, extensive necrosis , and local imbalance in TH1/TH2 cytokine levels.  
No previous studies have been conducted evaluating the elephant local immune response to tuberculosis 
or associated histologic lesions.  For this study, archival, formalin-fixed, paraffin-embedded lung samples 
from 5 tuberculosis negative and 9 tuberculosis positive, deceased Asian elephants (Elephas maximus) 
were obtained.  In the tuberculosis positive animals, pulmonary lesions assessed by routine light 
microscopy were described and compared.  Additionally, lymphoid infiltrates within lesions were 
characterized by CD3 immunolabeling.  In all of the archival lung samples, expression of TH1 (interleukin 
[IL]-2, IL-12, interferon [IFN]-, tumor necrosis factor [TNF]-) and TH2 (IL-4, IL-10, transforming 
growth factor [TGF]-) cytokines were then determined using in situ hybridization (ISH).  In all elephant 
tuberculosis pulmonary lesions, infection was characterized histologically by granulomatous 
inflammation.  In 6/9 samples, inflammation was widespread and poorly organized with large central 
regions of necrosis and mineralization, similar to morphologic changes associated with human/non-
human primate active disease.  In the majority of these lesions, CD3 positive lymphocytes were rare.  In a 
single sample, inflammation consisted of well demarcated, quiescent granulomas with numerous CD3 
positive lymphocytes.  Findings in this sample were compatible with latent human/non-human primate 
tuberculosis pulmonary lesions.  Histologically, remaining samples did not closely resemble human/non-
human primate active or latent disease.  For ISH, positive control signal was absent in samples from two 
negative and one positive elephant; consequently, these samples were excluded from subsequent analyses.  
Expression of  IFN- was detected in 3/8 of the positive samples, all with widespread granulomatous 
inflammation.  Expression of TNF- was also detected in 3/8 positive samples including the one 
characterized histologically by quiescent granulomas.  In all samples, both IFN- and TNF- expression 
occurred in viable portions of granuloma walls.  Very low-level expression of IL-4 was present in 4/8 
positive samples and distributed in viable tissues adjacent to granulomas.  Only single positive samples 
displayed any expression of IL-10 and TGF-.  No IL-2 or IL-12 expression was detected in any positive 
or negative samples; complications related to probe synthesis likely contributed to these results.  Elephant 
pulmonary tuberculosis lesions were characterized by granulomatous inflammation similar to that noted 
in other species, including humans.  Additionally, results indicated that both TH1 and TH2 cytokines 
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participate in the local immune response to mycobacterial infection.  Future studies will be necessary to 
better elucidate the precise roles particular cytokines play in elephant tuberculosis local immunity and 
disease progression.  
5.2: Introduction 
 Mycobacterium tuberculosis, the cause of human tuberculosis, also causes disease in elephants.  
The disease in elephants is typically subclinical and chronic, and the cause of elephant susceptibility to 
infection is currently unknown (Mikota et al, 2001; Mikota and Maslow, 2011; Miller, 2010; Mikota et al, 
2006, Payeur et al, 2002; Schmitt, 2003).  In humans, the character of the associated immune response is 
believed to be instrumental in determining infection outcome.  Consequently, numerous studies have been 
conducted comparing immune responses of individuals with active disease and those of healthy, 
presumably latently-infected, contacts (Al-Attiyah et al, 2006; Arriaga et al, 2002; Barnes et al, 1990; 
Barnes et al, 1993; Bhattacharyya et al, 1999; Boras et al, 2006; Boussiotis et al, 2000; van Crevel et al, 
2000; Demissie et al, 2004; Dlugovitzky et al, 1997; Fenhalls et al, 1999; Fenhalls et al, 2002; Fuller et al, 
2003; Herrera et al, 2009; Hussain et al, 2002; Kellar et al, 2011; Sanchez et al, 1994; Seah and Rook, 
2001; Smith et al, 2002; Surcel et al, 1994; Torres et al, 1999; Ulrichs et al, 2005; Wang et al, 2012; Wassie 
et al, 2008).  Immune responses can be evaluated by measuring levels of immune mediators, such as 
cytokines, in clinical samples.  The relative balance of cell-mediated (TH1) and humoral (TH2) cytokines 
can provide valuable information about an individual’s immune response (Abbas and Lichtman, 2003; 
Kidd, 2003).  For example, because M. tuberculosis is an intracellular pathogen, an effective immune 
response should be TH1 dominated.  An inadequate cell-mediated immune response with mycobacterial 
infection is associated with disease (Flynn and Chan, 2001; Kaufmann et al, 2005; Zuniga et al, 2012).  
Human studies demonstrating differences in systemic (peripheral blood) levels of TH1 and TH2 cytokines 
between healthy contacts and active tuberculosis patients have illustrated this association (Al-Attiyah et al, 
2006; Bhattacharyya et al, 1999; Boussiotis et al, 2000; Cavalcanti et al; 2012; Demissie et al, 2004; 
Dlugovitzky et al, 1997; Hussain et al, 2002; Sanchez et al, 1994; Seah and Rook, 2001; Surcel et al, 1994; 
Torres et al, 1999; van Crevel et al, 2000; Wang et al, 2012; Wassie et al, 2008; Zuniga et al, 2012). 
 The immune response to tuberculosis is two-fold, consisting of both local and systemic 
components.  Local immunity is the first line of defense, and the character of the local immune response 
will determine disease progression (Brighenti and Andersson, 2012; Cavalcanti et al, 2012; Flynn and 
Chan, 2001; Kaufmann et al, 2005; Raja, 2003).  In humans and non-human primates, latent and active 
tuberculosis appear to occur as separate entities governed by individual susceptibility and can be 
distinguished by unique local morphologic and immunologic features (Bhatt and Salgame, 2007; Fuller et 
al, 2003; Raja, 2003, Sundaramurthy and Pieters, 2007).  Infection of resistant individuals most 
commonly results in latent disease characterized locally by well-organized granulomas containing low 
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numbers of mycobacteria.  Susceptible individuals more commonly succumb to progressive disease 
characterized by poorly-organized, multi-bacillary granulomas.  Latent granulomas have richly 
vascularized walls and are typically solid with large numbers of activated, epithelioid macrophages.  
Progressive granulomas of active disease are poorly vascularized and often contain large central regions 
of necrosis with few activated macrophages (Fuller et al, 2003; Ulrichs et al, 2005; Ulrichs and 
Kaufmann, 2006).  In addition, progressive granulomas are associated with decreased expression of IFN-
, TNF-, and IL-12 as compared with latent granulomas (Arriaga et al, 2002; Fenhalls et al, 1999; 
Fenhalls et al, 2002; Fuller et al, 2003; Smith et al, 2002; Ulrichs et al, 2005).  Importantly, local immune 
responses of active tuberculosis patients are dependent on stage of disease and may not correlate with 
systemic immune responses (Barnes et al, 1990; Barnes et al, 1993; Boras et al, 2006; Herrera et al, 
2009).  Therefore, assessment of the local immune response at the site of infection may provide a more 
accurate representation of disease stage and ultimate infection outcome.    
 No previous studies have described the histopathology of lesions or evaluated local immune 
responses in Mycobacterium spp. infected elephants.  The contribution of local TH1 and TH2 cytokine 
expression to elephant pulmonary inflammation and disease progression may provide insight into disease 
susceptibility.  For this study, pulmonary lesions were evaluated via light microscopy in archival, 
formalin-fixed, paraffin-embedded lung samples from 9 tuberculosis positive, deceased Asian elephants 
(Elephas maximus).  Immunohistochemistry for the T lymphocyte marker, CD3, was done to evaluate T 
cell numbers and distribution within lesions.  In addition, local expression of TH1 (interleukin [IL]-2, IL-
12, interferon [IFN]-, tumor necrosis factor [TNF]-) and TH2 (IL-4. IL-10, transforming growth factor 
[TGF]-) cytokines was assessed in these same samples as well as in 5 tuberculosis negative controls 
using in situ hybridization (ISH).  Differences in ISH signal distribution and intensity between negative 
and positive samples were investigated. 
5.3: Materials and Methods 
5.3.1: Animals/Sample collection 
 Samples were from 14 deceased, captive, North American, Asian elephants.  Positive cases (N=9) 
were previously diagnosed based upon histologic lesions and postmortem mycobacterial culture.  
Negative cases (N=5) included animals that died or were euthanized due to a variety of causes and 
exhibited no postmortem evidence of mycobacterial infection.  Archival, formalin-fixed, paraffin-
embedded sections of lung collected during routine postmortem examinations were utilized.   
5.3.2: Light microscopy and CD3 immunohistochemistry 
The nine formalin-fixed, paraffin-embedded elephant pulmonary tuberculosis lesion samples 
were sectioned at 5 µm and stained with hematoxylin and eosin for routine light microscopic evaluation.  
Sections were also processed for routine immunohistochemistry using polyclonal, rabbit antiCD3 
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antibodies (Biocare Medical, Concord, CA).  Sections of normal Asian elephant lymph node used as a 
positive control ensured antibody cross-reactivity with elephant T lymphocytes.  Relative numbers of 
CD3 positive lymphocytes within elephant pulmonary tuberculosis lesions were determined by visual 
evaluation of ten 400X fields containing lymphocytes.  The percentage of total lymphocytes with CD3 
positive immunolabeling for each lesion was based upon the average percentage noted for each examined 
400X field. 
5.3.3: In situ hybridization probe synthesis 
 Riboprobes were designed using previously determined Asian elephant cytokine sequence 
information (Landolfi et al, 2009).  Elephant template DNA lengths varied from 250 to 600 bps dependent 
on cytokine.  Riboprobes were synthesized by in vitro transcription of linearized pGEM

-T (pGEM

-T 
Vector; Promega, Madison, WI) plasmid templates containing the appropriate insert to generate the 
antisense or corresponding sense probes using T7 or SP6 RNA polymerase.  In vitro transcription was 
performed using the Maxiscript SP6/T7 kit (Ambion, Austin, TX), with plasmid DNA (0.2 g/l) and 
35
S-UTP (0.05 mCi, ICN, Costa Rica, CA).  Transcription proceeded at 37C for 3 hours prior to addition 
of DNAse for an additional 20 minutes.  Newly synthesized probes were centrifuged for four minutes at 
1000 RCF in RNA Mini Quick Spin Columns (Roche Diagnostics, Indianapolis, IN) to remove 
unincorporated nucleotides.  For resuspension, 15 l RNAse free water was added, and probes were 
heated at 65C for 5 minutes.  Probes were then counted on a scintillation counter (Packard Tri-Carb 1500 
Liquid Scintillation Analyzer; Global Medical Instrumentation, Inc., Ramsey, MN).  For use in 
hybridization experiments, all probes were diluted with RNAse free water to final concentration of 50,000 
cpm/l.   
5.3.4: In situ hybridization 
 Five m thick, serial sections were cut from each sample and mounted on SUPERFROST 
PLUS-Adhesion slides (Fisher Scientific, Pittsburgh, PA).  For each sample, sense and antisense probes 
were hybridized in parallel on serial sections of lung.  Detection of Asian elephant β actin and CXCL9 
served as positive controls for ISH experiments.  To serve as a general protocol control, fresh frozen 
sections of lung from a Mycobacterium tuberculosis-infected rhesus macaque (Macaca mulatta) 
contributed by a collaborator, Dr. T. A. Reinhart, were hybridized with a macaque RANTES probe in 
parallel with the elephant samples.  The macaque tissue and probe had been previously validated with the 
ISH protocol during prior studies conducted by Dr. Reinhart.  Following deparaffinization and 
rehydration of elephant samples, pretreatment to expose mRNA targets for hybridization was performed.  
All samples were placed in 1X citrate buffer and microwaved at high power for 10 minutes.  To block any 
endogenous RNAses and to reduce the potential for highly positively charged proteins to bind riboprobes 
non-specifically, samples were then washed twice in 0.25% acetic anhydride in 0.1M triethanolamine 
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(TEA) for 6 minutes.  After brief rinsing in ultrapurified water, samples were dehydrated with ethanols, 
and air-dried prior to application of hybridization solution.   Hybridization solution was composed of 10X 
HYB buffer (20% 1M HEPES, pH 7.2 [Fisher Scientific]; 2% 0.5M EDTA, pH 8 [Fisher Scientific]; 20% 
50X Denhart’s Solution [Sigma-Aldrich, St. Louis, MO]; 5% 20mg/ml PolyA [Roche Diagnostics]; 53% 
ultrapurified water), 6M NaCl, 50% dextran sulfate formamide (Sigma-Aldrich), 50 g/ml yeast tRNA 
(Applied Biosystems, Foster City, CA), 50,000 cpm/l probe, 0.1M dithiothreitol (DTT; Roche 
Diagnostics), and ultrapurified water to final volume of 20 l per sample.  All components excepting 
DTT were combined and mixed well prior to a 3 minute incubation at 65C.  Following incubation, the 
hybridization solution was quenched on ice and DTT was added.  Hybridization solution (20 l) was 
applied to each sample.  Samples were covered with a siliconized glass coverslip and sealed with rubber 
cement to prevent dehydration during incubation.  Samples were incubated upright, overnight at 50C in a 
light-protected container. 
 Following incubation, samples were placed in 5X sodium chloride sodium citrate (SSC), and 
coverslips were removed.  A series of washes were then performed to remove hybridization solution.  
First, samples were incubated in 5X SSC with 10 mM DTT at 42C for 30 minutes.  Samples were then 
placed in 2M SSC/50% formamide with 10mM DTT at 60C for 20 minutes.  Samples were transferred to 
riboprobe wash solution consisting of 1M TRIS, pH 7.5, 0.5M EDTA, and 5M NaCl for 10 minutes at 
37C twice.  Samples were placed into new riboprobe wash solution containing 25U/ml RNAse A + T1 
(Roche Diagnostics) and incubated at 37C for 30 minutes.   Samples were then transferred to new 
riboprobe wash solution and incubated at 37C for an additional 10 minutes.  The final two washes 
consisted of 2X and 0.2X SSC, respectively, at 37C for 10 minutes.  To dehydrate, samples were then 
sequentially placed in 70%, 85%, and 95% ethanol with 0.3M ammonium acetate for 5 minutes prior to 
air-drying.  Dried samples were transferred to a dark room, dipped twice in heated NTB-2 radiography 
emulsion (Kodak Eastman, Rochester, NY), and allowed to air dry for 45 minutes.  Samples were 
packaged into light-tight containers with desiccant and stored at 4C for exposure.  Exposure time varied 
and was dependent upon each probe. Exposure times for each probe were as follows: RANTES – 7 days; 
 actin – 5 days; CXCL9 – 20 days; IL-2 – 35 days; IL-4 – 28 days; IL-10 – 39 days; IL-12 – 35 days; 
TGF- - 36 days; TNF- - 38 days; IFN- - 39 days.  Following exposure, samples were equilibrated to 
room temperature for 45 minutes.  Samples were then placed in D19 developer (Sigma-Aldrich) for 3 
minutes, rinsed in ultrapurified water, and placed in Rapid Fix (Sigma-Aldrich) for 4 minutes.  Following 
a final rinse, samples were air dried and counterstained with hematoxylin.  Each sample was then 
examined using a light microscope and evaluated for overall level of sense background signal and 
distribution and amount of antisense probe-specific signal.  Background was subjectively assessed as low, 
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medium, or high.  Antisense probe-specific signal was defined as aggregates of silver granules distinct 
from background and unique to antisense probe-labeled sections.  Microscopic distribution of any 
antisense probe-specific signal was determined.  Then intensity of noted signal was assessed and graded 
as follows: Grade 0 = no antisense probe-specific signal/section; Grade 1 = <10 antisense probe-specific 
signals/section; Grade 2 = 10-25 antisense probe specific signals/section; Grade 3 = 25-50 antisense 
probe-specific signals/section; Grade 4 = >50 antisense probe-specific signals/section. 
5.4: Results 
 Samples 1-5 were from tuberculosis negative animals that died or were euthanized due a variety 
of other causes including elephant endotheliotropic herpesvirus infection and chronic pododermatitis and 
osteoarthritis.  Samples 6-14 were from tuberculosis positive animals.  
5.4.1: Light microscopy and CD3 immunohistochemistry 
A summary of histologic lesions and CD3 immunolabeling results is provided in Table 5.1.  
Histologically, sections from six of the nine elephant pulmonary tuberculosis samples (samples 6-10 and 
12) shared similar morphology.  In these samples, the pulmonary interstitium was expanded by multiple 
and often coalescing, nodular accumulations of foamy to epithelioid macrophages and few multinucleated 
giant cells that replaced alveoli and typically obscured greater than 50% of the normal parenchyma.  In 
many areas, macrophages surrounded variably-sized though often expansive, central accumulations of 
hypereosinophilic, necrotic cellular debris and few admixed neutrophils.  Necrotic debris was often 
partially mineralized.  In samples 8, 10, and 12, granulomatous inflammation was surrounded by very few 
lymphocytes and plasma cells.  In samples 6, 7, and 9, lesions contained low to moderate numbers of 
lymphocytes and plasma cells.  Less than 10% of noted lymphocytes in samples 7, 8, 10, and 12 had 
positive immunolabeling for CD3; approximately 20-30% of lymphocytes from samples 6 and 9 were 
CD3 positive.  In some areas, scant moderately cellular, collagen-rich fibrous connective tissue 
surrounded foci of inflammation and minimally extended in the surrounding interstitium.  Occasionally, 
inflammation was centered on and obscured entire small bronchioles.  Alveoli adjacent to affected regions 
were segmentally lined by plump polygonal epithelial cells (type II pneumocyte hyperplasia).  
Regionally, alveoli were filled with eosinophilic homogenous (proteinic) material and contained few 
foamy macrophages (Figure 5.1, panels A and B).   
Lesions in samples 11 and 13 were both discrete and well-demarcated but differed in the amount 
of necrosis and degree of inflammation.  In sections from sample 11, the pulmonary interstitium 
contained a few discrete nodules characterized by scant, mineralized, central necrotic debris surrounded 
by low numbers of epithelioid macrophages, rare multinucleated giant cells, numerous lymphocytes, and 
large concentric accumulations of hypocellular, collagen-rich, dense fibrous connective tissue.  
Intervening pulmonary parenchyma was histologically within normal limits (Figure 5.1, panels C and D).  
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Greater than 50% of noted lymphocytes were CD3 positive (Figure 5.2).  In sections from sample 13, 
several large, discrete, nodular regions of the pulmonary parenchyma were hypereosinophilic and 
smudged with loss of individual cellular detail and karyolysis (necrosis).  Necrotic areas were surrounded 
by moderate numbers of foamy to epithelioid macrophages, scattered neutrophils, multinucleated giant 
cells, few plasma cells as well as low to moderate numbers of lymphocytes, 20-30% of which had 
positive immunolabeling for CD3.  The surrounding interstitium was expanded by moderate 
accumulations of hypercellular, well-vascularized, collagen-rich, and moderately dense fibrous 
connective tissue.  Intervening pulmonary parenchyma was histologically within normal limits (Figure 
5.1, panels E and F).   
The section from sample 14  was centered on a large bronchus and included a few adjacent 
bronchioles and only small amounts of intervening alveolar parenchyma.  Consequently, noted lesions 
were distinct from other samples.  Bronchial/bronchiolar submucosa was diffusely expanded by 
hyperplastic bronchus associated lymphoid tissue (BALT) with many large follicles containing prominent 
germinal centers.  Less than 10% of noted lymphocytes had CD3 positive immunolabeling.  Multifocally, 
the submucosa also contained nodular to coalescing aggregates of epithelioid macrophages that elevated 
the overlying mucosal epithelium.  Bronchial epithelium ranged from mildly hyperplastic to segmentally 
attenuated with loss of cilia.  One bronchiole lacked epithelium and was obscured by a large luminal 
accumulation of necrotic cellular debris.  Inflammation multifocally extended into the peribronchial 
interstitium.  In intervening areas, the interstitium contained few small nodular accumulations of 
epithelioid macrophages that displaced adjacent alveoli.  Affected alveoli had segmental type II 
pneumocyte hyperplasia, and some contained few macrophages and/or proteinic material. 
5.4.2: In situ hybridization 
Elephant IL-2 and IL-12 DNA failed to insert into plasmid templates.  Alternatively, rhesus 
macaque IL-2 and IL-12 DNA templates (provided by Dr. Reinhart) were used to synthesize sense and 
antisense probes for use in the ISH experiments.  For all other cytokines, probes were successfully 
synthesized using elephant DNA; probe sequences (insert only) are listed in Table 5.2.  
 Results of all ISH experiments are summarized in Table 5.3.  All macaque tissues hybridized with 
RANTES probes in parallel with the elephant study samples displayed anti-sense probe-specific signal in 
the vicinity of tuberculosis lesions as expected.  Neither  actin nor CXCL9 antisense probe-specific 
signals were detected in two negative (samples 3 and 4) and one positive (sample 10) samples.  Lack of 
positive control probe signal indicated these samples were unsuitable for ISH necessitating their exclusion 
from final analyses.  Expression of CXCL9 is a feature of pulmonary inflammation associated with 
tuberculosis lesions and thus was expected to be negative in samples 1-5, therefore the lack of expression 
in these samples did not exclude them from further analysis. 
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The patterns of expression for TNF- and IFN- were similar.  There was no TNF- antisense 
probe-specific signal in any of the tuberculosis negative samples.  Grade 1 IFN- specific signal was 
present in one tuberculosis negative sample (sample 5).    For TNF-, 3/8 tuberculosis positive samples 
contained antisense probe-specific signal (samples 6, 11, 12).  Samples 6, 9, and 12 had IFN- antisense 
probe-specific signal; samples 6 and 12 contained signal for both TNF- and IFN-.  Signal for both 
probes was located within viable portions of granuloma walls and adjacent to areas of necrosis (Fig. 5.3 
[TNF-]; Fig. 5.4 [IFN-]).  No signal was detected within necrotic tissue or portions of normal lung 
distant from areas of inflammation. 
 For IL-4, antisense probe-specific signal was noted only in tuberculosis positive samples (4/8; 
samples 6, 7, 9, 13).  Signal was scant when present and distributed multifocally in areas surrounding 
some granulomas.  For both IL-10 and TGF-, antisense probe-specific signal was noted only in a single 
tuberculosis positive sample each (Table 5.2).  Signal for IL-10 was noted regionally in a portion of 
unaffected lung adjacent to but distinct from a region of granulomatous inflammation.  Signal for TGF- 
was distributed multifocally in areas surrounding a few granulomas.  Antisense probe-specific signal was 
not detected in any samples hybridized with macaque IL-2 or IL-12 probes.   
5.5: Discussion 
In this study, elephant pulmonary tuberculosis lesions were histologically similar to those noted 
in mycobacterial infection of other species (Fuller et al, 2003; Ulrichs et al, 2005; Ulrichs and Kaufmann, 
2006; Thacker et al, 2006; Thacker et al, 2007).  Additionally, among samples from the positive elephants 
some distinct histologic and immunologic differences were present that paralleled features noted in cases 
of human/non-human primate active and latent pulmonary tuberculosis.  Inflammation was predominantly 
granulomatous and accompanied by variable amounts of necrosis, mineralization, and fibrosis.  In six of 
the nine elephant pulmonary tuberculosis samples, lesions were morphologically similar and 
histologically compatible with active infection/inflammation in humans/non-human primates as 
evidenced by the multifocal to coalescing distribution of noted lesions, lack or organization, extensive 
necrosis, and minimal fibrosis.   In contrast, lesions in sample 13 were more discrete and organized 
potentially suggesting infection was more chronic or that the local immune response was more effective 
in this individual.  In sample 11, only quiescent granulomas typical of chronic, largely resolved infection, 
and reminiscent of human/non-human primate latent disease, were detected.    In sample 14, the majority 
of the available section was occupied by a large bronchus, thus histologic variation in the lesions from 
this case was likely in part due to anatomy and sectioning.   
Lesions from samples 8, 10, and 12 appeared morphologically active and contained very few 
lymphocytes.  Samples 6, 7, 9, also morphologically active lesions, had higher overall numbers of 
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lymphocytes, however, in all six of these samples, only a low percentage of the noted lymphocytes were 
CD3 positive. Consequently, the majority of noted lymphocytes were presumed B lymphocytes.  
Attempts to confirm B cell lineage using a mouse monoclonal antiCD79a antibody (Biocare Medical) 
were unsuccessful; absence of CD79a immunolabeling in sections of normal Asian elephant lymph node 
suggested lack of antibody cross reactivity.   Overall, CD3 immunolabeling suggested that poorly 
organized, active lesions contained a paucity of T lymphocytes.  The lack of T lymphocytes could have 
reflected an early disease course where significant recruitment had not yet occurred.  Alternatively, 
defective T lymphocyte recruitment may be a feature of tuberculosis immunopathogenesis in elephants 
and could contribute to disease progression.  In contrast, sample 11 that was morphologically 
characterized by quiescent granulomas compatible with latent disease, contained numerous lymphocytes, 
greater than 50% of which were CD3 positive (Figure 5.2).  Findings in this sample suggested that local T 
lymphocyte recruitment may be associated with improved inflammatory organization and containment of 
disease.    
For this study, in situ hybridization (ISH) was selected as a technique that could provide 
information about location and distribution of cytokine expression within elephant tuberculosis lesions 
and allow for correlation between cytokine expression and lesion morphology.  Because previous studies 
utilizing ISH techniques in elephant tissues were lacking, however, several controls were incorporated 
into the procedure to ensure valid results.  First in order to ensure quality of study samples, expression of 
two positive control genes (β actin and CXCL9) was detected in all tissues.  The housekeeping gene,  
actin, was chosen for its ubiquitous expression, unaffected by exogenous stimuli (Overbergh et al, 2003).  
Within viable tissues,  actin hybridization resulted in low-level, diffuse, non-cell specific signal.  
Hybridization for the IFN- inducible chemokine, CXCL9, was selected as an additional control based 
upon previous ISH studies in nonhuman primates that demonstrated consistent expression of CXCL9 in 
association with pulmonary tuberculosis granulomas (Fuller et al, 2003).  These controls were deemed 
especially necessary considering precise fixation and processing history was unavailable for the majority 
of the archival elephant samples.  Hybridization with  actin and CXCL9 probes provided a way to assess 
overall tissue quality and thus sample viability for all subsequent experiments.  Neither  actin nor 
CXCL9 antisense probe-specific signals were detected in sample 10, indicating sample quality was 
inadequate and necessitating exclusion of this sample from further analyses.  In light of these ISH results, 
the low-level of CD3 immunolabeling present in this case may also have been impacted by sample 
quality.  Two negative samples were deemed inadequate based on lack of   actin antisense probe-specific 
signals (CXCL9 hybridization was not expected in the negative samples of normal lung).  All macaque 
tissues hybridized with RANTES probes in parallel with the elephant study samples displayed anti-sense 
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probe-specific signal in the vicinity of tuberculosis lesions as expected ensuring no protocol related errors 
occurred to impact ISH results.   
 Results reported here supported a role for certain TH1 cytokines (TNF- and IFN-) in elephant 
tuberculosis local immunity.  Both of these cytokines were detected in the viable walls of some elephant 
pulmonary granulomas.  Expression was lacking in necrotic and distant unaffected portions of lung.  All 
samples with IFN- expression were those characterized by widespread, poorly organized, granulomatous 
inflammation.  Interferon (IFN)- is the prototypical TH1 cytokine that is essential for effective defense 
against mycobacterial infection (Flynn and Chan, 2001; Kaufmann et al, 2005; Raja, 2003; Zuniga et al, 
2012).  It is secreted by T lymphocytes and results in activation of infected macrophages.  Macrophage 
activation is required for killing of intracellular mycobacteria and promotion of the cell-mediated immune 
response (Raja, 2003).   In the case of mycobacterial infection, TNF- is synergistic with IFN- in 
increasing macrophage phagocytic and mycobactericidal activities within infected tissues.  Effective 
organization and maintenance of granulomas responsible for control of mycobacterial disease also requires 
TNF- (Cavalcanti et al, 2012; Ehlers, 2003).  Sample 11 , morphologically characterized by the well 
demarcated, quiescent granulomas, was one of the samples with TNF- expression.  Expression of this 
cytokine may have contributed to containment of disease in this case.  Interestingly, sample 11 also lacked 
CXCL9 expression.  Because this chemokine has been shown to be highly expressed in active tuberculosis 
lesions of other species, absence of expression provided additional evidence of chronic, “latent” type local 
disease in this case (Fuller et al, 2003).  
 In addition to TNF- and IFN-, a proportion of the positive elephant samples displayed low 
levels of IL-4 expression.  In humans, local expression of IL-4 has only been reported with progressive 
granulomas of active disease and often correlates with greater degrees of necrosis (Fenhalls et al, 2002).  
In the elephants, IL-4 signal was scant and distributed multifocally in areas surrounding some 
granulomas.  Expression was not specifically correlated with central regions of necrosis.  No IL-4 
expression was detected in sample 11 characterized by the well demarcated, quiescent granulomas.  
Though these finding suggest IL-4 may contribute to the local immunopathogenesis of tuberculosis in 
elephants, additional information regarding the initiation and progression of the local pulmonary 
inflammatory response following mycobacterial infection is required prior to any definitive assessment of 
significance. 
 For both IL-10 and TGF-, antisense probe-specific signal was noted only in a single tuberculosis 
positive sample each.  Antisense probe-specific signal was not detected in any samples hybridized with 
IL-2 or IL-12 probes.  Presumably, use of rhesus macaque DNA templates for probe synthesis resulted in 
probes with insufficient affinity for detection of elephant mRNA targets.  Limited available data for 
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expression of these four cytokines in the elephant samples precluded meaningful interpretation of their 
potential contributions to tuberculosis local immunopathogenesis.  In this study, significance of ISH 
results was limited to correlation with the available pulmonary lesions, and thus may not have been 
representative of the local pulmonary immune response in each affected animal as a whole.  Because this 
was a retrospective study utilizing archival samples, interpretation of findings regarding local cytokine 
expression were made in light of these constraints.      
 Overall low expression of cytokines evaluated in this study was not unexpected.  Experience with 
ISH detection of cytokine mRNA in other species suggests low expression of these targets, especially 
compared with other targets such as chemokines, is the norm (T. A. Reinhart, personal communication).  
Additionally, sample quality due to the archival nature of available study material likely impacted success 
of ISH and IHC experiments.  When available, use of fresh frozen sections is preferred for ISH 
procedures (Hofler, 1990).  When frozen samples are not available and fixed samples must be utilized, as 
was the case for this study, target exposure as well as viability of mRNA targets within tissues must be 
considered.  With ISH procedures, target exposure within samples is essential for effective probe 
hybridization.  Conformational changes resulting from fixation can mask or otherwise alter targets within 
samples.  In addition, longer fixation times prior to tissue processing result in greater alteration of targets 
(Hofler, 1990).  Because the study samples were archival and contributed by several different facilities, 
formalin-fixation times varied, and in many cases, precise times were unknown.   
 Additionally, some degree of RNA degradation will accompany routine tissue fixation and 
processing (Hofler, 1990).  To increase the likelihood of cytokine detection within the archival elephant 
tissues, 
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S-labeled riboprobes were used in this study.  Radio-labeled probes have superior sensitivity to 
probes labeled with digoxigenin or fluorophores.  In addition, for the detection of RNA targets, 
riboprobes take advantage of RNA-RNA bonds that have higher affinity than DNA-RNA or DNA-DNA 
bonds (Lewis and Baldino, 1990).  Despite all efforts to optimize hybridization and detection, it was 
evident that sample quality remained a factor impacting success of the ISH procedures in this study.  
Three of the study samples were deemed nonviable based on lack of hybridization with both the  actin 
and CXCL9 positive control probes.  It is also possible that sample quality affected the intensity of 
hybridization in the other samples.  Interleukin-10 and TGF- signals were only detected in single 
positive samples.  Both cytokines are important in human local tuberculosis immunity (Bonecini-Almeida 
et al, 2004; Redpath et al, 2001; Toosi and Ellner, 1998).  Apparent low expression in elephant samples 
noted here may have been the result of suboptimum sample quality. 
 Results of this study suggest that histologic changes compatible with  active and latent 
manifestations of human pulmonary tuberculosis occur in elephants, however, further research is needed 
to correlate these lesions with clinical disease course.  Important information could be gained by more 
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systematic examination of postmortem lung samples collected from positive elephants during future 
necropsies.  To facilitate comparison among samples, standardized sample collection procedures and 
submission of materials to a coordinating veterinary pathologist for evaluation would be recommended.  
Descriptive information regarding the morphology and character of lesions within affected tissues from 
individual elephants and among different elephants could then be compiled and compared.  This 
additional prospective data could help determine the potential significance of variations in lesion 
morphology.  Recent and on-going advances in elephant tuberculosis diagnostics are improving the 
sensitivity of infection detection and may facilitate earlier diagnosis and prospective disease course 
monitoring (Greenwald et al, 2009; Larsen et al, 2005; Lyashchenko et al, 2006; Mikota et al, 2006).  
Such advances could allow for more accurate study of disease progression in this species.  Ultimately, the 
opportunity may arise for correlation of local cytokine expression and pathology at different diseases 
stages as is done in humans.  As additional samples become available, future studies examining cytokine 
and chemokine expression in fresh, frozen elephant tissue from Mycobacterium spp.-infected animals 
could also further advance current knowledge and potentially elucidate contributions of elephant local 
immunity to tuberculosis susceptibility.  
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5.7: Tables and Figures 
Table 5.1: Histopathology and CD3 immunolabeling of Asian elephant pulmonary tuberculosis lesions 
 
Sample Histologic lesion CD3 positive 
lymphocytes 
6 Widespread granulomatous inflammation with necrosis 20-30% 
7 Widespread granulomatous inflammation with necrosis <10% 
8 Widespread granulomatous inflammation with necrosis <10% 
9 Widespread granulomatous inflammation with necrosis 20-30% 
10 Widespread granulomatous inflammation with necrosis <10% 
11 Well demarcated, quiescent granulomas >50% 
12 Widespread granulomatous inflammation with necrosis <10% 
13 Well, demarcated granulomas with central necrosis 20-30% 
14 Bronchial granulomatous inflammation and lymphoid hyperplasia <10% 
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Table 5.2: Asian elephant riboprobe sequences 
Probe GenBank 
Numbers 
Sequence (5’  3’) 
 actin FJ423082, 
FJ423083, 
FJ423084, 
FJ423085, 
FJ423112 
aacggctcgggtatgtgtaaagctggctttgctggcgacgacgccccccgggccgtcttcccttccatcgtggggc
gcccccggcaccagggtgtgatggtgggcatgggccagaaggattcctatgtgggcgacgaggcccagagcaa
gagaggcatcctgaccctcaagtaccccattgagcatggtattgtcaccaactgggatgacatggagaagatttggc
accacaccttctacaacgagctgcgtgtggcccccgaagagcaccctgtgttgctgactgaggcccccctgaaccc
caaggccaacagggagaagatgacccagatcatgtttgagaccttcaacacgccagccatgtatgtggccatccag
gcggtgctgtccttgtatgcctctggccgaaccaccggtattgtcatggactctggcgatggtgtcactcacactgtg
cccatctacgagggctacgccctgccccacgccatcctgcgtcaggtcccggccagccaggtccagacgcagga
tggcgtgggggagagcatagccctcatagatgggcacagtgtgggta 
IL-4 FJ423094, 
FJ42395 
atgggtctcacctaccagctgattccaactctgttgtgcctactagtatgtaccagcaacttcatccacggccaaacat
gtggtaatatcttaagagagatcatcaaaactttgaacttcctcacagagaaaaagcatgcgtgcaccgagttgactg
tagcagacgcctttgctgccccgaagaacacaaccgagaaagaaaccttctgcagagctactactgtgctttggca
ggtctctaaacgccacgaatgctttaccaaatacctgagaggactcagtagaagcctcagcagcatgacaaacctg
gattactgtcctgtgaatgaagacaggacgactacattgaaagacttcttggaaaggctaaagacgatcatgaagga
gaaatactccaagtga 
IL-10 FJ423096, 
FJ423097, 
FJ423098, 
FJ423099 
ctcattcatggctttgtagacacctttctcttggagcttactgaaggcttccttcacttgctccaccgctttgctcttattttc
acagggaagaaatcggtgacagcgccgcagcctggtcctgagggtcgtcagcttttcccccagggaattcacatg
ctccttgatgtcggggccgtggttttcagcctgcggcatcaccatctccaggtaaaacttgatcatctctgacaaggct
tggcagcccaggtaacccttaaagtcctccagcaaggacttgtttaacaacatgttgtccagctgatccttcttttgaaa
gaaagtcttcaccctgtcgaaggccatccggagctctcggagcatgttgggcaggctgcctgggaagtaggtgca
gctgttctcagacggggtttcctggctctggctggcccccaccccagccaggaagaccaggcaacagagcagtgc
tgagcaggccatggcggagctctgccttctgtggtttggttttgcaagagcaa 
TNF- FJ423108, 
FJ423109, 
FJ423110, 
FJ423111 
 
gagatccaagtgacaagcctgtagcacacgttgtagcaaacccccaaaccgaggggcaacttcagtggctgagcc
ggcgtgccaataccctcctggccaatggtgtggagttgatagacaaccagctgatggtgccttccgatgggctgtac
ctcatctactcccaggtcctcttcaagggccaaggctgtcctgccacccaagtgctcctcacccacaccatcagccg
tatcgctgtctcctacaagaccaaggtcaacctcctctctgccatcaagagcccctgccatagggagaccccagag
ggggctgaggccaagccctggtatgagcccatctacctgggaggagtcttccagctagagaagggtgatcgactc
agcgctgagatcaatctgcctgactatctcgactttgctgagtctgggcaggtca 
TGF- FJ423104, 
FJ423105, 
FJ423106, 
FJ423107 
 
tatgaaccggcctttcctgctccttatggccacccccttggagagggcccagcacctgcacagctcccggcaccgg
cgggccctggacaccagctactgcttcagctccaccgagaagaactgctgcgtgcggcagctgtacatcgacttcc
gcaaggacctgggctggaagtggatccacgagcccaagggctaccacgccaacttctgcctggggccctgcccc
tacatctggagcctggacaca 
IFN- FJ423090, 
FJ423091 
cagctttgcatcattttgggttcttctagctgctactgccaggctacttttttgaaagagatacagaacctaaaggaatat
cttaatgcaactgattcagatgtagcggatggtgggcctcttttcatagatattttgaagaactggaaagaggacagtg
acaaaaaaataattcagagccagatcgtttccttttacctcaaaatctttgacaacttgaaagacaaccaggtcatcca
agagagcgtgaagacccttgaggaagacctctttgttaagttcttcaatagcagctccagcaaacgggatgacttcct
aaaagtgatgcaaactccggtaaatgaccggaacatccagcgcaaagccataagtgagctcgccaaggtgatgaa
tgacctgtcacacagatctaacgtggcaaaacgaaaaaggagacagtattcgtttcgaggccggagagagcatca
aaataaa 
CXCL9 None ttaagttttctagtcaaactaacaagcttatgcattagatgccttcccgtcttggtaaagtgttgtcttatgcagtcttctttt
gacgaggacgttgaaattttccaactgttttacctttcttgattttccaacgttttcccaacttcttttgctttttcttttggccg
gtctgtttctcccaggctttcaccaattttttcacatcttttaagtctgggtttaggcacgtttgatctccattcttcagtgtag
caatgatttcagctttcccacaggaagagcttggggcaaattgttggaggtctttcaaggattgtaattggatcttctctt
ggttaatgttaangcagaagca 
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Table 5.3: In situ hybridization results 
 
 Negative Positive 
1    2 3 4 5 6 7 8 9 10 11 12 13 14 
 actin L/2 L/4 L/0 L/0 L/1 L/0 L/0 L/2 L/4 L/0 L/3 L/1 L/3 L/0 
CXCL9 M/0 M/0 M/0 M/0 L/0 M/2 M/1 M/1 M/3 M/0 L/0 M/2 L/2 L/1 
IL-4 L/0 L/0 ND ND L/0 L/1 L/1 L/0 L/1 ND L/0 L/0 L/1 L/0 
IL-10 L/0 L/0 ND ND L/0 L/0 L/2 L/0 L/0 ND L/0 L/0 L/0 L/0 
TNF- L/0 L/0 ND ND L/0 L/1 L/0 M/0 M/0 ND L/1 L/2 L/0 L/0 
TGF- L/0 L/0 ND ND L/0 L/0 L/0 L/0 L/2 ND L/0 L/0 L/0 L/0 
IFN- L/0 L/0 ND ND L/1 L/1 L/0 L/0 L/2 ND L/0 L/2 L/0 L/0 
 
Legend: For each probe, every sample was independently assessed for overall level of background (L = 
low, M = medium, H = high) and amount of antisense-specific probe signal per section (Grade 0 = no 
antisense probe-specific signal/section; Grade 1 = <10 signals/section; Grade 2 = 10-25 signals/section; 
Grade 3 = 25-50 signals/section; Grade 4 = >50 signals/section); ND = Not done.  Sample numbers (1-14) 
are listed in the second row; evaluated probes are listed in the first column.  Because samples 3, 4, and 10 
lacked antisense probe-specific signal for both positive control probes ( actin and CXCL9), these 
samples were deemed nonviable and excluded from subsequent analyses.   
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Figure 5.1: Asian elephant pulmonary tuberculosis histologic lesions 
 
Fig 5.1: A and B, sample 6 – Pulmonary parenchyma is obscured by multiple nodular accumulations of poorly 
organized granulomatous inflammation with necrosis.  B and C, sample 11 – The lung contains discrete granulomas 
with mineralized necrotic centers surrounded by abundant mature fibrous connective tissue.  E and F, sample 13 – 
Foci of necrosis are surrounded by granulomatous inflammation and peripheral accumulations of granulation tissue 
and lesser mature fibrosis.  Asterisks note areas of central necrosis and/or mineralization; arrows delineate fibrous 
connective tissue surrounding granulomatous inflammation.  A,C, E – 40x; B, D, F – 100x.  Hematoxylin and eosin. 
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Figure 5.2: Elephant pulmonary tuberculosis lesion CD3 immunolabeling 
 
  
 
Fig 5.2: Serial sections of lung from tuberculosis positive Asian elephant (sample 11).  Panel A – 
negative control; Panel B – CD3 immunolabeling.  CD3 positive immunolabeling is present in Panel B as 
cytoplasmic brown staining.  Immunolabeling for CD3 is absent in the negative control depicted in Panel 
A.  400x. Diaminobenzidine label, hematoxylin counterstain.
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Figure 5.3: Tumor necrosis factor alpha in situ hybridization 
 
 
 
 
 
Fig. 5.3: Serial sections of lung from a tuberculosis positive Asian elephant (sample 12).  Panel A – 
Section hybridized with TNF- sense probe.  Panel B – Section hybridized with TNF- antisense probe.  
Antisense probe-specific signal is evident in Panel B as multiple, distinct aggregates of black silver 
granules.  Silver granule aggregates are absent in Panel A.  20X. Hematoxylin counterstain. 
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Figure 5.4: Interferon gamma in situ hybridization 
 
 
 
 
 
Fig. 5.4: Serial sections of lung from a tuberculosis positive Asian elephant (sample 9).  Panel A – 
Section hybridized with IFN- sense probe.  Panel B – Section hybridized with IFN- antisense probe.  
Antisense probe-specific signal is evident in Panel B as multiple, distinct aggregates of black silver 
granules.  Silver granule aggregates are absent in Panel A.  20X.  Hematoxylin counterstain. 
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CHAPTER 6: OPTIMIZATION OF PERIPHERAL BLOOD MONONUCLEAR CELL 
CULTURE TECHNIQUES FOR MYCOBACTERIAL ANTIGEN STIMULATION OF 
ELEPHANT SAMPLES  
6.1: Abstract 
Tuberculosis is the prototypical example of an infection in which the host cell-mediated immune 
response plays a crucial role in disease development.  Peripheral blood mononuclear cell (PBMC) culture 
techniques provide feasible, minimally invasive methods for studying cell-mediated immune responses in 
a laboratory setting.  Such techniques have been used routinely in studies of human and bovine 
tuberculosis and have led to the current understanding of disease pathogenesis in these species.  Though 
tuberculosis is an important health concern affecting both captive and free-ranging populations of 
elephants worldwide, little is known about elephant immunity to this disease.  The current study was 
undertaken to validate and optimize standard PBMC culture techniques for use with elephant samples in 
an effort to facilitate future investigations into cell-mediated immune function.  Parameters investigated 
included cell culture media composition, culture cell concentration, incubation time, and mitogen and 
antigen concentrations for optimal stimulation as evidenced by PBMC proliferation.  Results indicated 
optimal proliferative responses of elephant PBMCs were obtained at concentrations of 1 x 10
5
 viable 
cells/ml in the presence of culture media supplemented with beta mercaptoethanol and following 
stimulation with Mycobacterium bovis purified protein derivative (PPD-B) or recombinant M. 
tuberculosis culture filtrate protein (CFP)-10 at a concentration of 20 g/ml and an incubation time of 5 
days.  Findings also established that elephant PBMCs stimulated with 6 g/ml ConA could serve as a 
positive control for proliferation.  Culture of elephant PBMCs with recombinant M. tuberculosis 6 kDa 
early secretory antigen target (ESAT-6) did not result in detectable proliferation at any tested 
concentration.  These optimized elephant-specific protocols can be used to compare immune responses in 
PBMC cultures from tuberculosis positive and negative animals and may aid in understanding 
contributions of the elephant immune system to this disease. 
6.2: Introduction 
 With mycobacterial infection, pathogen virulence is not the only significant factor in 
determination of disease outcome.  The host immune response plays a crucial role in infection and disease 
development.  In humans, individuals susceptible to active disease are characterized by altered and/or 
inadequate cellular immune responses (Al-Attiyah et al, 2006; Bhattacharyya et al, 1999; Demissie et al, 
2004; Kellar et al, 2011; Raja, 2003; Surcel et al, 1994; Zuniga et al, 2012) .  Understanding the host 
contribution to disease development with mycobacterial infection can provide opportunity for illustrating 
pathogenesis, elucidating individual susceptibility, and improving diagnostic and treatment modalities.  
Interferon gamma release assays (i.e. QuantiFERON
®
 GOLD) that detect elevated cytokine production by 
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Mycobacterium spp.-infected macrophages in positive samples have become first-line screening tests in 
cases of human tuberculosis (Raja, 2003).  These tests can offer increased sensitivity and rapid results as 
compared with conventional tuberculin skin testing.  Similar diagnostics would be invaluable in cases of 
elephant tuberculosis where conventional tuberculin skin testing is impossible and development of 
serologic screening is ongoing (Greenwald et al, 2009; Lyashchenko et al, 2012;  Lyashchenko et al, 
2006).  Additionally, a better understanding of elephant tuberculosis pathogenesis and especially host 
immune contributions could be important in defining and identifying individual and species susceptibility 
to this disease.   
Peripheral blood mononuclear cell (PBMC) culture techniques provide feasible, minimally 
invasive methods for studying cell-mediated immune responses in a laboratory setting.  Whole blood that 
can be obtained by routine venipuncture is the only required sample.  Mononuclear cells (lymphocytes 
and monocytes) isolated from whole blood samples can then be cultured in the presence of a variety of 
stimulants in order to study immune responses of interest.  Comparison of culture responses between 
samples from infected and uninfected individuals could provide insight into immune responses and 
uncover differences that may be important to susceptibility.  Such techniques have been used routinely in 
studies of human and bovine tuberculosis (Al-Attiyah et al, 2006; Bhattacharyya et al, 1999; Demissie et 
al, 2004; Kellar et al, 2011; Rhodes et al, 2000; Surcel et al, 1994; Thacker et al, 2007).  In humans, 
differences in PBMC culture responses to mycobacterial antigen between active and latently infected 
individuals have provided the basis for current understanding of human tuberculosis pathogenesis.  
Similar information regarding specifics of elephant tuberculosis pathogenesis is needed for continued 
advances in diagnosis, treatment, and disease management.  This study was undertaken to validate and 
optimize standard PBMC culture techniques for use with elephant samples.  Optimal parameters for 
measurement of cell proliferation following mitogen and mycobacterial antigen stimulation were 
determined.  Because serologic studies have shown detection of the M. tuberculosis 6 kDa early secretory 
antigenic target (ESAT-6) and culture filtrate protein (CFP)-10 in combination to be associated with the 
greatest sensitivity and specificity (100% for the combination) for distinguishing Mycobacterium 
tuberculosis complex infected from uninfected elephants (Greenwald et al, 2009; Lyashchenko et al, 
2012; Lyashchenko et al, 2006), these specific mycobacterial antigens were tested, in addition to the more 
generic mycobacterial purified protein derivative (PPD).  Resultant elephant-specific protocols can be 
used to evaluate immune responses in PBMC cultures from tuberculosis positive and negative animals 
and may aid in understanding the contribution of the elephant immune system to this disease.  
 
 
 
 92 
6.3: Materials and methods   
6.3.1: Preparation of elephant PBMC cultures 
 For all validation/optimization experiments, 15 ml of heparinized peripheral whole blood 
collected from the ear vein using routine venipuncture technique from two tuberculosis trunk wash culture 
negative and seronegative, female Asian elephants (Elephas maximus), aged 38 and 42 years, were 
utilized.  Elephant PBMCs were isolated from whole blood samples using density gradient centrifugation 
with Ficoll-Paque
TM
 Plus, density 1.077 +/- 0.001 g/ml (GE Healthcare, Uppsala, Sweden).  For each 
sample, 15 ml of room temperature, heparinized whole blood were diluted with 33 ml of room 
temperature Hank’s Balanced Salt Solution (HBSS; Fisher Scientific, Pittsburgh, PA).  The diluted 
sample was divided into 6, equal 8 ml aliquots, and each aliquot was carefully layered over 4 ml of room 
temperature Ficoll- Paque
TM
 Plus in 15 ml sterile, plastic conical vials.  Separation was achieved through 
centrifugation at 400 RCF for 30 minutes.  Following centrifugation, the superficial buffer and plasma 
layers were removed from each vial via aspiration without disturbing the mononuclear cell layer interface.  
Next, the mononuclear cell layer was removed via aspiration and transferred to a new 15 ml vial.  
Mononuclear cells were washed with HBSS; individual aliquots from each sample were recombined and 
suspended in 37C cell culture medium.  Cell culture medium consisted of RPMI 1640 medium with 
HEPES and L-glutamine (HyClone; Thermo Scientific, Waltham, MA) supplemented with 10% heat 
inactivated fetal calf serum (MP Biomedicals, Solon, OH), 1% 100 mM sodium pyruvate (Invitrogen, 
Carlsbad, CA), 1%, 10 mM minimal essential medium (Sigma-Aldrich, St. Louis, MO), 1% 5000 U 
penicillin/5000 Fg/ml streptomycin (Invitrogen), and 0.1% 10 mg/ml gentamycin sulfate (Invitrogen).  
Mononuclear cell viability was assessed directly in an aliquot of each sample through evaluation of trypan 
blue dye (Sigma-Aldrich) retention (viable cells are able to pump dye out excluding the stain; nonviable 
cells retain stain).  Each sample was then diluted with cell culture medium to a final working 
concentration. 
6.3.2: Inclusion of beta mercaptoethanol in cell culture medium 
 Elephant PBMCs were cultured in the presence and absence of beta mercaptoethanol in order to 
assess utility of its inclusion in the medium for future experiments.  Separate aliquots of isolated PBMCs 
from each sample were suspended at 1 x 10
5
 viable cells/ml in cell culture medium lacking beta 
mercaptoethanol (as described above) and in medium containing 3.66 x 10
-4 
% beta mercaptoethanol (2 x 
10
-5
 M; Fisher Scientific).   Cultures were plated onto 96 well, flat bottom, clear plastic culture plates 
(Falcon
®
 3872 Primaria
®
; Becton Dickinson, Lincoln Park, NJ) in triplicate, 100 l aliquots.  Samples 
were incubated for 3 days (72 hours) at 37C, 5% CO2 in the presence of 8 g/ml concanavalin A (ConA; 
Sigma-Aldrich).  Based upon the results of previous preliminary experiments conducted by the 
investigator, this concentration of ConA was known to stimulate proliferation of elephant PBMCs.  
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Unstimulated sample aliquots and cell-free medium controls were included to serve as negative controls.  
Following the 3 day incubation, cellular proliferation was compared between cultures containing and 
lacking beta mercaptoethanol.  Proliferating cells were distinguished and quantified via brominated 
uridine (BrdU) incorporation using a commercially available cell proliferation 5-bromo-2’deoxyuridine 
ELISA kit (Roche Diagnostics Corporation; Indianapolis, IN) according to manufacturer’s instructions.  
Colorimetric reactions were assessed via spectrophotometry at 20 minutes post addition of kit substrate 
(SPECTRAmax PLUS; Molecular Devices, Sunnyvale, CA) and analyzed using SOFTmaxPRO software 
(Version 3.1.1; Molecular Devices).  In previous elephant PBMC experiments conducted by the 
investigator, peak absorbance in most samples was achieved by 20 minutes post addition of kit substrate; 
thus this time point was utilized for data collection in the current experiments. 
6.3.3: Cell culture concentration 
 In order to determine the concentration of elephant PBMCs associated with optimal proliferation 
following mitogen stimulation, elephant PBMCs were simultaneously cultured at a variety of 
concentrations within the BrdU ELISA kit recommended range (1 x 10
3
 - 1 x 10
5
 viable cells/ml).  
Elephant PBMCs were suspended at 1 x 10
3
, 5 x 10
3
, 1 x 10
4
, 5 x 10
4
, and 1 x 10
5
 viable cells/ml in cell 
culture medium supplemented with 3.66 x 10
-4 
% beta mercaptoethanol.  Cultures were plated onto 96 
well, flat bottom, clear plastic culture plates in triplicate, 100 l aliquots.  Samples were incubated for 3 
days at 37C, 5% CO2 in the presence of 8 g/ml ConA.  Unstimulated sample aliquots and cell-free 
medium controls were included to serve as negative controls.  Following the 3 day incubation, cellular 
proliferation was quantified via BrdU incorporation using the BrdU ELISA kit.  Colorimetric reactions 
were assessed via spectrophotometry at 20 minutes post addition of kit substrate and analyzed using 
SOFTmaxPRO software. 
6.3.4: Optimal mitogen concentration and incubation time for ConA stimulation 
 Based on results from the previous experiments, elephant PBMCs were suspended at 1 x 10
5
 
viable cells/ml in cell culture medium supplemented with 3.66 x 10
-4 
% beta mercaptoethanol.  Cultures 
were plated onto 96 well, flat bottom, clear plastic culture plates in triplicate, 100 l aliquots.  In order to 
determine optimal mitogen concentration for elephant PBMC proliferation, samples were incubated in the 
presence of 2, 4, 6, 8, 10, 15, or 20 g/ml ConA at 37C, 5% CO2 for 3 days (72 hours) prior to 
application of the BrdU label.  Samples were then incubated in the presence of ConA at the determined 
optimal concentration for 2, 3, or 4 days (48, 72, or  96 hours, respectively) at 37C, 5% CO2 to evaluate 
preferred incubation time.  Unstimulated sample aliquots and cell-free medium controls were included to 
serve as negative controls.  Following incubation, cellular proliferation was quantified via BrdU 
incorporation using the BrdU ELISA kit.  Colorimetric reactions were assessed via spectrophotometry at 
20 minutes post addition of kit substrate and analyzed using SOFTmaxPRO software. 
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6.3.5: Optimal antigen concentration and incubation time for Mycobacterium bovis purified protein 
derivative stimulation 
 Elephant PBMCs were suspended at 1 x 10
5
 viable cells/ml in cell culture medium supplemented 
with 3.66 x 10
-4 
% beta mercaptoethanol.  Cultures were plated onto 96 well, flat bottom, clear plastic 
culture plates in triplicate, 100 l aliquots.  In order to determine optimal antigen concentration for 
stimulation of elephant PBMCs with Mycobacterium bovis purified protein derivative (PPD-B; Prionics, 
Zurich, Switzerland), samples were incubated in the presence of 1, 5, 10, 15, 20, 25, or 30 g/ml PPD-B 
at 37C, 5% CO2 for 5 days (120 hours) prior to application of the BrdU label.  Samples were then 
incubated in the presence of PPD-B at the determined optimal concentration for 3, 4, 5, 6, or 7 days (72, 
96, 120, 144, or 168 hours, respectively) at 37C, 5% CO2 to evaluate preferred incubation time.  
Unstimulated sample aliquots and cell-free medium controls were included to serve as negative controls.  
Aliquots cultured in the presence of 6 g/ml ConA were included as positive controls.  Following 
incubation, cellular proliferation was quantified via BrdU incorporation using the BrdU ELISA kit.  
Colorimetric reactions were assessed via spectrophotometry at 20 minutes post addition of kit substrate 
and analyzed using SOFTmaxPRO software. 
6.3.6: Elephant PBMC stimulation with recombinant Mycobacterium tuberculosis antigens 
 In order to assess the viability of ESAT-6 and CFP-10 proteins as antigens in elephant PBMC 
stimulation assays, elephant PBMCs were cultured with commercially available recombinant ESAT-6 and 
CFP-10 proteins (BEI Resources, Manassas, VA).  Elephant PBMCs were suspended at 1 x 10
5
 viable 
cells/ml in cell culture medium supplemented with 3.66 x 10
-4 
% beta mercaptoethanol.  Cultures were 
plated onto 96 well, flat bottom, clear plastic culture plates in triplicate, 100 l aliquots.  Samples were 
then incubated in the presence of 2.5, 5, 10, 20, 30, 40, or 50 g/ml ESAT-6 and 10, 20, 30, 40, or 50 
g/ml CFP-10 at 37C, 5% CO2 for 5 days prior to application of the BrdU label.  Unstimulated sample 
aliquots and cell-free medium controls were included to serve as negative controls.  Aliquots cultured in 
the presence of 6 g/ml ConA were included as positive controls.  Following incubation, cellular 
proliferation was quantified via BrdU incorporation using the BrdU ELISA kit.  Colorimetric reactions 
were assessed via spectrophotometry at 20 minutes post addition of kit substrate and analyzed using 
SOFTmaxPRO software.   
6.3.7: Data analysis 
 Absorbance values obtained via spectrophotometry for each sample triplicate were averaged to 
produce a single representative value.  Any sample in which triplicate values varied more than 2 standard 
deviations from the mean were rejected and reanalyzed.  Then, absorbance values for stimulated sample 
aliquots were divided by absorbance values for the unstimulated sample aliquots to determine the 
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stimulation index for each sample.  For each tested parameter, the optimal value was that associated with 
peak PBMC proliferation as determined by calculated stimulation indices. 
6.4: Results 
6.4.1: Preparation of elephant PBMC cultures 
 Peripheral blood mononuclear cells were successfully isolated from samples from both animals 
using density gradient centrifugation.  Cell viability ranged from 98-99% in all samples.  
 6.4.2: Inclusion of beta mercaptoethanol in cell culture medium 
 Proliferation of elephant PBMCs following ConA stimulation was greater in samples cultured in 
media containing 3.66 x 10
-4 
% beta mercaptoethanol than in media without supplementation.  Sample 
stimulation indices for ConA when cultured with beta mercaptoethanol were 6.52 and 4.92, while aliquots 
cultured without beta mercaptoethanol had stimulation indices of 5.66 and 3.56, respectively.  Based upon 
these findings, all subsequent validation/optimization experiments were performed using cell culture 
media supplemented with beta mercaptoethanol. 
6.4.3: Cell culture concentration 
 The greatest proliferative responses were noted in sample aliquots cultured at a concentration of 1 
x 10
5 
viable cells/ml (Figure 6.1).  A concentration of 1x 10
6
 cells/ml was not tested because this was 
above the stated cell concentration limit of the proliferation kit.  Based upon these findings, all subsequent 
validation/optimization experiments utilized sample aliquots at a concentration of 1 x 10
5 
viable cells/ml. 
6.4.4: Optimal mitogen concentration and incubation time for ConA stimulation 
 Elephant PBMC proliferative responses were greatest for sample aliquots cultured in the presence 
of 4 or 6 g/ml ConA and incubated for 3 days (Figure 6.2).  Some proliferation was detected for all 
tested ConA concentrations, however, low to moderate concentrations (4 and 6 g/ml) were associated 
with the most robust responses.  The highest tested concentrations (15 and 20 g/ml) had the least 
proliferation as measured by BrdU incorporation.  Proliferation was also apparent at all three tested 
incubation times.  Proliferative responses were most pronounced, however, following 3 days of 
incubation prior to application of the BrdU label.  For subsequent experiments evaluating parameters for 
antigen stimulation of the elephant PBMCs, sample aliquots stimulated with 6 g/ml ConA served as 
positive controls for proliferation. 
6.4.5: Optimal antigen concentration and incubation time for PPD-B 
 Elephant PBMC proliferative responses were greatest for sample aliquots cultured in the presence 
of 20 g/ml PPD-B and incubated for 5 days (Figures 6.3A and 6.3B).  Tested higher and lower antigen 
concentrations resulted in less proliferation.  Proliferation was evident in samples incubated for 5, 6, and 
7 days.  Proliferative responses were less pronounced in samples incubated for only 3 or 4 days.  
Proliferative responses in the ConA stimulated positive control sample aliquots, though optimal at 3 days 
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of incubation, were still present at longer tested incubation times.  Based on these results, subsequent 
experiments evaluating responses to stimulation with recombinant M. tuberculosis antigens utilized a 5 
day incubation. 
6.4.6: Elephant PBMC stimulation with recombinant Mycobacterium tuberculosis antigens 
 Stimulation of elephant PBMCs with CFP-10 resulted in detectable proliferative responses.  
Similar to PPD-B, elephant PBMC proliferative responses were greatest for sample aliquots cultured in 
the presence of 20 g/ml CFP-10 (Figure 6.4).  Significant proliferation of the elephant PBMCs was not 
produced following stimulation with any of the tested concentrations of ESAT-6 (Figure 6.5).  
6.5: Discussion 
 The experiments in this study were undertaken to determine appropriate parameters for culture 
and stimulation of elephant PBMCs with mycobacterial antigens.  The ability to evaluate responses of 
elephant PBMCs in cell culture creates a new avenue for investigation of elephant immunity.  Such 
techniques allow for evaluation of functional responses unable to be detected or quantified via serologic 
methods alone.  In the case of mycobacterial infections specifically, utilization of PBMC culture methods 
could facilitate investigations into elephant disease pathogenesis similar to those previously done in 
human and bovine tuberculosis research (Al-Attiyah et al, 2006; Bhattacharyya et al, 1999; Demissie et 
al, 2004; Kellar et al, 2011; Rhodes et al, 2000; Surcel et al, 1994; Thacker et al, 2007; Zuniga et al, 
2012).  The ability to apply similar methodology would allow for more accurate comparisons with 
existing literature and research in these other species.  Information on functional responses may also 
prove useful in the development of new diagnostic and treatment monitoring tools.  In humans, interferon 
gamma release assays (i.e. QuantiFERON
®
 GOLD), have become the gold standard for tuberculosis 
infection screening (Raja, 2003).  A similar test for use in elephants could be invaluable considering the 
impracticality of tuberculin skin testing and difficulties in interpretation of serologic data in this species.  
Establishment of validated and optimized cell culture techniques for use with elephant PBMCs provides 
the foundation for related and specific research into elephant tuberculosis immunopathogenesis, 
diagnosis, and treatment monitoring. 
In serologic studies, the detection of ESAT-6 and CFP-10 in combination has been associated 
with the greatest sensitivity and specificity (100% together) for distinguishing Mycobacterium 
tuberculosis complex infected from uninfected elephants.  Tests that employed a more diverse cocktail of 
antigens, including MPB83, were associated with decreased specificity due to cross reaction for the 
MPB83 antigen in animals infected with nontuberculous mycobacteria (Greenwald et al, 2009; 
Lyashchenko et al, 2012; Lyashchenko et al, 2006).  Though the specific mycobacterial antigens 
recognized by the elephant cell-mediated immune response are unknown, findings of these serologic 
studies suggested culture of elephant PBMCs from tuberculosis positive individuals in the presence of 
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ESAT-6 and CFP-10 proteins might provide enhanced specificity as compared with PPD-B stimulation 
alone.  In this study, significant proliferative responses were not detected following incubation of the 
elephant PBMCs with any of the tested concentrations of ESAT-6.  At the time of collection, both study 
elephants were trunk wash mycobacterial culture negative and seronegative.  Because recognition of 
ESAT-6 and consequent proliferative response would not be expected in negative elephants lacking 
exposure to M. tuberculosis, results were not unexpected.  Interestingly, proliferation was detected after 
stimulation of the elephant PBMCs with both PPD-B and CFP-10.  Response to PPD-B could have been 
somewhat nonspecific considering PPD comprises a mixture of several protein antigens extracted from 
whole culture.  Culture filtrate protein-10, however, is a secreted protein antigen specific to tuberculous 
mycobacteria.  Thus, proliferative responses in these samples following PPD-B and CFP-10 stimulation 
were suggestive of at least previous exposure M. tuberculosis complex Mycobacterium spp..  The lack of 
response to ESAT-6 in the current study could indicate that this antigen may not be useful for eliciting 
cell-mediated immune responses in Mycobacterium sp. exposed, but negative (uninfected) elephants.  
Alternatively,  tested antigen concentrations and/or other cell culture parameters may have not been 
sufficient for generation of detectable responses to ESAT-6 in the available samples.   
 Based upon the results of these experiments, recommendations for future studies assessing 
proliferative responses of elephant PBMC cultures would include: inclusion of 3.66 x 10
-4 
% beta 
mercaptoethanol in the culture medium; culture at a concentration of 1 x 10
5 
viable cells/ml; stimulation 
with 6 g/ml ConA as a positive control for proliferation;  stimulation with mycobacterial antigen (PPD-
B, CFP-10) at a concentration of 20 g/ml; incubation for 5 days for antigen response.  Validated and 
optimized of PBMC culture protocols for use with elephant samples defined by this study have the ability 
to impact not only future research into elephant tuberculosis, but also investigations of cell-mediated 
immune responses in other infectious diseases and general immune function in this endangered species.  
Importantly, because the protocols established by this study will allow for evaluation of immune 
functional responses in elephants using peripheral blood samples collected via routine, minimally 
invasive venipuncture, these techniques should also be feasible and applicable in a variety of research 
settings.        
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6.7: Figures 
 
Figure 6.1: Optimal concentration for culture of elephant peripheral blood mononuclear cells (PBMCs) 
 
 
Fig. 6.1: Figure displays comparison of stimulation indices for PBMCs from 2 animals cultured at various 
cell concentrations and in the presence of 8 g/ml ConA at 37C, 5% CO2 for 3 days.  Stimulation index 
was calculated by dividing the absorbance value for the ConA-stimulated sample aliquot by the 
absorbance value for the unstimulated sample aliquot. 
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Figure 6.2: Optimal concanavalin A (ConA) concentration for stimulation of elephant PBMCs 
 
 
Fig. 6.2: Figure shows comparison of stimulation indices for PBMCs from 2 animals following culture in 
the presence of various concentrations of ConA at 37C, 5% CO2 for 3 days.  Stimulation index was 
calculated by dividing the absorbance value for the ConA-stimulated sample aliquot by the absorbance 
value for the unstimulated sample aliquot. 
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Figure 6.3a: Optimal Mycobacterium bovis purified protein derivative (PPD-B) concentration for 
stimulation of elephant PBMCs 
 
 
Fig. 6.3a: Figure shows comparison of stimulation indices for PBMCs from 2 animals following culture 
in the presence of various concentrations of PPD-B at 37C, 5% CO2 for 5 days.  Stimulation index was 
calculated by dividing the absorbance value for the PPD-B-stimulated sample aliquot by the absorbance 
value for the unstimulated sample aliquot. 
 
Figure 6.3b: Incubation time for stimulation of elephant PBMCs with PPD-B 
 
 
Fig. 6.3b: Figure shows comparison of stimulation indices for PBMCs from 2 animals following culture 
in the presence of 20 g/ml PPD-B at 37C, 5% CO2 for 3, 4, 5, 6, and 7 days of incubation.   Stimulation 
index was calculated by dividing the absorbance value for the PPD-B-stimulated sample aliquot by the 
absorbance value for the unstimulated sample aliquot. 
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Figure 6.4: Optimal M. tuberculosis culture filtrate protein (CFP)-10 concentration for stimulation of 
elephant PBMCs 
 
 
Fig. 6.4: Figure shows comparison of stimulation indices for PBMCs from 2 animals following culture in 
the presence of various concentrations of CFP-10 at 37C, 5% CO2 for 5 days.  Stimulation index was 
calculated by dividing the absorbance value for the CFP-10-stimulated sample aliquot by the absorbance 
value for the unstimulated sample aliquot. 
 
Figure 6.5: Stimulation of elephant PBMCs with M. tuberculosis 6 kDa early secretory antigenic target 
(ESAT-6) 
 
 
Fig. 6.5: Figure shows comparison of stimulation indices for PBMCs from 2 animals following culture in 
the presence of various concentrations of ESAT-6 at 37C, 5% CO2 for 5 days.  Stimulation index was 
calculated by dividing the absorbance value for the ESAT-6-stimulated sample aliquot by the absorbance 
value for the unstimulated sample aliquot. 
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CHAPTER 7: DIFFERENCES IN IMMUNE CELL FUNCTION BETWEEN 
MYCOBACTERIUM SPP. INFECTED AND UNINFECTED ASIAN ELEPHANTS 
7.1: Abstract 
 Tuberculosis is an important health concern for Asian elephant (Elephas maximus) populations 
worldwide.  Infections are typically due to Mycobacterium tuberculosis, though mechanisms underlying 
tuberculosis susceptibility in elephants are unknown.  In humans and other studied species, disease 
susceptibility is dependent on the host immune response following infection.  Differences in cytokine 
production by cultured peripheral blood mononuclear cells (PBMCs) between susceptible and resistant 
individuals following exposure to mycobacterial antigen are hallmarks of human disease.  Similar studies 
have not been pursued in elephants; therefore, this study aimed to evaluate proliferative responses and 
cytokine expression in PBMC cultures from 8 tuberculosis negative and 8 positive, captive, North 
American Asian elephants.  Cultures were stimulated with M. bovis purified protein derivative (PPD-B), 
M. tuberculosis culture filtrate protein (CFP)-10, and M. avium PPD (PPD-A).  Proliferation was assessed 
via brominated uridine incorporation.  Cytokine expression was measured in RNA extracted from cultures 
using elephant-specific, real time RT-PCR assays.  Differences in proliferative responses and cytokine 
mRNA levels between positive and negative samples were evaluated using Mann-Whitney U tests.  
Following stimulation with PPD-B and the mitogen, Concanavalin A, proliferation was higher in samples 
from positive elephants; no significant difference in proliferation was detected between groups following 
CFP-10 or PPD-A stimulation.  Fold differences in tumor necrosis factor (TNF)- and interleukin (IL)-12 
values following stimulation with PPD-B and CFP-10 were greater in the samples from positive elephants.  
Stimulation with PPD-A also produced greater IL-12 levels in the samples from positive elephants.  No 
significant differences in transforming growth factor (TGF)-  mRNA expression were detected for any of 
the tested stimulants.  Levels of interferon (IFN)- were undetectable in most unstimulated, control 
sample aliquots; thus fold differences in levels following culture stimulation could not be calculated.  
However comparison of IFN- normalized, raw Ct values from ConA, PPD-B and CFP-10 stimulated 
sample aliquots did reveal significant differences between positive and negative groups.  Levels of IFN- 
were higher in the samples from positive elephants.  The findings of this study suggested that differences 
in immune cell function do exist between tuberculosis positive and negative elephants.  Specifically, 
proliferative responses and expression of TNF-, IL-12, and possibly IFN- in response to stimulation 
with PPD-B and CFP-10 appear to distinguish Mycobacterium spp. infected from uninfected individuals.  
Results suggest these parameters are important to tuberculosis immunopathogenesis in this species and 
could serve as useful diagnostic markers. 
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7.2: Introduction 
 Tuberculosis is an important health concern for elephant populations worldwide.  The disease 
most commonly affects Asian elephants (Elephas maximus), and the majority of cases are due to 
Mycobacterium tuberculosis, the cause of human tuberculosis (Mikota et al, 2001; Mikota et al, 2006; 
Mikota and Maslow, 2011; Payeur, 2002).  Since 1994, 50 culture confirmed cases of tuberculosis have 
been documented in U.S. captive elephants (Mikota and Maslow, 2011).  Recent studies have also 
reported confirmed cases and increased seroprevalance in populations of domesticated Asian elephants in 
range countries (Angkawanish et al, 2010; Verma-Kumar et al, 2012).  Elephant infections are typically 
chronic and subclinical; consequently diagnosis of infected individuals is challenging (Mikota et al, 2001; 
Mikota et al, 2006; Mikota and Maslow, 2011; Schmitt, 2003).  The current gold standard test, trunk wash 
mycobacterial culture, is extremely insensitive (Mikota et al, 2006; Mikota and Maslow, 2011; 
Lyashchenko et al, 2006; Lyashchenko et al, 2012).  Newer serologic tests have been developed and 
recommended for screening.  These tests have much improved sensitivity and good specificity, however, 
validation is on-going (Greenwald et al, 2009; Larsen et al, 2005; Lyashchenko et al, 2006; Lyashchenko 
et al, 2012; Mikota et al, 2006).  In addition to individual animal and herd health concerns, elephant 
mycobacterial infection has significant public health implications.  Throughout the world, captive 
elephants interact closely with human handlers for work and exhibition providing opportunity for 
exposure and potential zoonotic and/or anthropozoonotic transmission of disease (Michalak et al, 1998; 
Mikota et al, 2001; Mikota et al, 2006; Murphree et al, 2011).  The threat of disease transmission also 
extends to wild populations of elephants.  Though to date, infection has not been documented in wild 
elephant populations, in range countries, captive working elephants frequently mingle with free-ranging 
elephants providing opportunity for disease transmission (Mikota et al, 2006).  Public health vigilance 
and effective conservation of this endangered species require a better understanding of the pathogenesis 
of tuberculosis in elephants. 
 Unfortunately, the mechanisms underlying tuberculosis susceptibility in elephants are unknown.  
Information regarding elephant immune function is scarce (De Jong et al, 2003; Landolfi et al, 2010; 
Landolfi et al, 2009; Sreekumar et al, 2007).  In humans and other studied species, disease susceptibility 
is dependent on the character of the host immune response following infection.  Generation of a specific, 
adaptive immune response to an infection is dependent on the balance between humoral and cell-mediated 
components of the immune system (Abbas and Lichtman, 2003).  The interplay and ultimate balance 
between cell-mediated and humoral responses are orchestrated by cytokines, secreted protein mediators 
that modulate immune cell proliferation and function.  Based upon their role in the immune response, 
cytokines are categorized as TH1 (cell-mediated) or TH2 (humoral).  Measurement of specific cytokine 
levels locally and systemically can provide valuable information about the immune response during 
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health and various states of disease (Abbas and Lichtman, 2003; Flynn and Chan, 2001; Kaufmann et al, 
2005; Raja, 2003).  
 Though immune responses to tuberculosis are complex, a disturbance in the normal TH1/ TH2 
balance is central to disease pathogenesis (Bhatt and Salgame, 2007; Bhattacharyya et al, 1999; Boom et 
al, 2003; Flynn and Chan, 2001; Kaufmann et al, 2005; Kellar et al, 2011; Raja, 2003; Rhodes and Buddle 
et al, 2000; Thacker et al, 2006; Wang et al, 2012; Welsh et al, 2005).
   
In general, successful clearance of 
intracellular pathogens such as Mycobacterium spp. requires an adequate TH1-dominated immune 
response (Abbas and Lichtman, 2003; Kaufmann et al, 2005; Raja, 2003).  The majority of exposed 
humans are able to mount an effective TH1-dominated immune response, and consequently only 5-10% of 
individuals exposed to M. tuberculosis become infected and develop clinical disease (Bhatt and Salgame, 
2007; Cooper, 2009; Flynn and Chan, 2001; Sundaramurthy and Pieters, 2007).  In these susceptible 
individuals, inadequate systemic TH1 responses have been documented with progression of disease (Al-
Attiyah et al, 2006; Bhattacharyya et al, 1999; Demissie et al, 2004; Hussain et al, 2002; Torres et al, 
1998; Wang et al, 2012). 
 
Considering altered immune responses to tuberculosis are believed to be 
instrumental in determining disease susceptibility and influencing pathogenesis in humans, it is plausible 
that immune function alterations may similarly contribute to Asian elephant tuberculosis susceptibility. 
 In a previous study, mRNA levels of several TH1 and TH2 cytokines significant in the 
pathogenesis of human tuberculosis were measured in peripheral whole blood samples from 106 (15 % 
tuberculosis seropositive) Asian elephants using elephant-specific, real time RT-PCR assays (Landolfi et 
al, 2010; Dissertation Chapter 4).  Cytokine levels were measured in the absence of any mitogenic or 
antigenic stimulation.  Though significant differences in levels of examined cytokines were not detected, 
the data illustrated some trends in cytokine expression between the two groups that warranted further 
investigation.  Consequently, the current study was undertaken to measure proliferative responses and 
cytokine mRNA expression in peripheral blood mononuclear cell (PBMC) cultures from 8 tuberculosis 
negative and 8 positive, captive, North American Asian elephants following stimulation with 
mycobacterial antigens. 
7.3: Materials and methods 
7.3.1: Animals/Sample collection 
 Samples were from 16 captive, North American, Asian elephants.  For the purposes of this study, 
positive cases were designated as elephants with positive trunk wash mycobacterial cultures and/or 
seroreactivity to both the Elephant TB STAT PAK

 screening test (Chembio, Medford, NY) and multiple 
antigen print immunoassay (MAPIA).  Negative cases were those with no history of positive trunk wash 
culture or serology and no history of exposure to a known positive elephant.  All study animals were zoo 
or retired performance elephants accustomed to human handlers and trained to cooperate voluntarily with 
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routine veterinary examinations and procedures.  The University of Illinois Institutional Animal Care and 
Use Committee approved the sample collection protocol for this study (approval # 09001).  Using 
minimal manual restraint, a total of 20 ml of peripheral whole blood was collected from the ear vein of 
each animal into two 10 ml collection tubes containing heparin sulfate (BD Biosciences, San Jose, CA).  
Samples were packaged on cool packs and shipped for next day delivery to the laboratory.  All samples 
were received for processing at the laboratory within 24 hours of collection.  In addition to blood samples, 
information regarding age, sex, current medical treatments and pertinent chronic inflammatory conditions 
was obtained for each of the study animals.   
7.3.2: Isolation of PBMCs  
 Upon receipt, blood samples were allowed to equilibrate to room temperature.  Whole blood 
smears were examined via light microscopy to determine the relative proportions of monocytes and 
lymphocytes in each sample.  Peripheral blood mononuclear cells were isolated from whole blood 
samples using density gradient centrifugation.  From each sample, 15 ml of room temperature heparinized 
whole blood were diluted with 33 ml of room temperature Hank’s Balanced Salt Solution (HBSS; Fisher 
Scientific, Pittsburgh, PA).  The diluted sample was divided into six equal 8 ml aliquots, and each aliquot 
was carefully layered over 4 ml of room temperature Ficoll-Paque
TM
 Plus, density 1.077 +/- 0.001 g/ml 
(GE Healthcare, Uppsala, Sweden) in 15 ml sterile, plastic conical vials.  Separation was achieved 
through centrifugation at 400 RCF for 30 minutes.  Following centrifugation, the superficial buffer and 
plasma layers were removed from each vial via aspiration without disturbing the mononuclear cell layer 
interface.  Next, the mononuclear cell layer was removed via aspiration and transferred to a new 15 ml 
vial.  Mononuclear cells were washed with HBSS; individual aliquots from each sample were recombined 
and suspended in 37C cell culture medium.  Cell culture medium consisted of RPMI 1640 medium with 
HEPES and L-glutamine (HyClone; Thermo Scientific, Waltham, MA) supplemented with 10% heat 
inactivated fetal calf serum (MP Biomedicals, Solon, OH), 1% 100 mM sodium pyruvate (Invitrogen, 
Carlsbad, CA), 1%, 10 mM minimal essential medium (Sigma-Aldrich, St. Louis, MO), 1% 5000 U 
penicillin/5000 Fg/ml streptomycin (Invitrogen), 0.1% 10 mg/ml gentamycin sulfate (Invitrogen) and 
3.66 x 10
-4 
% beta mercaptoethanol (2 x 10
-5
 M; Fisher Scientific).  Mononuclear cell viability was 
assessed directly in a 100 l aliquot of each sample through evaluation of trypan blue dye (Sigma-
Aldrich) retention (viable cells are able to pump dye out excluding the stain; nonviable cells retain stain).  
Each sample was then diluted with cell culture medium to a final concentration of 1 x 10
6
 viable cells/ml.    
7.3.3: Proliferation assays 
 For each sample, 100 l aliquots (1 x 105 viable cells), in triplicate, were plated onto 96 well, 
clear plastic, flat bottom culture plates (Falcon
®
 3872 Primaria
®
; Becton Dickinson, Lincoln Park, NJ).  
Samples were incubated based on previously optimized conditions for proliferation (see Dissertation 
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Chapter 6): 5 days (120 hours) at 37C, 5% CO2 in the presence of 20 g/ml Mycobacterium bovis 
purified protein derivative (PPD-B; Prionics, Zurich, Switzerland), 20 g/ml culture filtrate protein 
(CFP)-10 (BEI Resources, Manassas, VA), and 20 g/ml M. avium PPD (PPD-A; Prionics).  
Unstimulated sample aliquots and cell-free medium controls were included to serve as negative controls.  
Aliquots cultured in the presence of 6 g/ml concanavalin A (ConA; Sigma-Aldrich) were included as 
positive controls.  Following the 5-day incubation, proliferating cells were distinguished and quantified 
via brominated uridine (BrdU) incorporation using a commercially available cell proliferation 5-bromo-
2’deoxyuridine ELISA kit (Roche Diagnostics Corporation; Indianapolis, IN) according to 
manufacturer’s instructions.  Colorimetric reactions were assessed via spectrophotometry at 20 minutes 
post addition of kit substrate (SPECTRAmax PLUS; Molecular Devices, Sunnyvale, CA) and analyzed 
using SOFTmaxPRO software (Version 3.1.1; Molecular Devices).  Absorbance values obtained via 
spectrophotometry for each sample triplicate were averaged to produce a single representative value.  Any 
sample in which triplicate values varied more than 2 standard deviations from the mean were rejected and 
reanalyzed.  Then, absorbance values for stimulated sample aliquots were divided by absorbance values 
for the unstimulated sample aliquots to determine the stimulation index for each sample.  Differences in 
stimulation indices between positive and negative samples were evaluated for statistical significance with 
Mann-Whitney U tests.   
7.3.4: Quantification of cytokine expression 
7.3.4.1: Culture and RNA extraction 
 For each sample, 100 l aliquots (1 x 105 viable cells), in triplicate, were plated onto a second 96 
well, clear plastic, flat bottom culture plate for quantification of cytokine mRNA levels.  Samples were 
incubated for 2 days (48 hours) at 37C, 5% CO2 in the presence of 20 g/ml PPD-B (Prionics), 20 g/ml 
CFP-10 (BEI Resources), and 20 g/ml PPD-A (Prionics).  Unstimulated sample aliquots and cell-free 
medium controls were included to serve as negative controls.  Aliquots cultured in the presence of 6 
g/ml ConA (Sigma-Aldrich) were included as positive controls.  Following incubation, each culture 
triplicate was combined and transferred to a microcentrifuge tube.  Samples were pelleted at 18,000 RCF 
for 5 minutes.  Supernatant was discarded and RNA was extracted from cell pellets using a commercially 
available kit (RiboPure; Ambion, Austin, TX) according to manufacturer’s instructions.  Concentration of 
extracted RNA was measured using a NanoDrop
TM
 2000 spectrophotometer (Fisher Scientific).  To 
synthesize cDNA for use in real time PCR assays, 10 ng of RNA were reverse transcribed per sample in a 
90-l reaction using a commercially available kit (iScript cDNA synthesis kit; Bio-Rad, Hercules, CA). 
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7.3.4.2: Real time RT-PCR assays   
 Quantitative, real time RT-PCR assays previously developed and validated for specific use in 
elephant samples were utilized to measure mRNA levels of interleukin (IL)-4, IL-10, interferon (IFN)-, 
tumor necrosis factor (TNF)-, and transforming growth factor (TGF)-, (Landolfi et al, 2009; 
Dissertation Chapter 2).   Levels of IL-12 were measured using a newly developed and validated, 
elephant-specific assay with increased sensitivity (Table 7.1).  This assay was developed and validated 
using similar methodologies as detailed in Dissertation Chapter 2: Development of Asian elephant-
specific cytokine real time RT-PCR assays.  All real time PCR reactions were run in a simplex format in 
triplicate and contained Taqman
®
 Gene Expression Master Mix (Applied Biosystems, Foster City, CA), 
250 nmol probe, 900 nmol of both forward and reverse primers, and RNAse-free water to a final reaction 
volume of 25 l.  Reactions also included a commercially available exogenous, non-template, internal 
control (Taqman
®
 Exogenous Internal Control; Applied Biosystems) to confirm PCR amplification and 
detect potential amplification inhibitors within samples.  Real time RT-PCR assays were performed as 
previously described (Landolfi et al, 2009; Landolfi et al, 2010; Dissertation Chapters 2 and 4).  In 
addition to negative controls, each plate included cytokine-specific standards (diluted elephant PCR 
product, 1:1x10
6
 and 1:1x10
8
) used to monitor and control for interassay variation.  Amplification 
products of sample replicates were evaluated for consistency; variation among each sample’s replicate 
threshold amplification (Ct) values used in later quantitative calculations was less than one standard 
deviation from the mean. 
7.3.4.3: Housekeeping gene selection 
 To normalize the real time RT-PCR data for quantitative calculations, an appropriate 
housekeeping gene (HKG) unaffected by the experimental conditions (culture stimulation) was required.  
In order to assess candidate HKGs, levels of 18S rRNA, glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH), and beta actin were measured in both unstimulated and stimulated aliquots in a subset of the 
samples (N=6).  Levels of GAPDH and beta actin were measured using previously developed and 
validated elephant specific assays (Landolfi et al, 2009, Dissertation Chapter 2).  Levels of 18S rRNA 
were measured using a commercially available assay (Taqman
® 
Pre-Developed Assay Reagents – Human 
18S rRNA; Applied Biosystems) according to manufacturers’ guidelines.  Differences in Ct values 
between the unstimulated and stimulated aliquots for each sample were calculated for each candidate 
HKG.  The HKG with the lowest differences between unstimulated and stimulated aliquots represented 
the candidate least influenced by culture stimulation; this HKG was then used for subsequent 
normalization of the elephant cytokine real time RT-PCR data.       
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7.3.4.4: Data analysis 
 Relative quantification of cytokine mRNA amplification was determined using the Pfaffl Method 
(Pfaffl, 2001).  Replicate threshold amplification (Ct) values for each sample were averaged.  For each 
sample, values obtained from unstimulated cultures served as calibration controls.  Control average Ct 
values were subtracted from experimental/stimulated culture average Ct values to determine the fold 
increase in each cytokine/HKG as a function of the particular assay’s efficiency following the 40 cycles 
of amplification.  For each sample, the fold difference was then determined by dividing each calculated 
cytokine fold increase value by the HKG fold increase value.  In cases where the Pfaffl method could not 
be employed to calculate fold difference in mRNA levels due to lack of cytokine amplification in the 
unstimulated sample aliquot, normalized cytokine Ct values (cytokine average Ct  - HKG average Ct) 
were examined instead.  Differences in calculated values between positive and negative samples were 
evaluated for statistical significance with Mann-Whitney U tests.   
7.4: Results 
7.4.1: Animal demographic information and tuberculosis status 
Study animal demographic information and tuberculosis status are summarized in Table 7.2.  The 
mean age for the positive animals was 41 years (range 29-60); the mean age for the negative animals was 
34.5 years (12-45).  All elephants were female with exception of a single male (bull) elephant in the 
positive group.    Based on the most recent annual test results, four of the tuberculosis positive animals 
were culture positive; the remaining four were double seropositive.  At the time of sampling, Animal 3 
had been under treatment (isoniazid and pyrazinamide) for approximately 1 year.  Animal 2 had initiated 
treatment (rifampin and enrofloxacin) approximately 2 months prior to sampling.  The remaining six 
positive animals had not received any anti-tuberculosis medications.  All negative animals were culture 
negative, non-reactive on the Elephant TB STAT-PAK
®
, and lacked history of exposure to any known 
positive elephants.  The MAPIA test was not done in the negative elephants, because this assay is used as 
a confirmatory test for animals that have Elephant TB STAT-PAK
®
 positive results.  In addition to 
demographics and tuberculosis status, general information regarding the presence of common chronic 
inflammatory conditions was obtained for each of the study animals.  In six of the positive animals and 
four of the negative animals, chronic inflammatory conditions (osteoarthritis and/or pedal sole abscesses, 
specifically) were reported.  In all cases, these conditions were considered clinically mild.      
7.4.2: Isolation of PBMCs  
 Elephant PBMCs isolated via density gradient centrifugation had greater than 98% viability for 
all samples.  Cytologically, smears from all samples had similar proportions of monocytes and 
lymphocytes (Table 7.3).  The average lymphocyte to monocyte ratio for the negative samples was 1.1999 
(standard deviation = 0.253) and for the positive samples was 1.2391 (standard deviation = 0.324).  No 
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significant difference was detected in the lymphocyte to monocyte ratio between the two groups using a 
student’s t test (p = 0.789)  
7.4.3: Proliferation assays 
 Proliferation, as quantified by BrdU incorporation, was present in ConA stimulated aliquots for 
all samples confirming viability in culture (Fig. 7.1).  Trends towards greater proliferation were noted in 
the positive group for all stimulants (Fig 7.1).  Significant differences in stimulation indices between the 
positive and negative groups as indicated by Mann-Whitney U test results were present for ConA ( = 
0.025) and PPD-B ( = 0.005; Table 7.4).  
7.4.4: Quantification of cytokine expression 
 For all assays, amplification of exogenous internal positive control DNA confirmed PCR 
amplification.  Diluted elephant PCR product standards amplified as expected for all cytokines ensuring 
consistent assay efficiency and minimal interassay variation.  Levels of IL-12, TNF-, and TGF- were 
measurable in unstimulated and stimulated culture aliquots for all samples.  Interferon- was below the level 
of detection in unstimulated culture aliquots for the majority (13/16) of samples.  Interleukin-4 and IL-10 
failed to amplify in the majority of sample unstimulated and stimulated aliquots.  Due to lack of usable 
data, further analyses of potential differences in levels of IL-4 and IL-10 between the positive and 
negative groups were not pursued. 
 To facilitate selection of an appropriate housekeeping gene for normalization of real time PCR 
data, levels of GAPDH, beta actin, and 18S rRNA were measured in the subset of 6 samples.  The HKG 
with the lowest differences between unstimulated and stimulated aliquots was 18S rRNA (Table 7.5).  
Because 18S rRNA was the HKG least influenced by culture stimulation, it was utilized for normalization 
of the elephant cytokine real time RT-PCR data.   
 For all samples and all cytokines, ConA stimulation resulted in increased cytokine levels as 
compared with levels in unstimulated aliquots, confirming the use of this mitogen as a positive control for 
stimulation of cytokine mRNA expression in elephant PBMC cultures.  Differences in cytokine fold 
difference values (TNF-, IL-12, TGF-)  between the positive and negative groups following ConA 
stimulation, however, were not statistically significant (Table 7.6).  Following PPD-B stimulation, fold 
difference values for both TNF- and IL-12 were higher in the positive group, and differences between the 
positive and negative groups were statistically significant.   Similar results were seen for TNF- and IL-12 
with CFP-10 stimulation (Figs. 7.2 and 7.3; Table 7.6).  No statistically significant difference in TNF- 
levels between the two groups was detected following PPD-A stimulation.  In the case of IL-12, however, 
PPD-A stimulation did result in a difference between the two groups.  Significant differences in TGF- 
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levels between the positive and negative groups were not present with any of the tested mycobacterial 
antigens (Fig. 7.4; Table 7.6).   
For the IFN- data, lack of amplification in the majority of sample unstimulated aliquots precluded 
conventional calculation of fold difference using the Pfaffl method.  Alternatively, normalized cytokine Ct 
values (cytokine average Ct  - HKG average Ct) were determined for each of the culture stimulants and 
compared between the two groups.  Following ConA, PPD-B and CFP-10 stimulation, IFN- normalized 
Ct values were, on average,  lower in the positive group, and differences between the positive and negative 
groups were statistically significant (Fig 7.5; Table 7.6).  No statistically significant difference in IFN- 
normalized Ct values following PPD-A stimulation was detected between the two groups.  
7.5: Discussion 
 The findings of this study suggest that differences in immune cell function do exist between 
tuberculosis positive and negative elephants.  Though additional studies with larger numbers of samples 
would be ideal for confirmation, results presented here provide evidence for host immune system 
contribution in the pathogenesis of elephant tuberculosis.  Specifically, proliferative responses and 
expression of TNF-, IL-12, and possibly IFN- in response to stimulation with PPD-B and CFP-10 
appear to distinguish Mycobacterium spp. infected from uninfected individuals.  Results suggest these 
parameters may influence tuberculosis immunopathogenesis in this species and could serve as useful 
diagnostic markers. 
 Following both PPD-B and CFP-10 stimulation, levels of IL-12 mRNA were higher in positive 
samples, and differences in levels between the positive and negative groups were statistically significant 
(Fig 7.3, Table 7.6).  Interleukin-12 is produced by macrophages/monocytes and B lymphocytes 
following antigenic stimulation and results in the differentiation of naïve T lymphocytes into TH1 cells as 
well as TH1 cell production of IFN-.  Interferon- produced by mature TH1 cells then activates 
macrophages/monocytes for additional IL-12 production.  In the case of the positive elephant samples, 
noted IL-12 expression could have been the result of stimulation of mycobacterial antigen specific TH1 
cells within the samples followed by subsequent induction of IFN- secretion, and macrophage activation.  
Alternatively, as a nonspecific consequence of infection, positive samples could have contained relatively 
increased numbers of activated macrophages/monocytes, primed for IL-12 expression, as compared with 
negative samples.  Asian elephants normally possess high numbers of peripheral blood circulating 
monocytes (Schmitt, 2003).  Increased numbers of activated macrophages/monocytes present in the 
positive samples could have resulted in the elevated levels detected in this group following antigenic 
stimulation.  The later would represent a non Mycobacterium tuberculosis antigen-specific, possibly 
innate mechanism for increased expression of IL-12 in the positive samples.  Examination of direct whole 
blood smears revealed both positive and negative samples contained similar proportions of lymphocytes 
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and monocytes indicating differences between the two groups could not be attributed to discrepancies in 
absolute cell numbers.  Greater expression of IL-12 in samples from tuberculosis positive elephants was 
not limited to stimulation with M. tuberculosis specific antigens.  Stimulation of samples from positive 
elephants with PPD-A, a nontuberculous mycobacterial antigen, produced increased IL-12 in comparison 
with levels in samples from negative elephants.  These findings provided evidence for contribution of a 
non M. tuberculosis antigen-specific response to overall results.  Furthermore, lack of differences in IL-12 
levels between the groups with ConA stimulation indicated above results could not be attributed to 
nonspecific hyper-reactivity in the positive group.  Noted IL-12 expression in samples from positive 
elephants was mycobacterial antigen specific.  Altogether findings suggested differences in IL-12 mRNA 
levels between the positive and negative groups were likely secondary to both antigen-specific and 
innate/nonspecific responses to stimulation.   
Findings of elevated IL-12 mRNA levels in positive samples were contrary to the trend reported in 
previous human studies where IL-12 levels in samples from healthy controls were higher than levels from 
patients (Cooper, 2009; Cooper et al, 2007; Demissie et al, 2004, Mendez-Samperio,  2010; Song et al, 
2003).  In humans, decreased production of IL-12, a key TH1cytokine, is a manifestation of the inadequate 
systemic immune response associated with active tuberculosis susceptibility.  The importance of IL-12 in 
mycobacterial immunity is illustrated by mycobacterial susceptibility in individuals with genetic defects in 
IL-12 production and/or receptor pathways.  Murine IL-12 knock-out models of pulmonary tuberculosis also 
demonstrate the contribution of this cytokine to tuberculosis immunity (Azad et al, 2012; Cooper, 2009; 
Cooper et al, 2007; Mendez-Samperio 2010).  Findings in this study indicate tuberculosis positive elephants 
express IL-12 following stimulation with mycobacterial antigens suggesting aberrations in IL-12 levels 
alone are not responsible for susceptibility in this species.   
 Similar to IL-12, both PPD-B and CFP-10 stimulation resulted in higher levels of TNF- mRNA 
in positive samples, and differences in levels between the positive and negative groups were statistically 
significant (Fig 7.2, Table 7.6).  These results were in accordance with a previous study comparing 
baseline cytokine mRNA levels in unstimulated whole blood samples from tuberculosis seropositive and 
seronegative elephants (Landolfi et al, 2010; Dissertation Chapter 4).  In that study, a trend toward higher 
levels of TNF- in the seropositive group was evident though statistically significant differences were 
absent, and it was postulated that absence of stimulation accounted for lack of statistically significant 
differences.  Findings of the current study indicate that mitogen/antigen stimulation is effective at 
inducing TNF- expression by elephant PBMCs, and that tuberculosis positive samples produce higher 
levels.  In human studies that have evaluated systemic TNF- levels, elevated and decreased levels have 
been documented following mycobacterial antigen stimulation of PBMCs from patients as compared with 
healthy controls (Al-Attiyah, 2006; Hussain et al, 2002; Kellar et al, 2011; Kim et al, 2012; Wang et al. 
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2012).  With mycobacterial infection, the contribution of TNF- to local immunity is well-established.  This 
cytokine is required for granuloma formation and maintenance.  However, excess TNF- has been linked 
with tissue damage and pulmonary necrosis in mouse models of human pulmonary tuberculosis (Ehlers, 
2003).  Thus, the contribution of TNF- to tuberculosis local immunity is multifaceted and imbalance in 
absolute or relative levels of this cytokine may influence disease course.  The significance of this cytokine in 
the systemic immune response to mycobacterial infection is less well understood.  Tumor necrosis factor- 
participates in mediation of the systemic inflammatory acute phase response.  This response is considered 
nonspecific and may be initiated by a variety of insults.  In addition, a prolonged acute phase response may 
be detrimental to the host (Abbas and Lichtman, 2003).   
 Elevated systemic TNF- levels in tuberculosis positive elephants could be a nonspecific 
component of systemic inflammation associated with infection, or alternatively, the manifestation of a 
Mycobacterium spp. specific prolonged acute phase response.  In either case, tuberculosis positive as 
compared to tuberculosis negative elephants appeared to exhibit exaggerated TNF- expression in response 
to mycobacterial antigen stimulation.  Similar to IL-12, lack of differences in TNF- levels between the 
groups with ConA stimulation indicated results could not be attributed to nonspecific hyper-reactivity in 
the positive group.  In contrast to IL-12, however, there was no difference in TNF- expression between 
samples from positive or negative elephants in response to nontuberculous mycobacterial antigen (PPD-A) 
providing evidence that the response noted to CFP-10 and PPD-B was indeed M. tuberculosis antigen 
specific.   Though differences in systemic TNF- levels between positive and negative elephants seem 
compelling, TNF- is first and foremost a nonspecific mediator of the innate immune response.  Overall 
health and/or any concurrent disease have the potential to influence TNF- levels in both positive and 
negative elephants (Landolfi et al, 2010).  Consideration of such information would be essential for accurate 
interpretation of TNF- levels for the purpose of tuberculosis diagnosis or treatment monitoring in 
elephants.  
 In the current study, IFN- mRNA could not be detected in the majority of unstimulated sample 
aliquots.  Similar findings were noted in the previous study comparing baseline cytokine mRNA levels in 
unstimulated whole blood samples from tuberculosis seropositive and seronegative elephants (Landolfi et 
al, 2010; Dissertation Chapter 4).  In a subset of those samples, detection of IFN- required design of a 
new assay with improved sensitivity.  In the current study, levels of IFN- mRNA in unstimulated sample 
aliquots were still below the threshold of detection despite enhanced sensitivity of the new assay.  These 
findings suggested baseline systemic levels of IFN- mRNA in Asian elephants are normally very low.  
Inability to measure IFN- levels in the unstimulated sample aliquots precluded conventional calculation of 
fold difference using the Pfaffl method.  Alternatively, normalized cytokine Ct values (cytokine average Ct  
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- HKG average Ct) were determined for each of the culture stimulants and compared between the two 
groups.  Comparison of IFN- normalized, raw Ct values from PPD-B and CFP-10 stimulated sample 
aliquots revealed significant differences between positive and negative groups.  Values of IFN- were 
lower in the positive samples (Fig 7.5, Table 7.6).   Because lower normalized Ct values correlate with 
higher mRNA levels within samples, results indicated increased IFN- expression was present in the 
positive elephant samples.  
Many human studies have documented lower IFN- levels in stimulated samples from patients as 
compared with healthy controls (Bhattacharyya et al, 1999; Demissie et al, 2004; Hussain et al, 2002; 
Sanchez et al, 1994; Seah and Rook, 2001; Torres et al, 1999).  Fewer human studies have found higher 
levels of IFN- in patients than controls (Al-Attiyah et al, 2006; Demissie et al, 2004).  Presumably, this 
discrepancy among human studies is a consequence of duration of infection at the time of cytokine 
evaluation.  In both susceptible and resistant humans, the initial immune response following infection is 
characterized by TH1 domination that includes elevated IFN- levels.  In the resistant individuals, this 
response is persistent and prevents active disease.  In fact, human IFN--release assays (i.e. QuantiFERON® 
GOLD) used for the diagnosis of latent tuberculosis rely on detection of this appropriate TH1 immune 
response by measuring IFN- production in blood samples following mycobacterial antigen stimulation.  In 
susceptible individuals, however, initial robust TH1 responses dwindle resulting in relative TH2 dominance 
and disease progression (Boussiotis et al, 2000; Dlugovitzky et al, 1997; Flynn and Chan, 2001; Raja, 2003; 
Kaufmann et al, 2005).  It is likely that disease stage similarly affects the elephant immune response to 
tuberculosis.   
In elephants, mycobacterial infection is a chronic, subclinical disease that typically only manifests 
in aged and/or otherwise stressed individuals (Mikota and Maslow, 2011; Mikota et al, 2001; Schmitt, 
2003).  The nature of the disease in elephants and limitations of current elephant tuberculosis diagnostics 
impair accurate identification of disease stage in this species (Greenwald et al, 2009; Larsen et al, 2005; 
Lyashchenko et al, 2012; Lyashchenko et al, 2006; Mikota et al, 2006).  Consequently, parallels to human 
tuberculosis immunopathogenesis reliant upon clinical manifestations of disease alone are difficult to 
extrapolate to elephants.  Currently, elephants with positive trunk wash mycobacterial culture are considered 
to have “active” disease, regardless of presence or absence of clinical signs.  Culture negative, seropositive 
animals have been categorized as “latently” infected.  In the current study, application of these designations 
divided the positive group into culture positive (“active”) and culture negative, seropositive (“latent”) 
subgroups.  Evaluation of the data in light of these subgroups revealed distinct and more pronounced trends 
in IL-12 and, to a lesser extent, IFN- levels (Figs 7.6a and 7.6b).  For IL-12, no overlap existed between 
fold difference values of the four culture positive samples and the negative samples following both PPD-B 
 115 
and CFP-10 stimulation.  With PPD-B stimulation, fold difference values for the culture positive samples 
were among the highest of all samples, and three of the four were 2-3 times higher than any of the culture 
negative, seropositive samples.  For IFN-, similar though less pronounced trends were apparent.    
 Stimulation of elephant PBMCs with mycobacterial antigen did not result in significant expression 
or suppression of TGF-, and no difference in TGF- levels were detected between the positive and 
negative groups.  Results suggest TGF- may not be an integral component of the elephant systemic 
immune response to tuberculosis.  Alternatively, expression may be disease stage dependent.  More potent 
stimuli, potentially associated with an advanced disease course, may be required to affect production of this 
cytokine. 
 Levels of IL-4 and IL-10 mRNA were undetectable in the majority of unstimulated and stimulated 
elephant PBMC culture aliquots prohibiting further examination of potential differences in expression of 
these cytokines between the positive and negative groups.  Lack of amplification indicated cytokine mRNA 
levels were below the sensitivities of the assays.  In previous studies, these same assays were able to detect 
both IL-4 and IL-10 in RNA extracted from unstimulated, elephant peripheral whole blood samples 
(Landolfi et al, 2010; Landolfi et al, 2009; Dissertation Chapters 2 and 4).  With the whole blood samples, 
extraction yielded higher amounts of total RNA as compared with PBMC culture samples and thus total 
RNA levels may have been insufficient.  Similar discrepancies in RNA extraction yields from whole blood 
and PBMC culture samples have been found in human studies (Dheda et al, 2004).   
 Significant differences in proliferative responses between the two groups were apparent following 
stimulation with both ConA and PPD-B.  Stimulation resulted in greater proliferation of positive samples.  
Though differences in proliferative responses following ConA stimulation suggested some degree of 
nonspecific, hyper-reactivity may have been present in the positive group, the calculated U value for ConA 
(12) was much higher than the calculated U value for PPD-B (0; Table 7.4).  These results suggested 
responses following PPD-B stimulation were not due solely to nonspecific hyper-reactivity in the positive 
samples.  Additionally, no significant difference between the groups was noted following PPD-A 
stimulation suggesting the proliferative response with PPD-B stimulation was specific.  In humans with 
manifestations of advanced tuberculosis-related disease or general immune compromise, evaluation of 
systemic cytokine levels, specifically IFN-, has been shown to have diminished diagnostic sensitivity (Lee 
et al, 2012).  In such cases, evaluation of additional parameters may be necessary for reliable diagnosis.  
Elephant study results indicate lymphocyte proliferative response may be another valuable parameter to 
evaluate in cases of confirmed or suspected elephant tuberculosis.  Further studies, potentially employing 
new methodologies (i.e. Flow-cytometric Assay for Specific Cell-mediated Immune-response in Activated 
whole blood [FASCIA]) could be useful to better define elephant PBMC proliferative responses with 
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tuberculosis and aid in discrimination between recent infection, active disease, latent disease, and 
immunological memory of previous exposure (Borgstrom et al, 2011). 
 The findings of this study add to the foundation of knowledge on elephant tuberculosis 
immunopathogenesis.  In addition, these results provide validation of PBMC culture techniques for use in 
evaluation of elephant immune responses.  Documentation of differences in functional responses of 
PBMCs between tuberculosis positive and negative elephants represents the first step towards not only 
obtaining a better understanding of immunopathogenesis of this disease but also development of new and 
valuable diagnostic and treatment monitoring options.  Measurement of cell-mediated immune responses 
evidenced by cytokine production of PBMCs following mycobacterial antigen stimulation is the 
mechanism behind current human first line tuberculosis screening tests (i.e. QuantiFERON

 GOLD).  
These tests are preferred over traditional tuberculin skin tests for screening in humans due to their high-
sensitivity and availability of rapid results (Pai et al, 2008).  A similar test developed for use in elephants 
could be invaluable for facilitating early diagnosis based on measurement of a cell-mediated immune 
response, confirming serodiagnostic results, and providing an additional tool for prospective treatment 
monitoring.  In order to move towards the creation of such a test for use in elephants, additional research 
needs to confirm that equivalent results achieved by the current study utilizing PBMC samples can be 
obtained with elephant whole blood samples. 
In addition to evaluating immune functional responses in mycobacterial antigen stimulated 
elephant whole blood samples, future directions inspired by this work should include prospective 
monitoring of systemic cytokine levels in living tuberculosis positive individuals.  Prospective monitoring 
could be achieved in stimulated PBMC samples using protocols established and validated in this study, or 
alternatively, in stimulated whole blood samples if research indicates results are equivalent.  Prospective 
monitoring of systemic cell-mediated immune responses using these techniques could provide 
information about response to treatment in individuals undergoing therapy.  Additionally, analysis of 
trends in cytokine expression over time facilitated by prospective monitoring may be a viable and 
objective way to establish some relevant definitions of tuberculosis disease stages in this species.  Such 
tools and techniques will be essential to the continued study of this and other diseases in elephants.  
Persistent and innovative directed research will be the key to elucidating elephant tuberculosis susceptibility 
for the long-term conservation of this charismatic and endangered species.  
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7.7: Tables and figures 
 
Table 7.1: Newly developed, Asian elephant-specific IL-12 real time RT-PCR assay 
 
Primers F: 
443
ATGCAAAGCTTTTGATGGACC
463 
R: 
517
AAATTCAGGGCCTGCAT
533 
Probe 
491
ACATGTTGGCAGCTAT
506
 
Standard curve slope 96% 
Efficiency -3.43 
Sensitivity 34.4  dsDNA copies 
 
Legend: Postulated intron-exon junction site is within the amplicon but is not within the primer or probe 
sequence.   All primer/probe sequences are listed 5’ to 3’.  F = forward primer; R = reverse primer.  
Superscript numbers refer to the location of the primers/probe within the Asian elephant sequence 
(Genbank accession numbers FJ423100 - FJ423103).  Efficiency is calculated as 10
(-1/slope)
 -1.  Sensitivity 
represents the minimal detectable number of dsDNA copies within 10 µl of sample (copy number = [ng 
DNA * 6.022x10
23
] / [length (bps) * 1x10
9
 ng/g * 650 g/mole of bps]).  DNA concentration was 
determined via spectrophotometry. 
 
Table 7.2: Asian elephant demographic information and tuberculosis status 
 
Sample Sex Age (years) Culture
*
 STAT-PAK
†
 MAPIA
‡
 Concurrent 
conditions 
1 F 37 + + + SA
**
 
2 F 40 + + + None 
3 F 60 + + + OA
††
; SA 
4 F 41 + - Inconclusive None 
5 M 29 - + + OA; SA 
6 F 35 - + + OA; SA 
7 F 44 - + + OA; SA 
8 F 44 - + + OA 
9 F 12 - - NA None 
10 F 22 - - NA None 
11 F 38 - - NA None 
12 F 38 - - NA OA 
13 F 40 - - NA OA; SA 
14 F 40 - - NA OA; SA 
15 F 41 - - NA None 
16 F 45 - - NA OA; SA 
 
* Mycobacterial culture of trunk wash sample; † Elephant TB STAT-PAK® serologic test; ‡ Multiple 
antigen print immunoassay; ** SA =  pedal sole abscess; †† OA = osteoarthritis 
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Table 7.3: Proportion of lymphocytes and monocytes in Asian elephant whole blood smears 
 
Sample TB Status % Lymphocytes % Monocytes Lymphocytes/ 
Monocytes 
1 + 25 32 0.781 
2 + 31 20 1.550 
3 + 30 21 1.429 
4 + 30 21 1.429 
5 + 20 24 0.833 
6 + 34 27 1.259 
7 + 39 25 1.560 
8 + 26 21 1.238 
9 - 22 26 0.846 
10 - 34 29 1.172 
11 - 36 24 1.500 
12 - 32 22 1.455 
13 - 32 30 1.067 
14 - 27 27 1.000 
15 - 24 27 0.889 
16 - 30 20 1.500 
 
Table 7.4: Mann-Whitney U test results for differences in stimulation indices of PBMC cultures from 
tuberculosis positive and negative Asian elephants 
 
Stimulant* Calculated U value 
ConA 12** 
PPD-B 0** 
CFP-10 13 
PPD-A 16 
 
* ConA = concanavalin A; PPD-B = Mycobacterium bovis purified protein derivative; CFP-10 = M. 
tuberculosis culture filtrate protein 10; PPD-A = M. avium purified protein derivative.  ** Statistically 
significant; Ucritical ( = 0.005) = 7, Ucritical ( = 0.025) = 13. 
 
Table 7.5: Determination of appropriate housekeeping gene (HKG) for normalization of Asian elephant 
PBMC culture real time PCR data 
 
HKG CtUnstimulated – 
CtConA 
CtUnstimulated – 
CtPPD-B 
CtUnstimulated – 
CtCFP-10 
CtUnstimulated – 
CtPPD-A 
GAPDH 2.24 1.69 1.70 1.50 
Beta actin 2.30 1.81 1.34 1.77 
18S rRNA 1.60 1.13 1.28 1.17 
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Table 7.6: Mann-Whitney U test results for differences in cytokine mRNA expression in PBMC cultures 
from tuberculosis positive and negative Asian elephants 
 
Cytokine UConA UPPD-B UCFP-10 UPPD-A 
TNF- 26 11* 8.5* 20 
TGF- 22 24 15 30 
IL-12 32 9* 8* 11* 
IFN- 9* 9* 2** 15 
 
Legend: For TNF-, TGF-, and IL-12, differences in calculated cytokine mRNA fold difference values 
between positive and negative groups were examined.  For IFN-, differences in cytokine normalized 
average Ct values (IFN- average Ct – 18S average Ct) between positive and negative groups were 
examined.  * Statistically significant at  = 0.025; ** Statistically significant  at  = 0.005 
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Figure 7.1: Proliferation of PBMCs in tuberculosis positive and negative Asian elephants following 
stimulation with mitogen and mycobacterial antigens  
 
 
Fig. 7.1: Graph depicts proliferative response as measured by stimulation index of Asian elephant 
PBMCs following stimulation in culture.  Positive samples were from animals with positive trunk wash 
mycobacterial culture and/or seropositivity with both the Elephant TB STAT-PAK
®
 and MAPIA tests. 
ConA = concanavalin A; PPD-B = Mycobacterium bovis purified protein derivative; CFP-10 = M. 
tuberculosis culture filtrate protein 10; PPD-A = M. avium purified protein derivative.  Asterisks denote 
stimulants for which stimulation indices were significantly different between positive and negative 
groups.  
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Figure 7.2a: Expression of tumor necrosis factor- by PBMCs from tuberculosis positive and negative 
Asian elephants following stimulation with mitogen and mycobacterial antigens  
 
Figure 7.2b: Expression of tumor necrosis factor- by PBMCs from tuberculosis positive and negative 
Asian elephants following stimulation with mycobacterial antigens  
 
Figs. 7.2a/2b: Graphs depict cytokine levels as measured by mRNA fold difference of Asian elephant 
PBMCs following stimulation in culture.  Positive samples were from animals with positive trunk wash 
mycobacterial culture and/or seropositivity with both the Elephant TB STAT-PAK
®
 and MAPIA tests. 
ConA = concanavalin A; PPD-B = Mycobacterium bovis purified protein derivative; CFP-10 = M. 
tuberculosis culture filtrate protein 10; PPD-A = M. avium purified protein derivative.  Asterisks denote 
stimulants for which fold difference values were significantly different between positive and negative 
groups.  
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Figure 7.3: Expression of interleukin-12 by PBMCs from tuberculosis positive and negative Asian 
elephants following stimulation with mitogen and mycobacterial antigens  
 
Fig. 7.3: Graph depicts cytokine levels as measured by mRNA fold difference of Asian elephant PBMCs 
following stimulation in culture.  Positive samples were from animals with positive trunk wash 
mycobacterial culture and/or seropositivity with both the Elephant TB STAT-PAK
®
 and MAPIA tests. 
ConA = concanavalin A; PPD-B = Mycobacterium bovis purified protein derivative; CFP-10 = M. 
tuberculosis culture filtrate protein 10; PPD-A = M. avium purified protein derivative.  Asterisks denote 
stimulants for which fold difference values were significantly different between positive and negative 
groups.  
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Figure 7.4: Expression of transforming growth factor- by PBMCs from tuberculosis positive and 
negative Asian elephants following stimulation with mitogen and mycobacterial antigens 
 
Fig. 7.4: Graph depicts cytokine levels as measured by mRNA fold difference of Asian elephant PBMCs 
following stimulation in culture.  Positive samples were from animals with positive trunk wash 
mycobacterial culture and/or seropositivity with both the Elephant TB STAT-PAK
®
 and MAPIA tests. 
ConA = concanavalin A; PPD-B = Mycobacterium bovis purified protein derivative; CFP-10 = M. 
tuberculosis culture filtrate protein 10; PPD-A = M. avium purified protein derivative. 
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Figure 7.5: Expression of interferon- by PBMCs from tuberculosis positive and negative Asian 
elephants following stimulation with mitogen and mycobacterial antigens 
 
Fig. 7.5: Graph depicts IFN- levels, represented by normalized average Ct values, of Asian elephant 
PBMCs following stimulation in culture.  Positive samples were from animals with positive trunk wash 
mycobacterial culture and/or seropositivity with both the Elephant TB STAT-PAK
®
 and MAPIA tests. 
ConA = concanavalin A; PPD-B = Mycobacterium bovis purified protein derivative; CFP-10 = M. 
tuberculosis culture filtrate protein 10; PPD-A = M. avium purified protein derivative.  Asterisks denote 
stimulants for which normalized Ct values were significantly different between positive and negative 
groups.  
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Figure 7.6a: Expression of interleukin-12 by PBMCs from tuberculosis culture positive, seropositive, and 
negative Asian elephants following stimulation with PPD-B and CFP-10 
 
Figure 7.6b: Expression of interferon- by PBMCs from tuberculosis culture positive, seropositive, and 
negative Asian elephants following stimulation with PPD-B and CFP-10 
 
Figs. 7.6a/6b: Graphs depict cytokine levels in Asian elephant PBMCs following stimulation in culture.  
Positive samples were from animals with positive trunk wash mycobacterial culture; seropositive animals 
were culture negative but reactive on both the Elephant TB STAT-PAK
®
 and MAPIA tests.  PPD-B = 
Mycobacterium bovis purified protein derivative; CFP-10 = M. tuberculosis culture filtrate protein 10. 
0
2
4
6
8
10
12
14
Fo
ld
 d
if
fe
re
n
ce
 
NEGATIVE
CULTURE POSITIVE
SEROPOSITIVE
PPD-B CFP-10 
Stimulant 
0
5
10
15
20
25
N
o
rm
a
li
ze
d
 C
t 
v
a
lu
e
 
NEGATIVE
CULTURE POSITIVE
SEROPOSITIVE
PPD-B CFP-10 
Stimulant 
 130 
 
CHAPTER 8: CONCLUSIONS 
8.1: Elephant immunology 
Prior to initiation of this study, information on elephant immune function was extremely limited.  
In the case of tuberculosis, the majority of previous investigations have evaluated character and dynamics 
of elephant humoral immune responses (Greenwald et al, 2009; Larsen et al, 2005; Lyashchenko et al, 
2006; Lyashchenko et al, 2012).  These studies have led to the identification of specific mycobacterial 
protein antigens that elicit humoral responses (Lyashchenko et al, 2006).  Such findings have contributed 
significantly to the field of serodiagnostics through development of new tests that facilitate early detection 
of infection and provide opportunity for treatment monitoring (Greenwald et al, 2009; Lyashchenko et al, 
2006).  As illustrated by the results of previous studies, humoral immunity undoubtedly plays a role in 
tuberculosis pathogenesis in this species.  However, because mycobacteria are intracellular pathogens, 
cell-mediated immune responses are ultimately those responsible for protection against disease (Abbas 
and Lichtman, 2003).  A better understanding of elephant cell-mediated immune function will be required 
to identify factors that contribute to disease susceptibility in tuberculosis and other similar infections.  
Consequently, one of the major goals of the current investigation was to broaden the existing knowledge 
base of elephant immunology, and specifically cell-mediated immunology, not only for elucidation of 
tuberculosis immunopathogenesis but also to improve understanding of elephant immune function in 
general.  Such information is widely applicable to the study of disease pathogenesis as well as normal 
immune function necessary for protection against infectious diseases.  As long as infectious disease 
contributes to the endangered status of the Asian elephant, concerted efforts to achieve better 
understanding of disease pathogenesis in this species will be necessary.  Information and tools discovered 
and developed by this study will be useful to on-going investigations of elephant tuberculosis 
immunopathogenesis.  Importantly, such information and tools can also be applied to the study of other 
important elephant maladies.  The combined understanding of both host and pathogen contribution to 
disease development following infection is a universal theme in the study of infectious disease.  It is the 
interplay of host- and pathogen-mediated effects that determine disease susceptibility, and the balance 
between humoral and cell-mediated components of the immune system that influence disease progression. 
8.2: Summary of study accomplishments 
 Results of this study provide several significant contributions to the fields of both elephant 
tuberculosis immunopathogenesis and general Asian elephant immunology.   
8.2.1: Definition of Asian elephant cytokine and housekeeping gene mRNA sequences 
One major accomplishment was the definition of eight Asian elephant cytokine and two 
housekeeping gene (HKG) mRNA sequences: interleukin (IL)-2, IL-4, IL-10, IL-12, transforming growth 
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factor (TGF)-, tumor necrosis factor (TNF)-, interferon (IFN)-, beta actin and glyceraldehyde 3-
phosphate dehydrogenase (GAPDH).  Prior to the initiation of this work, only partial Asian elephant 
sequences were available for two cytokines (IL-4 and IFN-); African elephant (Loxodonta africana) 
partial mRNA sequences existed for the HKG, GAPDH, and TNF-.  Sequence information determined 
by this study may be utilized for genetic analyses and/or to facilitate comparison with cytokine genes of 
other species.  This information is also applicable to the development of various molecular tests.  Such 
tests may facilitate infection diagnosis, disease monitoring, and/or elucidation of factors involved in 
susceptibility.  For this study, cytokine and HKG sequence information was utilized for the development 
of Asian elephant specific, real time RT-PCR assays and in situ hybridization (ISH) riboprobes.    
8.2.2: Development of Asian elephant-specific cytokine real time RT-PCR assays 
Another significant contribution of this study was the development and validation of Asian 
elephant-specific real time RT-PCR assays for interleukin IL-2, IL-4, IL-10, IL-12, TGF-, TNF-, IFN-
, beta actin and GAPDH.  Development of these molecular assays provided a means for measuring 
cytokine levels in samples from elephants, exotic species for which validated commercial reagents, such 
as antibodies for use in enzyme-linked immunosorbent assays (ELISA), are not available.   The elephant-
specific cytokine real time RT-PCR assays were used to evaluate differences in cytokine expression in 
samples from tuberculosis negative and positive animals.  Application of this technology is not limited to 
the study of tuberculosis, however.  The elephant specific, real time RT-PCR assays could be used to 
characterize immune responses of elephants in health or various other states of disease.  In fact, a portion 
of this study involved characterization of cytokine expression in healthy tuberculosis negative elephants 
to establish baseline information on cytokine expression in Asian elephants.  Results of these experiments 
showed that variance in baseline cytokine levels within multiple peripheral blood samples from individual 
elephants was lower than variance in levels among samples from different elephants.  This finding 
suggested that normal variation in baseline cytokine levels of individual elephants was not of sufficient 
magnitude to preclude identification of significant differences between animals.  These experiments also 
indicated that cytokine level variance among normal Asian elephants was negligible in the cases of most 
analyzed cytokines for which sufficient mRNA amplification data was available. 
8.2.3: Validation and optimization of standard in situ hybridization and peripheral blood mononuclear 
cell culture techniques for use with elephant samples 
 Prior to undertaking this study, previously published reports successfully utilizing ISH or 
peripheral blood mononuclear cell culture (PBMC) techniques with elephant samples did not exist.  A 
significant accomplishment of this work was validating and optimizing these techniques for use with 
elephant samples.  The protocols that were developed are available for use in future related as well as 
unrelated investigations into elephant infectious disease and immunology. 
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8.2.4: Morphologic description of Asian elephant pulmonary tuberculosis lesions 
Though tuberculosis has been recognized as an important disease in captive elephants for more 
than two decades, published descriptions of the histologic lesions associated with disease do not exist.  
Through this work, the histopathology of Asian elephant pulmonary tuberculosis lesions was 
documented.  Additionally, examination of the elephant lesions revealed a spectrum of morphologic 
changes reminiscent of the distinct manifestations of active and latent pulmonary tuberculosis lesions in 
humans and non-human primates (Fuller et al, 2003; Ulrichs et al, 2005; Ulrichs and Kaufmann, 2006).  
The similarities in lesion morphology noted in the elephant samples to human active and latent lesions 
suggested that the two forms of the disease do exist in this species, and that morphology of lesions may 
provide a means of determining disease stage in the absence of clinical signs or other outward indicators.  
Investigation of lymphocyte subpopulations via CD3 immunohistochemistry within the available archival 
elephant pulmonary tuberculosis lesions revealed that quiescent lesions most consistent with latent 
disease contained the highest numbers of T lymphocytes.  Additionally, ISH experiments showed local 
expression of IFN-, TNF-, and IL-4 in a subset of the elephant lesions.   
8.2.5: Identification of immune functional differences between tuberculosis positive and negative Asian 
elephants 
 Considering the contribution of the host immune response to development and progression of 
disease following infection, a major hypothesis of this work was that detectable differences in immune 
function exist between tuberculosis positive and negative elephants.  Importantly, an inherent difference 
in immune function could be a crucial factor in determining individual disease susceptibility or resistance.  
The experiments comparing PBMC proliferation and cytokine mRNA expression in samples from 
tuberculosis positive and negative Asian elephants, following mycobacterial antigen stimulation, 
confirmed that differences in these functional responses do exist.  Samples from the positive elephants 
had enhanced proliferation and increased levels of IL-12 and TNF-.  Results also showed that similar 
increased expression of IFN- in samples from positive elephants might also occur.  These findings were 
only noted following stimulation of samples with mycobacterial antigen.  Measurement of baseline 
cytokine levels in RNA-preserved, unstimulated whole blood samples from tuberculosis positive and 
negative elephants revealed no significant differences in cytokine mRNA levels between the groups.   
 Elevated levels of IL-12, TNF-, and IFN-, all TH1 type cytokines, in the positive elephants 
were not in agreement with many of the previous human studies that have evaluated levels of TH1 and 
TH2 cytokines in tuberculosis patients compared with healthy, in-contact controls.  In human disease, 
susceptibility to active infection has been linked to imbalance in systemic levels of TH1 and TH2 cytokines 
that typically manifests with diminished TH1 and relatively elevated TH2 levels (Bhattacharyya et al, 
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1999; Boom et al, 2003; Flynn and Chan, 2001; Kaufmann et al, 2005; Kellar et al, 2011; Raja, 2003; 
Wang et al, 2012).  Similar imbalance in systemic humoral and cell-mediated immune responses was 
postulated to contribute to elephant tuberculosis susceptibility.  In human disease, distinctions between 
responses in latently detected and clinically manifest infection are believed to provide the key to 
susceptibility (Flynn and Chan, 2001; Raja, 2003).  Parallels do not exist for elephants, because disease is 
typically subclinical and, latent disease detection is currently unreliable (Mikota et al, 2001; Mikota and 
Maslow, 2011).  In the case of elephants, identification of disease stage based upon clinical 
manifestations as done in humans is not possible.  Yet because assessment of susceptibility is reliant upon 
the progression of the immune response over time, information on stage of infection is needed.  Though 
this study was able to identify specific differences in immune functional responses between tuberculosis 
positive and negative elephants, evaluation of these findings in the context of disease stage and further 
examination of how such differences may contribute to systemic TH1/TH2 imbalance should be a goals of 
future research. 
8.3: Future directions 
 The information on tuberculosis immunopathogenesis gained by this study represents a 
foundation for investigation of the immune response to this disease in elephants.  The results indicate that 
distinguishing features do exist in systemic immune responses between positive and negative animals and 
among pulmonary lesions of positive animals.  Much of the impediment to definitive interpretation of 
results to date can be attributed to deficiency of knowledge regarding disease stage in positive animals.  
Persistent and diligent study of elephant tuberculosis has brought about recent advances in both 
diagnostics and treatment.  Such advancements may eventually lead to more accurate clinical 
characterizations of infected individuals, as currently disease stage can only be assessed postmortem 
(retrospectively) as described in this study.  As more information is gained, and disease stage can be 
realized more precisely, the significance of noted differences in immune responses between positive and 
negative individuals will become clearer. 
 Based upon the results of histologic evaluation of archival elephant pulmonary tuberculosis 
lesions, important information could be gained by more systematic examination of postmortem lung 
samples collected from positive elephants during future necropsies.  To facilitate comparison among 
samples, standardized sample collection procedures and submission of materials to a coordinating 
veterinary pathologist for evaluation would be recommended.  Descriptive information regarding the 
morphology and character of lesions within affected tissues from individual elephants and among 
different elephants could then be compiled and compared.  This additional prospective data could help 
determine the potential significance of variations in lesion morphology, particularly with respect to 
correlation with disease stage as noted in human and non-human primate tuberculosis lesions. 
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 Documentation of differences in functional responses of PBMCs between tuberculosis positive 
and negative elephants provided by this study represents the first step towards not only obtaining a better 
understanding of immunopathogenesis of this disease but also development of new and valuable 
diagnostic and treatment monitoring options.  Measurement of cell-mediated immune responses 
evidenced by cytokine production of PBMCs following mycobacterial antigen stimulation is the 
mechanism behind current human first line tuberculosis screening tests (i.e. QuantiFERON

 GOLD).  
These tests are preferred over traditional tuberculin skin tests for screening in humans due to their high-
sensitivity and availability of rapid results (Pai et al, 2008).  A similar test developed for use in elephants 
could be invaluable for facilitating early diagnosis based on measurement of a cell-mediated immune 
response, confirming serodiagnostic results, and providing an additional tool for prospective treatment 
monitoring.  In order to move towards the creation of such a test for use in elephants, additional research 
needs to confirm that equivalent results achieved by the current study utilizing PBMC samples can be 
obtained with elephant whole blood samples.  Isolation and culture of PBMCs is a labor-intensive 
technique most suited for a research setting.  In order to have practical diagnostic utility, significant 
differences in immune functional responses between tuberculosis positive and negative elephants must be 
detectable in antigen stimulated whole blood samples.   
In addition to evaluating immune functional responses in mycobacterial antigen stimulated 
elephant whole blood samples, future directions inspired by this work should include prospective 
monitoring of systemic cytokine levels in living tuberculosis positive individuals.  Prospective monitoring 
could be achieved in stimulated PBMC samples using protocols established and validated in this study, or 
alternatively, in stimulated whole blood samples if research indicates results are equivalent.  Use of 
unstimulated whole blood samples, however, will not be adequate as the results of this study indicated no 
significant differences exist in baseline systemic cytokine levels between samples from tuberculosis 
positive and negative elephants.  Prospective monitoring of systemic cell-mediated immune responses 
using these techniques could provide information about response to treatment in individuals undergoing 
therapy.  Additionally, analysis of trends in cytokine expression over time facilitated by prospective 
monitoring may be a viable and objective way to establish some relevant definitions of tuberculosis 
disease stages in this species.  
Each advancement achieved by this study has prompted additional questions and highlighted the 
challenges of working with this species.  Though results gained by this work have established a solid 
foundation for the continued investigation of elephant tuberculosis immunopathogenesis, much remains 
to be learned.  Additional and on-going investigations are necessary to further understanding of 
tuberculosis pathogenesis in elephants for the benefit of human and individual animal health as well as the 
long-term conservation of this endangered species.  
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Appendix 
A.1: Dose response data for proliferation of elephant peripheral blood mononuclear cells with mitogen 
and mycobacterial antigen stimulation 
For proliferation assays (as described in Chapter 7, Section 7.3.3), in addition to stimulation with 
the optimal concentration (20 g/ml) of tested mycobacterial antigens (PPD-B, CFP-10, and PPD-A), 
elephant PBMC culture samples were also simultaneously incubated in the presence of each 
mycobacterial antigen at a lower concentration (5 g/ml) to provide documentation of a dose dependent 
response to stimulation.  Dose response to mitogen stimulation was confirmed as well by simultaneous 
incubation of samples with low, optimal, and high concentrations of ConA (1.5, 6, and 24 g/ml, 
respectively).  Stimulation indices were determined for each tested concentration of mycobacterial 
antigen and ConA in all samples as previously described.  Dose dependent stimulation was achieved with 
all tested mycobacterial antigens and ConA; results are presented in the following figures.  
A.2: Dose response figures for proliferation assays 
A.2.1: Dose response for proliferation of Asian elephant PBMCs following stimulation with concanavalin 
A 
  
 
Legend: Graph depicts proliferative response as measured by stimulation index of Asian elephant 
PBMCs following stimulation in culture.  Positive samples are represented by light gray data points and 
lines; negative samples are represented by dark gray data points and lines. 
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A.2.2: Dose response for proliferation of Asian elephant PBMCs following stimulation with 
Mycobacterium bovis purified protein derivative 
 
 
Legend: Graph depicts proliferative response as measured by stimulation index of Asian elephant 
PBMCs following stimulation in culture.  Positive samples are represented by light gray data points and 
lines; negative samples are represented by dark gray data points and lines. 
 
A.2.3: Dose response for proliferation of Asian elephant PBMCs following stimulation with 
Mycobacterium tuberculosis culture filtrate protein-10 
   
 
Legend: Graph depicts proliferative response as measured by stimulation index of Asian elephant 
PBMCs following stimulation in culture.  Positive samples are represented by light gray data points and 
lines; negative samples are represented by dark gray data points and lines. 
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A.2.4: Dose response for proliferation of Asian elephant PBMCs following stimulation with 
Mycobacterium avium purified protein derivative 
 
 
Legend: Graph depicts proliferative response as measured by stimulation index of Asian elephant 
PBMCs following stimulation in culture.  Positive samples are represented by light gray data points and 
lines; negative samples are represented by dark gray data points and lines. 
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